&/,1,&$/75,$/[ZIP_CODE]&2/
6WXG\7LWOH$3KDVH0XOWLFHQWHU5DQGRPL]HG'RXEOHÂ±
0DVNHGDQG3ODFHERÂ±&RQWUROOHG6WXG\
(YDOXDWLQJWKH(IILFDF\DQG6DIHW\RI+/2SKWKDOPLF6ROXWLRQ&RPSDUHGWR
3ODFHERLQ6XEMHFWVZLWK'U\(\H
3URWRFRO1XPEHU +/'('863
'HYHORSPHQW3KDVH 3KDVH
,QYHVWLJDWLRQDO3URGXFW +/2SKWKDOPLF6ROXWLRQ
,1'1XPEHU 
,QGLFDWLRQ 'U\(\H'LVHDVH
,QYHVWLJDWRUV 0XOWLFHQWHUHG8SWRVLWHV
6SRQVRU+DQ$OO%LRSKDUPD&R/WG
'DH:RRQJ%XLOGLQJ)O
%RQJHXQVDURJLO6HRXO*DQJQDPJX
6RXWK.RUHD
&RQWUDFW5HVHDUFK2UJDQL]DWLRQ2UD,QF
%ULFNVWRQH6TXDUHUG)ORRU
$QGRYHU0$
+DQ$OO%LRSKDUPDÂ¶V5HVSRQVLEOH
0HGLFDO2IILFHU
'LUHFWRU3URGXFWDQG% XVLQHVV'HYHORSPHQW
+3,,QF+DQ$OO%LRSKDUPD&R/WG
&KXUFK6W6XLWH
5RFNYLOOH0'86$
,5%,(&$OSKD,5%
$YHQLGD3LFR
6XLWH&6DQ&OHPHQWH&$
86$
'DWHRI3URWRFRO
2ULJLQDO3URWRFRO-DQ
6WDWHPHQWRI&RPSOLDQFHZL WK*RRG&OLQLFDO3UDFWLFH
7KLVVWXG\ZLOOEHSHUIRUPHGLQFRP SOLDQFHZLWKWKHHWKLFDOSUL QFLSOHVRIWKH'HFODUDWLRQ
RI+HOVLQNLDQGWKH,QWHUQDWLRQD O&RQIHUHQFHRQ+DUPRQL]DWLRQ ,&++DUPRQL]HG
7ULSDUWLWH*XLGHOLQHIRU*RRG& OLQLFDO3UDFWLFH*&3
&RQILGHQWLDOLW\6WDWHPHQW
7KLVSURWRFROLVFRQILGHQWLDOD QGWKHLQIRUPDWLRQDYDLODEOHZLW KLQLWPD\QRWEH
UHSURGXFHGRURWKHUZLVHGLVVHPLQDWHGHL036 Ophthalmic Solution 
Clinical Study Protocol HL036-DED-US-P301Sponsor: HanAll Biopharma, Co., Ltd. 
24 January 2019
Confidential Page 1
63216253([ZIP_CODE](/
+HDG%LR5HVHDUFK&HQWHU 

'LUHFWRU3URGXFWDQG%XVLQHVV'HYHORSPHQW+3,,QF

$OOLDQFH$GYLVRU3URGXFWDQG%XVLQHVV'HYHORSPHQW+3,,QF


$VVLVWDQW0DQDJHU3URGXFWDQG%XVLQHVV'HYHORSPHQW+3,,QF

0HGLFDO$GYLVRU3UR GXFWDQG%XVLQHVV
'HYHORSPHQW+3,,QF 

0DQDJHU&OLQLFDO'HYHORSPHQW


0(',&$/021,725
0HGLFDO0RQLWRU


HL036 Ophthalmic Solution 
Clinical Study Protocol HL036-DED-US-P301Sponsor: HanAll Biopharma, Co., Ltd. 
24 January 2019
Confidential Page 2
25$3([ZIP_CODE](/
'HSDUWPHQW9LFH3UHVLGHQW


'HSDUWPHQW'LUHFWRU

&OLQLFDO3URMHFW0DQDJHU



HL036 Ophthalmic Solution 
Clinical Study Protocol HL036-DED-US-P301Sponsor: HanAll Biopharma, Co., Ltd. 
24 January 2019
Confidential Page 3
6<1236,6 
1$0(2)&203$1<
+DQ$OO%LRSKDUPD&R/WG
'DH:RRQJ%XLOGLQJ)O
%RQJHXQVDURJLO
6HRXO*DQJQDPJX
6RXWK.RUHD1$0(2)'58*352'8&7
+/2SKWKDOPLF6ROXWLRQIRU7UHDWPHQWRI'U\
(\H

7,7/(2)678'< 
$3KDVH0XOWLFHQWHU5DQGRPL]HG'RXEOHÂ±0DVNHGDQG3ODFHERÂ±& RQWUROOHG6WXG\(YDOXDWLQJWKH
(IILFDF\DQG6DIHW\RI+/2SKWKDOPLF6ROXWLRQ&RPSDUHG WR3ODFHERLQ6XEMHFWVZLWK'U\(\H
[ZIP_CODE]&2/180%(5  +/'('863
678'<6,7(6 0XOWLFHQWHUVWXG\LQYROYLQJXSWRVLWHVORFDWHGLQWKH8QLWH G6WDWHV
678'<3(5,2' 
$SSUR[LPDWHO\GD\V3+$6(2)'(9(/230(17
3KDVH
678'<)2508/$7,216 +/2SKWKDOPLF6ROXWLRQ
3ODFHER9HKLFOH6ROXWLRQ 
2%-(&7,9(
7KHREMHFWLYHRIWKLVVWXG\LVWRFRPSDUHWKHVDIHW\DQGHIILFD F\RI+/2SKWKDOPLF6ROXWLRQWR
SODFHERIRUWKHWUHDWPHQWRIWKHVLJQVDQGV\PSWRPVRIGU\H\H 
'26(5287($1'5(*,0(1
6FUHHQLQJ'XULQJWKHGD\Â“GD\VUXQLQSHULRGRSHQÂ±ODE HOSODFHERRFXODUGURSVZLOOEHVHOIÂ±
DGPLQLVWHUHGWZLFHGDLO\%,'LQERWKH\HVLQWKHPRUQLQJDQG WKHHYHQLQJE\DOOVXEMHFWV
7UHDWPHQW'XULQJWKHÂ±ZHHNÂ“GD\VWUHDWPHQWSHULRG +/2SKWKDOPLF6ROXWLRQRU
SODFHERRSKWKDOPLFVROXWLRQZLOOEHVHOIDGPLQLVWHUHG%,'E\EL ODWHUDOWRSLFDORFXODUGRVLQJ6XEMHFWVZLOO
EHUDQGRPL]HGWRRQHRIWZRWUHDWPHQWDUPVWRUHFHLYHVWX G\GUXJVHOIDGPLQLVWHUHGE\VXEMHFWDIWHU
WKH3RVWÂ±2UD&RQWUROOHG$GYHUVH(QYLURQPHQWÂŠ&$(DVVHVVPHQWVDW9LVLW
'85$7,212)75($70(17 
$SSUR[LPDWHO\GD\VZHHNV
5()(5(1&(7+(5$3<'26(5287($1'5(*,0(1 
2SHQÂ±ODEHOSODFHERRSKWKDOPLFVRO XWLRQSODFHERZLOOEHSURYLG HGWRVXEMHFWVIURP'D\Â±WR'D\
3ODFHERRFXODUGURSVZLOOEHVHOIÂ±DGPLQLVWHUHG%,'LQERWKH\HV LQWKHPRUQLQJDQGWKHHYHQLQJ
)ROORZLQJUDQGRPL]DWLRQSODFHERZLOOEHGRVHGDFFRUGLQJWRWKH VDPHVFKHGXOHDVWKH+/2SKWKDOPLF
6ROXWLRQ
180%(52)68%-(&763/$11(' 
$SSUR[LPDWHO\VXEMHFWVZLOOEHHQUROOHGLQWKHVWXG\7KHW RWDOQXPEHURIH[SHFWHGSDUWLFLSDQWV
LQFOXGLQJVFUHHQIDLOXUHVLVDSSUR[LPDWHO\VXEMHFWV
',$*126,6$1'$//&5,7(5,$) 25,1&/86,21$1'(;&/86,21 
,1&/86,21&5,7(5,$
,QGLYLGXDOVHOLJLEOHWRSDUWLFLSDWHLQWKLVVWXG\PXVWPHHWDOO RIWKHIROORZLQJFULWHULD
%HDWOHDVW\HDUVRIDJH
3URYLGHZULWWHQLQIRUPHGFRQVHQW
%HZLOOLQJDQGDEOHWRFRPSO\ZLWKDOOVWXG\SURFHGXUHV
+DYHDSDWLHQWUHSRUWHGKLVWRU\RIGU\H\HIRUDWOHDVWPRQWK VSULRUWR9LVLW
+DYHDKLVWRU\RIXVHRUGHVLUHWRXVHH\HGURSVIRUGU\H\HV\ PSWRPVZLWKLQ RI9LVLWHL036 Ophthalmic Solution 
Clinical Study Protocol HL036-DED-US-P301Sponsor: HanAll Biopharma, Co., Ltd. 
24 January 2019
Confidential Page 4
1$0(2)&203$1<
+DQ$OO%LRSKDUPD&R/WG
'DH:RRQJ%XLOGLQJ)O
%RQJHXQVDURJLO
6HRXO*DQJQDPJX
6RXWK.RUHD1$0(2)'58*352'8&7
+/2SKWKDOPLF6ROXWLRQIRU7UHDWPHQWRI'U\
(\H

+DYHDEHVWFRUUHFWHGYLVXDODFXLW\%&9$RI ORJ0$5RUEHWWHU 6QHOOHQHTXLYDOHQWVFRUHRI
LQHDFKH\HDW9LVLW
5HSRUWDVFRUHRI DFFRUGLQJWRWKH2UD&DOLEUDÂŠ2FXODU'LVFRPI[INVESTIGATOR_13318]	6 \PSWRP4XHVWLRQQDLUHLQ
DWOHDVWRQHRIWKHGU\H\HV\PSWRPVDW9LVLWVDQG
+DYHD6FKLUPHUÂ¶V7HVWVFRUHRIÂ”PPDQGÂ•PPDW9LVLWV DQG
+DYH D FRUQHDO IOXRUHVFHLQ VWDLQLQJ VFRUH RI  DFFRUGLQJ WR WKH 2UD &DOLEUDÂŠ &RUQHDO DQG
&RQMXQFWLYDO6WDLQLQJ6FDOHIRU*UDGLQJRI)OXRUHVFHLQ6WDLQLQJ LQDWOHDVWRQHH\HDW9LVLWVDQG
+DYHDFRQMXQFWLYDOUHGQHVVVFRUH DFFRUGLQJWRWKH2UD&DOLEUD ÂŠ&RQMXQFWLYDO5HGQHVVIRU'U\
(\H6FDOHLQDWOHDVWRQHH\HDW9LVLWVDQGSUH&$(
'HPRQVWUDWHLQWKHVDPHH\HVD UHVSRQVHWRWKH&$(ÂŠDW9LVLWV DQGDVGHILQHGE\
 



+DYHDWOHDVWRQHH\HWKHVDPHH\HVDWLVI\DOOFULWHULDIRU DQGDERYH
$QHJDWLYHXULQHSUHJQDQF\WHVWLIIHPDOHRIFKLOGEHDULQJSRWHQ WLDOWKRVHZKRDUHQRWVXUJLFDOO\
VWHULOL]HG>ELODWHUDOWXEDOOLJDWLRQK\VWHUHFWRP\RUELODWHUDO RRSKRUHFWRP\@RUSRVWÂ±PHQRSDXVDO>
PRQWKVDIWHUODVWPHQVHV@DQGPXVWXVHDGHTXDWHELUWKFRQWURO WKURXJKWKHVWXG\SHULRG)RUQRQ
VH[XDOO\DFWLYHIHPDOHVDEVWLQHQFHPD\EHUHJDUGHGDVDQDGHTX DWHPHWKRGRIELUWKFRQWURO 
(;&/86,21&5,7(5,$
,QGLYLGXDOVZKRPHHWDQ\RIWKHIROORZLQJH[FOXVLRQFULWHULDZL OOQRWEHHOLJLEOHWRSDUWLFLSDWHLQWKHVWXG\
+DYHDQ\FOLQLFDOO\VLJQLILFDQWVOLWODPSILQGLQJVDW9LVLWW KDWPD\LQFOXGHDFWLYHEOHSKDULWLV
PHLERPLDQJODQGG\VIXQFWLRQOLGPDUJLQLQIOD[COMPANY_003]WLRQRUDFWLYH RFXODUDOOHUJLHVWKDWUHTXLUH
WKHUDSHXWLFWUHDWPHQWDQGRULQWKHRSLQLRQRIWKHLQYHVWLJDWR UPD\LQWHUIHUHZLWKVWXG\SDUDPHWHUV
%HGLDJQRVHGZLWKDQRQJRLQJRFXODULQIHFWLRQEDFWHULDOYLUDO RUIXQJDORUDFWLYHRFXODU
LQIOD[COMPANY_003]WLRQDW9LVLW
+DYHZRUQFRQWDFWOHQVHVZLWKLQGD\VRI9LVLWRUDQWLFLSDWH XVLQJFRQWDFWOHQVHVGXULQJWKHVWXG\
+DYHSUHYLRXVO\KDGODVHUDVVLVWHG LQVLWXNHUDWRPLOHXVLV/$6,.VXUJHU\ZLWKLQWKHODVWPRQWKV
+DYHXVHG5HVWDVLVÂŠ;LLGUDÂŠRU&HTXDÂŠZLWKLQGD\VRI9LVLW
+DYHDQ\SUHYLRXVH[SHULHQFHXVLQJ+/
+DYHKDGDQ\RFXODUDQGRUOLGVXUJHULHVLQWKHSDVWPRQWKVR UKDYHDQ\SODQQHGRFXODUDQGRUOLG
VXUJHULHVRYHUWKHVWXG\SHULRG
%HXVLQJRUDQWLFLSDWHXVLQJWHPSRUDU\SXQFWDOSOXJVGXULQJWKH VWXG\WKDWKDYHQRWEHHQVWDEOHZLWKLQ
GD\VRI9LVLW
%HFXUUHQWO\WDNLQJDQ\WRSLFDORSKWKDOPLFSUHVFULSWLRQLQFOXG LQJPHGLFDWLRQVIRUJODXFRPDRURYHU
WKHFRXQWHUVROXWLRQVDUWLILFLDOWHDUVJHOVRUVFUXEVDQGFD QQRWGLVFRQWLQXHWKHVHPHGLFDWLRQVIRUWKH
GXUDWLRQRIWKHWULDOH[FOXGLQJPHGLFDWLRQVDOORZHGIRUWKHFR QGXFWRIWKHVWXG\WKHUHVSHFWLYHZDVK
RXWSHULRGVDUHUHTXLUHGIRUWKHIROORZLQJPHGLFDWLRQV
D$QWLKLVWDPLQHVLQFOXGLQJRFXODUKRXUVSULRUWR9LVLW
E2UDODVSLULQRUDVSLULQÂ±FRQWDLQLQJSURGXFWVDOORZHGLIGRVHKDV EHHQVWDEOHRYHUSDVWGD\V
SULRUWR9LVLWDQGQRFKDQJHLQGRVHDQWLFLSDWHGGXULQJWKHV WXG\SHULRG
F&RUWLFRVWHURLGVRUPDVWFHOOVWDELOL]HUVLQFOXGLQJRFXODU GD\VSULRUWR9LVLWHL036 Ophthalmic Solution 
Clinical Study Protocol HL036-DED-US-P301Sponsor: HanAll Biopharma, Co., Ltd. 
24 January 2019
Confidential Page 5
1$0(2)&203$1<
+DQ$OO%LRSKDUPD&R/WG
'DH:RRQJ%XLOGLQJ)O
%RQJHXQVDURJLO
6HRXO*DQJQDPJX
6RXWK.RUHD1$0(2)'58*352'8&7
+/2SKWKDOPLF6ROXWLRQIRU7UHDWPHQWRI'U\
(\H

G$Q\PHGLFDWLRQRUDORUWRSLFDONQRZQWRFDXVHRFXODUGU\LQJW KDWKDVQRWEHHQDGPLQLVWHUHG
DVDVWDEOHGRVHIRUDWOHDVWGD\VSULRUWR9LVLWDQGGXUL QJWKHVWXG\
H$OORWKHUWRSLFDORSKWKDOPLFSUHSDUDWLRQVLQFOXGLQJDUWLILFLDO WHDUVXEVWLWXWHVRWKHUWKDQWKH
VWXG\GURSVKRXUVSULRUWR9LVLW
+DYHDQXQFRQWUROOHGV\VWHPLFGLVHDVH
%HDZRPDQZKRLVSUHJQDQWQXUVLQJRUSODQQLQJDSUHJQDQF\
%HXQZLOOLQJWRVXEPLWDXULQHSUHJQDQF\WHVWDW9LVLWDQG9L VLWRUHDUO\WHUPLQDWLRQYLVLWLIRI
FKLOGEHDULQJSRWHQWLDO1RQFKLOGEHDULQJSRWHQWLDOLVGHILQHG DVDZRPDQZKRLVSHUPDQHQWO\
VWHULOL]HGHJKDVKDGDK\VWHUHFWRP\RUWXEDOOLJDWLRQRU LVSRVWPHQRSDXVDOZLWKRXWPHQVHVIRU
FRQVHFXWLYHPRQWKV
%HDZRPDQRIFKLOGEHDULQJSRWHQWLDOZKRLVQRWXVLQJDQDFFHSW DEOHPHDQVRIELUWKFRQWURO
DFFHSWDEOHPHWKRGVRIFRQWUDFHS WLRQLQFOXGHKRUPRQDOÂ±RUDOL PSODQWDEOHLQMHFWDEOHRUWUDQVGHUPDO
FRQWUDFHSWLYHVPHFKDQLFDOÂ±VSH UPLFLGHLQFRQMXQFWLRQZLWKDE DUULHUVXFKDVDGLDSKUDJPRUFRQGRP
LQWUDXWHULQHGHYLFHRUVXUJLFDOVWHULOL]DWLRQRISDUWQHU)RU QRQVH[XDOO\DFWLYHIHPDOHVDEVWLQHQFH
PD\EHUHJDUGHGDVDQDGHTXDWHPHWKRGRIELUWKFRQWUROKRZHYHU LIWKHVXEMHFWEHFRPHVVH[XDOO\
DFWLYHGXULQJWKHVWXG\VKHPXVWDJUHHWRXVHDGHTXDWHELUWKF RQWURODVGHILQHGDERYHIRUWKHUHPDLQGHU
RIWKHVWXG\
+DYHDNQRZQDOOHUJ\DQGRUVHQVLWLYLW\WRWKHWHVWDUWLFOHRU LWVFRPSRQHQWV
+DYHDFRQGLWLRQRUEHLQDVLWXDWLRQZKLFKWKHLQYHVWLJDWRUIH HOVPD\SXWWKHVXEMHFWDWVLJQLILFDQWULVN
PD\FRQIRXQGWKHVWXG\UHVXOWVRUPD\LQWHUIHUHVLJQLILFDQWO\ ZLWKWKHVXEMHFWÂ¶VSDUWLFLSDWLRQLQWKH
VWXG\
%HFXUUHQWO\HQUROOHGLQDQLQYHVWLJDWLRQDOGUXJRUGHYLFHVWXG \RUKDYHXVHGDQLQYHVWLJDWLRQDOGUXJRU
GHYLFHZLWKLQGD\VRI9LVLW
%HXQDEOHRUXQZLOOLQJWRIROORZLQVWUXFWLRQVLQFOXGLQJSDUWLF LSDWLRQLQDOOVWXG\DVVHVVPHQWVDQG
YLVLWV
(1'32,176 
7KHSULPDU\HIILFDF\HQGSR LQWVRIWKHVWXG\DUH
x,QIHULRUFRUQHDOVWDLQLQJVLJQ3UHWR3RVW&$(DW'D\: HHN
x2FXODUGLVFRPI[INVESTIGATOR_13318]V\PSWRP3UH&$(DW'D\:HHN 
7KHVHFRQGDU\HIILFDF\HQG SRLQWVRIWKHVWXG\DUH
x)OXRUHVFHLQVWDLQLQJE\UHJLRQFHQWUDOVXSHULRULQIHULRUWH PSRUDOQDVDOFRUQHDOVXP
FRQMXQFWLYDOVXPDQGWRWDOVWDLQLQJ
x&RQMXQFWLYDOOLVVDPLQHJUHHQVWDLQLQJE\UHJLRQFHQWUDOVXSHU LRULQIHULRUWHPSRUDOQDVDO
FRUQHDOVXPFRQMXQFWLYDOVXPDQGWRWDOVWDLQLQJ
x&RQMXQFWLYDOUHGQHVV
x6FKLUPHUÂ¶V7HVW
x7HDUILOPEUHDNXSWLPH7)%87
x2FXODU6XUIDFH'LVHDVH,QGH[Â‹26',Â‹
x9LVXDO$QDORJ6FRUH9$6
x'DLO\V\PSWRPGLDU\2UD&DOLEUD2FXODU'LVFRPI[INVESTIGATOR_13318]	6\PSWRP 4XHVWLRQQDLUH2FXODU
'LVFRPI[INVESTIGATOR_13318]6FRUH
x'DLO\V\PSWRPGLDU\E\&$(4XDOLILFDWLRQ7LPH
x'URSFRPI[INVESTIGATOR_13318] HL036 Ophthalmic Solution 
Clinical Study Protocol HL036-DED-US-P301Sponsor: HanAll Biopharma, Co., Ltd. 
24 January 2019
Confidential Page 6
1$0(2)&203$1<
+DQ$OO%LRSKDUPD&R/WG
'DH:RRQJ%XLOGLQJ)O
%RQJHXQVDURJLO
6HRXO*DQJQDPJX
6RXWK.RUHD1$0(2)'58*352'8&7
+/2SKWKDOPLF6ROXWLRQIRU7UHDWPHQWRI'U\
(\H

7KHVDIHW\HQGSRLQWVRIWKHVWXG\DUH
x9LVXDODFXLW\
x6OLWODPSHYDOXDWLRQ
x$GYHUVHHYHQWTXHU\
x,QWUDRFXODU3UHVVXUH
x'LODWHGIXQGRVFRS\
x,PPXQRJHQLFLW\WR+/LQ6HUXP 
67$7,67,&$/0(7+2'6
$QDO\VLV3RSXODWLRQV
x,QWHQWWR7UHDW3RSXODWLRQÂ±7KHLQWHQWWRWUHDW,77SRSXODWL RQLQFOXGHVDOOUDQGRPL]HGVXEMHFWV
7KHSULPDU\DQDO\VLVZLOOEHSHUIRUPHGRQWKH,77SRSXODWLRQZL WKWKH0DUNRY&KDLQ0RQWH&DUOR
0&0&LPSXWDWLRQPHWKRGIRUPLVVLQJYDOXHV7KH,77SRSXODWLRQ PD\DOVREHDQDO\]HGZLWK/DVW
2EVHUYDWLRQ&DUULHG)RUZDUG/2&)LPSXWDWLRQLPSXWDWLRQYLDS DWWHUQPL[WXUHPRGHOVDQGZLWK
REVHUYHGGDWDRQO\WRDVVHVVVHQVLWLYLW\6XEMHFWVLQWKH,77S RSXODWLRQZLOOEHDQDO\]HGDV
UDQGRPL]HG
x3HU3URWRFRO3RSXODWLRQÂ±7KHSHUSURWRFRO33SRSXODWLRQLQFO XGHVVXEMHFWVLQWKH,77SRSXODWLRQ
ZKRGRQRWKDYHVLJQLILFDQWSURWRFROGHYLDWLRQVDQGZKRFRPSOHW HWKHVWXG\3URWRFROGHYLDWLRQV
ZLOOEHDVVHVVHGSULRUWRGDWDEDVHORFNDQGXQPDVNLQJ7KH33S RSXODWLRQZLOOEHDQDO\]HGXVLQJ
REVHUYHGGDWDRQO\IRUHIILFDF\YDULDEOHV6XEMHFWVLQWKH33S RSXODWLRQZLOOEHDQDO\]HGDVWUHDWHG
x6DIHW\3RSXODWLRQÂ±7KHVDIHW\SRSXODWLRQLQFOXGHVDOOUDQGRPL] HGVXEMHFWVZKRKDYHUHFHLYHGDW
OHDVWRQHGRVHRIWKHLQYHVWLJDWLRQDOSURGXFW7KHVDIHW\SRSXO DWLRQZLOOEHDQDO\]HGIRUDOOVDIHW\
DVVHVVPHQWV6XEMHFWVLQWKH6DIHW\SRSXODWLRQZLOOEHDQDO\]HG DVWUHDWHG
6DPSOH6L]H
7KLVVWXG\LVH[SHFWHGWRHQUROOVXEMHFWVLQHDFKRIWKHWZ RWUHDWPHQWDUPVIRUDWRWDORI
UDQGRPL]HGVXEMHFWV$VVXPLQJDGURSRXWUDWHVXEMHFWV SHUJURXSDUHH[SHFWHGWRFRPSOHWHWKH
VWXG\
$VVXPLQJDFRPPRQVWDQGDUGGHYLDWLRQLQWKHFKDQJHIURPEDVHOLQ HIRUWKHSUH&$(ÂŠWRSRVW&$(ÂŠ
FKDQJHLQLQIHULRUFRUQHDOIOXRUHVFHLQVWDLQLQJRIXQLWV DVDPSOHVL]HRIVXEMHFWVSHUJURXSZLOO
KDYHSRZHUWRGHWHFWDGLIIHUHQFHRIXQLWVEHWZHHQWKH DFWLYHWUHDWPHQWJURXSDQGWKHSODFHER
JURXSDWDVLJQLILFDQFHOHYHORI$VDPSOHVL]HRIVXE MHFWVSHUWUHDWPHQWDUPZLOOKDYHSRZHU
WRGHWHFWDPHDQGLIIHUHQFHRI XQLWVLQWKHFKDQJHIURPEDV HOLQHIRUWKHSUH&$(ÂŠRFXODUGLVFRPI[INVESTIGATOR_13318]DV
DVVHVVHGE\WKH2UD&DOLEUDÂŠ2FXODU'LVFRPI[INVESTIGATOR_13318]6FDOHDVVXPLQJDVWDQGDUGGHYLDWLRQRI XQLWV7KH
SRZHUIRUERWKWKHVLJQDQGV\PSWRPHQGSRLQWVLVDVVXPLQJ LQGHSHQGHQFHEHWZHHQWKHHQGSRLQWV
0XOWLSOLFLW\&RQVLGHUDWLRQ
+LHUDUFKLFDOIL[HGVHTXHQFHWHV WLQJZLOOEHXVHGWRPDLQWDLQWK HW\SH,HUURUUDWH7KHSULPDU\DQDO\VLVZLOO
ILUVWWHVWWKHGLIIHUHQFHLQWKHFKDQJHIURPEDVHOLQHRIWKHSU H&$(ÂŠWRSRVW&$(ÂŠFKDQJHLQLQIHULRU
FRUQHDOIOXRUHVFHLQVWDLQLQJDW'D\,IWKHWHVWRIWKHGLII HUHQFHLVVWDWLVWLFDOO\VLJQLILFDQWDWWKHWZRVLGHG
DOSKD OHYHOLQIDYRURI+ /WKHQWKHVWXG\ZLOOEHFR QVLGHUHGDVXFFHVV+/ZLOOEHGHFODUHG
WREHVXSHULRUWRSODFHERLQWKH FKDQJHIURPEDVHOLQHRIWKHSU H&$(ÂŠWRSRVW&$(ÂŠFKDQJHLQLQIHULRU
FRUQHDOIOXRUHVFHLQVWDLQLQJDW'D\DQGWKHGLIIHUHQFHLQW KHFKDQJHIURPEDVHOLQHRIWKHSUH&$(ÂŠ
RFXODUGLVFRPI[INVESTIGATOR_13318]DW'D\ZLOO EHWHVWHGDWWKHWZRVLGHGDOS KD OHYHO
,ILQDGGLWLRQWRDVWDWLVWLFDOO\VLJQLILFDQWWHVWRIWKHGLII HUHQFHLQFKDQJHIURPEDVHOLQHRIWKHSUH&$(ÂŠWR
SRVW&$(ÂŠFKDQJHLQLQIHULRUFRUQHDOIOXRUHVFHLQVWDLQLQJDW'D\LQI DYRURI+/WKHWHVWRIWKH
GLIIHUHQFHLQWKHFKDQJHIURPEDVHOLQHRIWKHSUH&$(ÂŠRFXODUGLVFRPI[INVESTIGATOR_13318]DW'D\LVDOVRVWDWLVWLFDOO\
VLJQLILFDQWLQIDYRURI+/WKHQ+/ZLOOEHGHFODUHGVXSH ULRUWRSODFHERLQERWKWKHFKDQJHIURPHL036 Ophthalmic Solution 
Clinical Study Protocol HL036-DED-US-P301Sponsor: HanAll Biopharma, Co., Ltd. 
24 January 2019
Confidential Page 7
1$0(2)&203$1<
+DQ$OO%LRSKDUPD&R/WG
'DH:RRQJ%XLOGLQJ)O
%RQJHXQVDURJLO
6HRXO*DQJQDPJX
6RXWK.RUHD1$0(2)'58*352'8&7
+/2SKWKDOPLF6ROXWLRQIRU7UHDWPHQWRI'U\
(\H

EDVHOLQHRIWKHSUH&$(ÂŠWRSRVW&$(ÂŠFKDQJHLQLQIHULRUFRUQHDOIOXRUHVFHLQVWDLQLQJDQGWKHFKDQJH IURP
EDVHOLQHRIWKHSUH&$(ÂŠRFXODUGLVFRPI[INVESTIGATOR_13318]DW'D\
3ULPDU\(IILFDF\$QDO\VHV
)RUERWKHQGSRLQWVFKDQJHIURPEDVHOLQHZLOOEHFDOFXODWHGDV YLVLWÂ±EDVHOLQHVXFKWKDWDSRVLWLYH
GLIIHUHQFHLQGLFDWHVDZRUVHQLQJRIGU\H\HVLJQVRUV\PSWRPV ,QDGGLWLRQWUHDWPHQWFRPSDULVRQVEHWZHHQ
DFWLYHDQGSODFHERZLOOEHFDOFXODWHGDVDFWLYHÂ±SODFHERVXFK WKDWDQHJDWLYHUHVXOWLQGLFDWHVDEHWWHUVFRUH
IRUWKHDFWLYHWUHDWPHQWLHWKHDFWLYHWUHDWPHQWKDGDVPDO OHULQFUHDVHLQGU\H\HVLJQVRUV\PSWRPVWKDQ
WKHSODFHERJURXS
$QDO\VLVRI&RYDULDQFH$1&29$PRGHOVZLOOEHXVHGWRFRPSDUH WKHFKDQJHIURPEDVHOLQHLQWKHSUH
&$(ÂŠWRSRVW&$(ÂŠFKDQJHLQLQIHULRUFRUQHDOIOXRUHVFHLQVWDLQLQJDW'D\9LV LWDVPHDVXUHGRQWKH
2UD&DOLEUDÂŠVFDOHEHWZHHQ+/2SKWKDOPLF6ROXWLRQDQG3ODFHER7K H$1&29$PRGHOVZLOO
LQFOXGHWHUPVIRUEDVHOLQHSUH&$(ÂŠWRSRVW&$(ÂŠFKDQJHLQLQIHULRUFRUQHDOIOXRUHVFHLQVWDLQLQJDQG
VWXG\VLWH,QDGGLWLRQWKHVWXG\VLWHE\WUHDWPHQWLQWHUDFWLR QZLOOEHH[SORUHGLQDVHSDUDWHPRGHOWR
HYDOXDWHKRZWKHWUHDWPHQWHIIHFWPD\GLIIHUDFURVVVWXG\VLWHV 7KHSULPDU\DQDO\VLVZLOOXVH0&0&
LPSXWDWLRQWRKDYHDIXOODFFRXQWLQJRIWKH,77SRSXODWLRQDWW KH'D\YLVLWDVGHVFULEHGLQ6HFWLRQ
$VVXSSRUWLYHDQDO\VHVLPSXWDWLRQE\/2&)PXOWLSOHLP SXWDWLRQE\SDWWHUQPL[WXUHPRGHOVDQG
DQDO\VHVRIREVHUYHGGDWDRQO\ZLOODOVREHFRQGXFWHG7ZRVDPS OHWWHVWVDQG:LOFR[RQUDQNVXPWHVWV
ZLOODOVREHFRQGXFWHGDVVXSSRUWLYHDQDO\VHV
2FXODUGLVFRPI[INVESTIGATOR_13318]ZLOOEHDQDO\]HGVLPLODUO\$1&29$PRGHOVZLO OEHXVHGWRFRPSDUHWKHFKDQJHIURP
EDVHOLQHLQWKHSUH&$(ÂŠRFXODUGLVFRPI[INVESTIGATOR_13318]VFRUHDW'D\9LVLWDVPHDVXUHGRQWK H2UD&DOLEUDÂŠ
2FXODU'LVFRPI[INVESTIGATOR_13318]6FDOHEHWZHHQ+/2SKWKDOPLF6ROXWLR QDQG3ODFHER7KH$1&29$PRGHOV
ZLOOLQFOXGHWHUPVIRUEDVHOLQH 9LVLWRFXODUGLVFRPI[INVESTIGATOR_13318]DQG VWXG\VLWH,QDGGLWLRQWKHVWXG\VLWHE\
WUHDWPHQWLQWHUDFWLRQZLOOEHH[SORUHGLQDVHSDUDWHPRGHOWRH YDOXDWHKRZWKHWUHDWPHQWHIIHFWPD\GLIIHU
DFURVVVLWHV
6HFRQGDU\(IILFDF\$QDO\VHV
7KHFRQWLQXRXVDQGRUGLQDOVHFRQGDU\HIILFDF\YDULDEOHVFROOHFW HGDWHDFKYLVLWZLOOEHVX[COMPANY_003]UL]HG
GHVFULSWLYHO\QPHDQVWDQGDUGGHYLDWLRQPHGLDQPLQDQGPD[ DQGDQDO\]HGZLWKWZRVDPSOHWWHVWV
FRPSDULQJHDFKRIWKHDFWLYHWUHDWPHQWJURXSVWRSODFHER$OOY LVLWEDVHGGDWDZLOOEHDQDO\]HGDWHDFKYLVLW
DQGFKDQJHIURPEDVHOLQH&KDQJHVFRUHVIURPSUHWRSRVW&$(ÂŠZLOOEHFDOFXODWHGDV3RVW&$(ÂŠVFRUHÂ±
3UH&$(ÂŠVFRUH$:LOFR[RQUDQNVXPWHVWDQGDQ$1&29$PRGHODGMXVWLQJ IRUEDVHOLQHDQGVLWHZLOO
DOVREHDVVHVVHGZKHUHDSSURSULDWH1RLPSXWDWLRQZLOOEHSHUIR UPHGIRUVHFRQGDU\HIILFDF\YDULDEOHV
&RUQHDOIOXRUHVFHLQVWDLQLQJE\UHJLRQDQGWRWDOFRQMXQFWLYDO OLVVDPLQHJUHHQVWDLQLQJE\UHJLRQ7)%87
FRQMXQFWLYDOUHGQHVVXQDQHVWKHWL]HG6FKLUPHUÂ¶VWHVWGURSFRPI [INVESTIGATOR_13318]DVVHVVPHQW26',Â‹RFXODUGLVFRPI[INVESTIGATOR_13318]
DQGGU\H\HV\PSWRPVRFXODUGLVFRPI[INVESTIGATOR_13318]GXULQJ&$(ÂŠSUHWRSRVW&$(ÂŠFKDQJHVDQGFKDQJHVIURP
EDVHOLQHLQWKHVHPHDVXUHVZLOOEHDQDO\]HGE\YLVLWXVLQJWZR VDPSOHWWHVWVDQG:LOFR[RQUDQNVXPWHVWV
DVDSSURSULDWH
7KHZRUVWV\PSWRPIRUHDFKVXEMHFWZLOOEHLGHQWLILHGDVWKHV\ PSWRPZLWKWKHKLJKHVWDYHUDJHVFRUH
GXULQJWKHUXQLQSHULRG'D\VWRDVUHFRUGHGLQWKHVX EMHFWGLDU\)RUPRUQLQJHYHQLQJDQGGDLO\
DYHUDJHDVVHVVPHQWVWKHZHHNO\DYHUDJHVRIWKHZRUVWV\PSWRPD QGHDFKLQGLYLGXDOV\PSWRPZLOOEH
DQDO\]HGXVLQJWZRVDPSOHWWHVWVDQG:LOFR[RQUDQNVXPWHVWV 
6DIHW\9DULDEOHV
$GYHUVHHYHQWVZLOOEHFRGHGXVLQJWKH0HGLFDO'LFWLRQDU\IRU5 HJXODWRU\$XWKRULWLHV0HG'5$
)UHTXHQFLHVDQGSHUFHQWDJHVRIVXEMHFWVZLWKWUHDWPHQWHPHUJHQW DGYHUVHHYHQWV7($(VVHULRXV7($(V
DQG7($(VFDXVLQJSUHPDWXUHGLVFRQWLQXDWLRQZLOOEHSURYLGHGE\ WUHDWPHQWJURXS$Q$(LVWUHDWPHQW
HPHUJHQWLILWRFFXUVRUZRUVHQVDIWHUWKHILUVWGRVHRIVWXG\ WUHDWPHQW)XUWKHUPRUHIUHTXHQFLHVZLOOEH
JLYHQRIVXEMHFWVZLWK7($(VE\V\VWHPRUJDQFODVVE\V\VWHPR UJDQFODVVDQGSUHIHUUHGWHUPE\V\VWHP
RUJDQFODVVSUHIHUUHGWHUPDQGPD[LPDOVHYHULW\E\V\VWHPRUJ DQFODVVSUHIHUUHGWHUPDQGVWURQJHVWHL036 Ophthalmic Solution 
Clinical Study Protocol HL036-DED-US-P301Sponsor: HanAll Biopharma, Co., Ltd. 
24 January 2019
Confidential Page 8
1$0(2)&203$1<
+DQ$OO%LRSKDUPD&R/WG
'DH:RRQJ%XLOGLQJ)O
%RQJHXQVDURJLO
6HRXO*DQJQDPJX
6RXWK.RUHD1$0(2)'58*352'8&7
+/2SKWKDOPLF6ROXWLRQIRU7UHDWPHQWRI'U\
(\H

UHODWLRQVKLSDQGE\V\VWHPRUJDQFODVVSUHIHUUHGWHUPPD[LPD OVHYHULW\DQGVWURQJHVWUHODWLRQVKLS
6HSDUDWHDQDO\VHVZLOOEHSHUIRUPHGIRURFXODUVSHFLILFDQGDOO $(VLQFOXGLQJV\VWHPLF
2WKHUVDIHW\HQGSRLQWVLQFOXGLQJYLVXDODFXLW\VOLWODPSELRPL FURVFRS\GLODWHGIXQGRVFRS\DQG
LQWUDRFXODUSUHVVXUHZLOOEHVX[COMPANY_003]UL]HGE\WUHDWPHQWJURXSDQG YLVLWXVLQJGHVFULSWLYHVWDWLVWLFV&KDQJHV
RUVKLIWVIURPEDVHOLQHZLOODOVREHVX[COMPANY_003]UL]HGZKHUHDSSURSULD WH)RUDVVHVVPHQWVSHUIRUPHGE\H\H
VWXG\H\HDQGIHOORZH\HZLOOEHVX[COMPANY_003]UL]HGVHSDUDWHO\,QDGGL WLRQVKLIWVIURPEDVHOLQHWRZRUVWRQ
WUHDWPHQWYDOXHIRURFXODUVDIHW\DVVHVVPHQWVZLOOEHVX[COMPANY_003]UL]H G
HL036 Ophthalmic Solution 
Clinical Study Protocol HL036-DED-US-P301Sponsor: HanAll Biopharma, Co., Ltd. 
24 January 2019
Confidential Page 9
7$%/(2)&217(176
6<1236,6    
7$%/(2)&217(176   
/,672)$%%5(9,$7,216   
 ,1752'8&7,21   
 1RQFOLQLFDO6WXGLHV   
 3UHYLRXV&OLQLFDO6WXGLHV   
 6WXG\5DWLRQDOH   
 6X[COMPANY_003]U\RI2YHUDOO5LVNVDQG%HQHILWV   
 678'<2%-(&7,9(6   
 &/,1,&$/+<327+(6(6   
 29(5$//678'<'(6,*1   
 678'<3238/$7,21   
 1XPEHURI6XEMHFWV   
 6WXG\3RSXODWLRQ&KDUDFWHULVWLFV   
 ,QFOXVLRQ&ULWHULD   
 ([FOXVLRQ&ULWHULD   
 :LWKGUDZDO&ULWHULD   
 678'<3$5$0(7(56   
 (IILFDF\0HDVXUHV   
  3ULPDU\(IILFDF\(QGSRLQWV   
  6HFRQGDU\(IILFDF\(QGSRLQWV   
  &ULWHULDIRU(IIHFWLYHQHVV   
 6DIHW\0HDVXUHV   
 678'<0$7(5,$/6   
 6WXG\7UHDWPHQWV   
  6WXG\7UHDWPHQWV   
  'HVFULSWLRQDQG-XVWLILFDWLRQIRU WKH5RXWHRI$GPLQLVWUDWLRQ 'RVDJH
'RVDJH5HJLPHQDQG7UHDWPHQW3HULRG   
  ,QVWUXFWLRQVIRU8VH DQG$GPLQLVWUDWLRQ   
 2WKHU6WXG\6XSSOLHV   
 678'<0(7+2'6$1'352&('85(6   
 6XEMHFW(QWU\3URFHGXUHV   
  2YHUYLHZ   
  ,QIRUPHG&RQVHQW   
  :DVKRXW,QWHUYDOV   
  3URFHGXUHVIRU)LQDO6WXG\(QWU\   
  0HWKRGVIRU$VVLJQPHQWW R7UHDWPHQW*URXSV   
 &RQFXUUHQW7KHUDSLHV   
  3URKLELWHG0HGLFDWL RQV7UHDWPHQWV   
  (VFDSH0HGLFDWLRQV   
  6SHFLDO'LHWRU$FWLYLWLHV   
 ([DPLQDWLRQ3URFHGXUHV   
  9LVLW'D\Â±Â“Â±&$(ÂŠ6FUHHQLQJ   
  9LVLW'D\Â±&$(ÂŠ&RQILUPDWLRQDQG%DVHOLQH  HL036 Ophthalmic Solution 
Clinical Study Protocol HL036-DED-US-P301Sponsor: HanAll Biopharma, Co., Ltd. 
24 January 2019
Confidential Page 10
  9LVLW'D\   
  9LVLW'D\Â“   
  9LVLW'D\Â“   
  9LVLW'D\Â“   
 6FKHGXOHRI9LVLWV0HDV XUHPHQWVDQG'RVLQJ   
  6FKHGXOHG9LVLWV   
  8QVFKHGXOHG9LVLWV   
  (DUO\7HUPLQDWLRQ9LVLW   
 &RPSOLDQFHZLWK3URWRFRO   
 6XEMHFW'LVSRVLWLRQ   
  &RPSOHWHG6XEMHFWV   
  'LVFRQWLQXHG6XEMHFWV   
 6WXG\7HUPLQDWLRQ   
 6WXG\'XUDWLRQ   
 0RQLWRULQJDQG4XDOLW\$VVXUDQFH   
 $'9(56((9(176   
  5HSRUWLQJDQ$GYHUVH(YHQWRI6SHFLDO,QWHUHVW   
  6HYHULW\   
  5HODWLRQVKLSWR,QYHVW LJDWLRQDO3URGXFW   
  ([SHFWHGQHVV   
 6HULRXV$GYHUVH(YHQWV   
 3URFHGXUHVIRU5HSRU WLQJ$GYHUVH(YHQWV   
  5HSRUWLQJD6XVSHFWHG8QH[SHFWHG$GYHUVH5HDFWLRQ   
  5HSRUWLQJD6HULRXV$GYHUVH(YHQW   
 3URFHGXUHVIRU8QPDVNLQJLIDSSOLFDEOH   
 7\SHDQG'XUDWLRQRIWKH)ROORZ XSRI6XEMHFWVDIWHU$GYHUVH(Y HQWV  
 67$7,67,&$/+<327+(6(6$1'0(7+2'62)$1$/<6(6   
  $QDO\VLV3RSXODWLRQV   
  6WDWLVWLFDO+\SRWKHVHV   
  6DPSOH6L]H   
  6WDWLVWLFDO$QDO\VLV   
  *HQHUDO&RQVLGHUDWLRQV   
  8QLWRI$QDO\VLV   
  0LVVLQJ'DWD   
  0XOWLSOLFLW\&RQVLGHUDWLRQ   
  3ULPDU\(IILFDF\$QDO\VHV   
  6HFRQGDU\(IILFDF\$QDO\VHV   
  6DIHW\9DULDEOHV   
  ,QWHULP$QDO\VHV   
 &203/,$1&(:,7+*22'&/,1,&$/35$&7,&(6(7+,&$/
&216,'(5$7,216$1'$'0,1,675$7,9(,668(6   
  3URWHFWLRQRI+XPDQ6XEMHFWV   
  6XEMHFW,QIRUPHG&RQVHQW   
  ,QVWLWXWLRQDO5HYLHZ%RD UG,5%$SSURYDO   
  (WKLFDO&RQGXFWRIWKH6WXG\   
  6XEMHFW&RQILGHQWLDOLW\   HL036 Ophthalmic Solution 
Clinical Study Protocol HL036-DED-US-P301Sponsor: HanAll Biopharma, Co., Ltd. 
24 January 2019
Confidential Page 11
  'RFXPHQWDWLRQ   
  5HWHQWLRQRI'RFXPHQWDWLRQ   
  /DEHOLQJ3DFNDJLQJ6WRUDJH$ FFRXQWDELOLW\DQG5HWXUQRU'LV SRVDORI
,QYHVWLJDWLRQDO3URGXFW   
  /DEHOLQJ3DFNDJLQJ   
  6WRUDJHRI,QYHVWLJDWLRQDO3URGXFW   
  $FFRXQWDELOLW\RI,QYHVW LJDWLRQDO3URGXFW   
  5HWXUQRU'LVSRVDORI,QY HVWLJDWLRQDO3URGXFW   
  5HFRUGLQJRI'DWDRQ6RXUFH'RFXPH QWVDQG&DVH5HSRUWV)RUPV& 5)V  
  +DQGOLQJRI%LRORJLFDO6SHFLPHQV   
  3XEOLFDWLRQV   
 5()(5(1&(6   
 $33(1',&(6   
$SSHQGL[6FKHGXOHRI9 LVLWVDQG0HDVXUHPHQWV   
$SSHQGL[ ([DPLQDWLRQ3URFHGXU HV7HVWV(TXLSPHQWDQG7HFKQ LTXHV  
$SSHQGL[ &RQMXQFWLYLWLV$GYHUVH(YHQWV5HSRUW)RUP   
$SSHQGL[ 3URWRFRO$PHQGPHQW6X[COMPANY_003]U\   
$SSHQGL[ 6SRQVRUDQG2UD$SSURYDOV   
$SSHQGL[ ,QYHVWLJDWRUÂ¶V6LJQDWXUH   HL036 Ophthalmic Solution 
Clinical Study Protocol HL036-DED-US-P301Sponsor: HanAll Biopharma, Co., Ltd. 
24 January 2019
Confidential Page 12
/,672)$%%5(9,$7,216
$( $GYHUVH(YHQW
$1&29$ $QDO\VLVRI&RYDULDQFH
$3, $FWLYH3KDUPDFHXWLFDO,QJUHGLHQWV
%&9$ %HVW&RUUHFWHG9LVXDO$FXLW\
%,' %LV,Q'LH7ZR7LPHV'DLO\
&$( &RQWUROOHG$GYHUVH(QYLURQPHQW
&)5 &RGHRI)HGHUDO5HJXODWLRQV
'(' 'U\(\H'LVHDVH
H&5) (OHFWURQLF&DVH5HSRUW)RUP
(7'56 (DUO\7UHDWPHQWRI' LDEHWLF5HWLQRSDWK\6WXG\
*&3 *RRG&OLQLFDO3UDFWLFH
+,3$$ +HDOWK,QVXUDQFH3RUWDELOLW\DQG$FFRXQWDELOLW\$FW
,&) ,QIRUPHG&RQVHQW)RUP
,&+ ,QWHUQDWLRQDO&RQIHUHQFHRQ+DUPRQL]DWLRQ
,(& ,QGHSHQGHQW(WKLFV&RPPLWWHH
,23 ,QWUDRFXODU3UHVVXUH
,3 ,QYHVWLJDWLRQDO3URGXFW
,5% ,QVWLWXWLRQDO5HYLHZ%RDUG
,77 ,QWHQWWR7UHDW
,9 ,QWUDYHQRXV
/$6,. /DVHUÂ±DVVLVWHGLQVLWXNHUDWRPLOHXVLV
/'3( /RZ'HQVLW\3RO\HWK\OHQH
/2&) /DVW2EVHUYDWLRQ&DUULHG)RUZDUG
/RJ0$5 0LQLPXP$QJOHRI5HVROXWLRQ
0&0& 0DUNRY&KDLQ0RQWH&DUOR
0HG'5$ 0HGLFDO'LFWLRQDU\IRU5HJXODWRU\$XWKRULWLHV
2' 5LJKW(\H
2'6 2FXODU'LVFRPI[INVESTIGATOR_13318]6FRUH
26', 2FXODU6XUIDFH'LVHDVH,QGH[
28 2FXOXV8WHUTXH(DFKH\HRU%RWKH\HV
3, 3ULQFLSDO,QYHVWLJDWRU
33 3HU3URWRFRO
6$( 6HULRXV$GYHUVH(YHQW
7)%87 7HDU)LOP%UHDN8S7LPH
71) 7XPRU1HFURVLV)DFWRU
71)5 7XPRU1HFURVLV)DFWRU5HFHSWRU
9$ 9LVXDO$FXLW\
9$6 9LVXDO$QDORJ6FDOH
HL036 Ophthalmic Solution 
Clinical Study Protocol HL036-DED-US-P301Sponsor: HanAll Biopharma, Co., Ltd. 
24 January 2019
Confidential Page 13
,1752'8&7,21
'U\H\HLVDFRPSOH[GLVHDVHWK DWUHVXOWVLQV\PSWRPVRIGLVFRP IRUWYLVXDOGLVWXUEDQFH
DQGWHDUILOPLQVWDELOLW\,WLVDFFRPSDQLHGE\LQFUHDVHGRVPRO DULW\RIWKHWHDUILOPDQG
LQIOD[COMPANY_003]WLRQRIWKHRFXO DUVXUIDFH(VWLPDWHVRIWKHSUHYDOHQFH RIGU\H\HYDU\
FRQVLGHUDEO\GHSHQGLQJRQWKHFU LWHULDXVHGWRGHILQHWKHV\QG URPHEXWLQWKH86DV
PDQ\DVPLOOLRQZRPHQDQG PLOOLRQPHQRYHUWKHDJHRI KDYHGU\H\HZLWKD
SURMHFWHGLQFUHDVHLQQXPEH URISDWLHQWVDIIHFWHGE\:LWKWKHDJLQJ
SRSXODWLRQLQWKH8QLWH G6WDWHVDQGRWKHUF RXQWULHVRIWKHGHYH ORSHGZRUOGDQGZLWK
LQFUHDVLQJFRPSXWHUXVHGU\H\H LVH[SHFWHGWREHFRPHPRUHSUH YDOHQWDQGILQGLQJD
WUHDWPHQWLVEHFRPLQJPRUHLPSRUWDQ W
+/RSKWKDOPLFVROXWLRQLVDPROHFX ODUO\HQJLQHHUHGWXPRUQHF URVLVIDFWRUUHFHSWRU
71)5IUDJPHQW+/0ROHFXOHIUDJPHQWDWLRQDQGHQJLQHHULQ JWHFKQLTXHVDUH
DSSOLHGIRUHQKDQFHG WLVVXHGLVWULEXWLRQLQFUHDVHGVWDELOLW\D QGSRWHQF\
+/LVD71)5IUDJPHQWFRP SRVHGRIDPLQRDFLGVIURP aUHVLGXHVRI
71)5RXWVLGHGRPDLQDQGDPHWKLRQL QHUHVLGXHDGGHGDWWKH1WH UPLQDO+/LVD
SURWHLQPROHFXODUO\HQJLQHHUH GE\DPLQRDFLGVXEVWLWXWLRQRIWK HWKOHXFLQHUG
KLVWLGLQHWKKLVWLGLQHWKD UJLQLQHWKKLVWLGLQHDQG QGO\VLQHZLWKYDOLQH
PHWKLRQLQHSKHQ\ODODQL QHSUROLQHJO\FLQHDQGDVSDUDJLQHUHV SHFWLYHO\
+/RSKWKDOPLFVROXWLRQGHPRQVWU DWHGSRWHQWDQWLLQIOD[COMPANY_003]WRU\ HIIHFWVLQD
FDUUDJHHQDQLQGXFHGDFXWHLQYL YRPRGHORILQI OD[COMPANY_003]WLRQDQGVL JQLILFDQWHIILFDF\LQD
FROODJHQLQGXFHGDUWKULWLVPRGH O+/RSKWKDOPLFVROXWLRQKDV DOVREHHQVKRZQWR
FDXVHVWDWLVWLFDOO\VLJQLILFDQWFOLQLFDOLPSURYHPHQWVLQDGU\ H\HDQLPDOPRGHO+/
RSKWKDOPLFVROXWLRQVLJQLILFDQWO\LPSURYHGWKHVLJQVDQGV\PSWR PVRIGU\H\HLQD3KDVH
FOLQLFDOWULDOLQRQH KXQGUHGILIW\VXEMHFWVZLWKDKLVWRU\R IGU\H\H
1RQFOLQLFDO6WXGLHV









HL036 Ophthalmic Solution 
Clinical Study Protocol HL036-DED-US-P301Sponsor: HanAll Biopharma, Co., Ltd. 
24 January 2019
Confidential Page 14



3UHYLRXV&OLQLFDO6WXGLHV
$3KDVHFOLQLFDOVWXG\DVVHVVHG WKHVDIHW\ORFDOWROHUDQFH DQGSKDUPDFRNLQHWLF
SURSHUWLHVRI+/RSKW KDOPLFVROXWLRQVE\ WRSLFDORSKWKDOPLF LQVWLOODWLRQRI+/
WZLFHLQRQHGD\KRXUVDSDUW LQWRWKHOHIWH\HVRIKHDOWK\ PDOHYROXQWHHUZKLOHWKH
ULJKWH\HVUHFHLYHGYHKLFOHSO DFHER$WRWDORIVXEMHFWVZHU HUDQGRPL]HGLQDUDWLR
WRUHFHLYH+/RURUSO DFHERLQWKHOHIWH\HV
,QVWLOODWLRQRIRU+/ RSKWKDOPLFVROXWLRQLQWRWK HOHIWH\HVRIKHDOWK\
PDOHYROXQWHHUVUHVXOWHGLQQRFOLQL FDOO\VLJQLILFDQWV\VWHPLF DEVRUSWLRQREVHUYHGLQDQ\
RIWKHVXEMHFWV%ORRGVDPSOLQJ IRUSKDUPDFRNLQHWLFVDVVHVVPHQW VKRZHGWKDWRQHGURS
Â—ORI+/WRSLFDOLQVWLOOD WLRQWZLFHLQRQHGD\UHVXOWHG LQQRGHWHFWDEOHV\VWHPLF
DEVRUSWLRQDWHLWKHUFRQFHQWUD WLRQ$PRQJWKH$(VFRQMXQFWLYD OK\SHUHPLDZDVWKHPRVW
IUHTXHQWO\UHSRUWHG$(EXW WKHUHZDVQRVLJQLILFDQWGLIIHUH QFHLQQXPEHURIVXEMHFWVWKDW
KDGFRQMXQFWLYDOK\SHUHPLDLQWKHO HIWRUULJKWH\HV6DIHW\DQ GORFDOWROHUDQFHDVVHVVPHQW
UHVXOWVVKRZHGQRFOLQLFDOO\VLJQLILFDQWREVHUYDWLRQV
$3KDVHPXOWLFHQWHUUDQGRPL] HGSURVSHFWLYHGRXEOHÂ±PDVNHG SODFHERÂ±FRQWUROOHG
SDUDOOHOÂ±DUPVWXG\FRPSDUHGWKH VDIHW\DQGHIILFDF\RIDQ G+/
RSKWKDOPLFVROXWLRQVWRSODFHERIRU WKHWUHDWPHQWRIWKHVLJQV DQGV\PSWRPVRIGU\H\H
GLVHDVH'('2QHKXQGUHGILIW\ VXEMHFWVZHUHUDQGRPO\DVVLJQH GWRRQHRIWKUHH
WUHDWPHQWJURXSVWRUHFHL YHHLWKHU+/2SKWKDOPLF6RO XWLRQRU
SODFHERVROXWLRQDVWRSLFDORSKW KDOPLFGURSVDGPLQ LVWHUHGELODW HUDOO\WZLFHGDLO\%,'
RYHUDSHULRGRIHLJKWZHHNV
+/RSKWKDOPLFVROXWLRQVDW RUGHPRQVWUDWHGVWURQ JHIILFDF\WRWUHDWWKH
VLJQVDQGV\PSWRPVRI'('+/ 2SKWKDOPLF6ROXWLRQZDVVDIHD QGZHOOWROHUDWHGLQ
WKHPDMRULW\RISDWLHQWV7KHVH GDWDVXSSRUWWKHIXUWKHUGHYHOR SPHQWRI+/
2SKWKDOPLF6ROXWLRQIRUW KHLQGLFDWLRQRI'('
6WXG\5DWLRQDOH
+/RSKWKDOPLFVROXWLRQLVDPROHFX ODUO\71)5IUDJPHQWDFWL YHSKDUPDFHXWLFDO
LQJUHGLHQWDOVRGHQRWHGDV+/0ROHFXOHIUDJPHQWDWLRQDQ GHQJLQHHULQJ
WHFKQLTXHVDUHDSSOLHGIRUHQKDQF HGWLVVXHGLVWULEXWLRQLQFUHD VHGVWDELOLW\DQGSRWHQF\
$QWLWXPRUQHFURVLVIDFWRU71) PROHFXOHVKDYHEHHQDSSURYHGI RU[LOCATION_006]HXPDWRLGDUWKULWLV
SVRULDVLVDQN\ORVLQJVSRQ G\OLWLVXOFHUDWLYHFROLWLVDQG&URK QÂ¶VGLVHDVHV7KH\DUHDOVR
SUHVFULEHGIRURIIODEHOXVHIR UXYHLWLVGU\H\HGLVHDVHPDFX ODUGHJHQHUDWLRQVFLDWLF
QHXUDOJLDFKURQLFREVWUXFWLYH SXOPRQDU\GLVHDVHVDQGDVWKPD
7KHUROHRI71)DVDPDMRUF\WRNLQHLQGU\H\HSURYLGHVDUDWLR QDOHIRUXVHRI71)
LQKLELWRUVLQWKLVGLVHDVH+RZ HYHUWKHPDMRULW\RI71)LQKLEL
WRUVDUHDQWLERG\EDVHG
ZLWKDODUJHPROHFXODUVL]H aN'DWKDWOLPLWVWLVVXHSHQHW UDWLRQ&RQVLGHULQJWKHHL036 Ophthalmic Solution 
Clinical Study Protocol HL036-DED-US-P301Sponsor: HanAll Biopharma, Co., Ltd. 
24 January 2019
Confidential Page 15
OLPLWHGRFXODUGLVWULEXWLRQDQGH[FH VVLYHWR[LFLW\RI71)LQKLE LWRUWKHUDSLHVDGPLQLVWHUHG
V\VWHPLFDOO\+/2SKWKDOPLF6 ROXWLRQZDVGHYHORSHGDVD71) LQKLELWRUZLWK
LQFUHDVHGSHQHWUDWLRQDQGGLVWUL EXWLRQDQGPLQLPDOV\VWHPLFVLG HHIIHFWV


6X[COMPANY_003]U\RI2YHUDOO5LVNVDQG%HQHILWV





$GRXEOHPDVNHG3KDVHVWXG\FRP SDUHGWZRFRQFHQWUDWLRQVRI+/ RSKWKDOPLF
VROXWLRQDQGWRSODFHERL QDQZHHNWUHDWPHQWGX UDWLRQ%RWK
FRQFHQWUDWLRQVRI+/GHPRQVWU DWHGVLJQLILFDQWFOLQLFDOGLIIH UHQFHVRYHUSODFHERLQDW
OHDVWRQHVLJQRUV\PSWRPRI' ('7KHSULPDU\HQGSRLQWVRIWKLV VWXG\ZHUHPHDQ
FKDQJHLQLQIHULRUFRUQHDOVWDL QLQJVLJQDW9LVLWDQGPHDQ FKDQJHLQRFXODUGLVFRPI[INVESTIGATOR_13318]
V\PSWRPDW9LVLWSULRUWRW KH2UD&RQWUROOHG$GYHUVH(QYLUR QPHQWÂŠ&$(ÂŠDQDO\]HG
E\DQ$QDO\VLVRI&RYDULDQFH $1&29$:KLOHQRVLJQLILFDQWILQ GLQJVIDYRUHG+/
2SKWKDOPLF6ROXWLRQWU HDWPHQWSULRUWR&$(ÂŠLWZDVGHPRQVWUDWHGWKDWWKH+/
WUHDWPHQWVLJQLILFDQWO\SU RWHFWHGVXEMHFWVIURP&$(ÂŠH[SRVXUH7KDWLVDW9LVLW
VXEMHFWVZKRKDGEHHQSUHYLRXVO\ WUHDWHGZLWK+/KDGDVLJQL ILFDQWO\UHGXFHG
H[DFHUEDWLRQRIRFXODUVXUIDFHVWDLQLQJDIWHUWKH&$(ÂŠ)XUWKHUZKHQWKHSULPDU\
HQGSRLQWRIRFXODUGLVFRPI[INVESTIGATOR_13318]ZDV DQDO\]HGE\DWWHVWVLJQLIL FDQWLPSURYHPHQWZDV
REVHUYHG
:KLOHVWDWLVWLFDOO\VLJQLILFDQW ILQGLQJVZHUHQRWLGHQWLILHGIR UDOOHQGSRLQWVDOOVLJQVDQG
V\PSWRPVWUHQGHGLQIDYRURI+ /2SKWKDOPLF6ROXWLRQ7KHV\P SWRPVRI'('LH
RFXODUGLVFRPI[INVESTIGATOR_13318]ZHUHPRV WLPSURYHGZLWK+/2SKWKDOP LF6ROXWLRQZKLOH
WKHVLJQVRI'('LHOLVVDPLQ HRUIOXRUHVFHLQVWDLQLQJZHUH EHWWHULPSURYHGE\+/
2SKWKDOPLF6ROXWL RQ3RVWKRFDQDO\VHV VKRZHGWKDWWKDWZ KLOHVLJQLILFDQW
LPSURYHPHQWVIURPEDVHOLQHZHUH VHHQLQERWKJURXSVVWUDWLILHG E\WLPHWRTXDOLI\
PLQXWHVYHUVXVÂ•PLQXWHVWKHP RVWQRWDEOHLPSURYHPHQWVZHU HLQWKHV\PSWRPVRI
VXEMHFWVZLWKWLPHWRTXDOLI\ PLQXWHVGHPRQVWUDWLQJWKDW VXEMHFWVZKRZHUHPRUH
VHQVLWLYHWRWKH&$(ÂŠZHUHPRUHUHVSRQVLYHWRWUHDWPHQWZLWK+/
,QWKLVVWXG\VXEMHFWVVHOIDGPLQLVWHUHG+/LQERWKH\H V%,'7KHUHZHUHQR
VLJQLILFDQWVDIHW\FRQFHUQVFDXVHGE\+/WUHDWPHQWDWHLWKHU FRQFHQWUDWLRQ7KHUH
ZHUHQRVHULRXVDGYHUVHHYHQWV6$ (VRUGHDWKVLQWKLVVWXG\ (LJKWSDWLHQWVGHYHORSHG
FRQMXQFWLYLWLVWRZHHNVDIWHUVW DUWRIWUHDWPHQWDQGWKXVZ HUHGLVFRQWLQXHGSHUHL036 Ophthalmic Solution 
Clinical Study Protocol HL036-DED-US-P301Sponsor: HanAll Biopharma, Co., Ltd. 
24 January 2019
Confidential Page 16
SURWRFRO$OO$(VZHUHOLPLWHGW RPLOGVHYHULW\ZLWKFDVHVRI FRQMXQFWLYLWLVZKLFKDOO
UHVROYHGZLWKLQKRXUVRIW UHDWPHQWGLVFRQW LQXDWLRQ'URS FRPI[INVESTIGATOR_13318]VFDODULQTXLUHV
DQGGHVFULSWRUVGHPRQVWUDWHGD IDYRUDEOHGURSFRPI[INVESTIGATOR_13318]SURILOH ,PPXQRJHQLFLW\WHVWLQJLV
RQJRLQJWKHUHIRUHWKHUHVX OWVZLOOEHXSGDWHGL QWKHQH[W3UR WRFRO$PHQGPHQW
2YHUDOO+/2SKWKDOPLF6ROXWL RQZDVVDIHDQGZHOOWROHUDWHG LQWKHPDMRULW\RI
SDWLHQWV
678'<2%-(&7,9(6
7KHREMHFWLYHRIWKLVVWXG\LVW RFRPSDUHWKHVDIHW\DQGHIILFD F\RI+/
2SKWKDOPLF6ROXWLRQWRSODFHERIRU WKHWUHDWPHQWRIWKHVLJQVD QGV\PSWRPVRIGU\H\H
&/,1,&$/+<327+(6(6
7KHFOLQLFDOK\SRWKHVHVIRUWKLVVWXG\DUHWKDW+/2SK WKDOPLF6ROXWLRQLV
VXSHULRUWRSODFHERIRUWKHSULPD U\HQGSRLQWVRIVLJQVDQGV\PS WRPVDVIROORZV
x3UHWR3RVW&$(ÂŠLQIHULRUFRUQHDOIOXRUHVFHLQV WDLQLQJVFRUHRQWKH2UD&DOLEUDÂŠ
VFDOHPHDVXUHGE\PHDQFKDQJH IURPEDVHOLQH9LVLWWR9LVLW 
x3UH&$(ÂŠRFXODUGLVFRPI[INVESTIGATOR_13318]VFRUHRQWKH2UD&DOLEUDÂŠ2FXODU'LVFRPI[INVESTIGATOR_13318]6FDOH
PHDVXUHGE\PHDQFKDQJHIURP EDVHOLQH9LVLWWR9LVLW
29(5$//678'<'(6,*1
7KLVLVD3KDVHPXOWLFHQWHU UDQGRPL]HGSURV SHFWLYHGRXEOH Â±PDVNHG
SODFHERFRQWUROOHGSDUDOOHODUP GHVLJQZLWKEORFNHQUROOPHQW 6XEMHFWVZLOOEH
UDQGRPL]HGWRRQHRIWKHIROORZLQJ WUHDWPHQWDUPVDW9LVLWDQ GZLOOEHLQVWUXFWHGWR
IROORZD%,'GRVLQJUHJLPHQ
x+/2SKWKDOPLF6ROXWLRQ1a
x3ODFHER6ROXWLRQ1a
$SSUR[LPDWHO\VXEMHFWVZLOOEH UDQGRPO\DVVLJQHGWRRQHRI WZRWUHDWPHQWJURXSV
WRUHFHLYHHLWKHU+ /2SKWKDOPLF6ROXWLRQRUSODF HERVROXWLRQDVWRSLFDO
RSKWKDOPLFGURSVDGPLQLVWH UHGELODWHUDOO\%,'
6XEMHFWV6SRQVRU&OLQLFDO5HV HDUFK2UJDQL]DWLRQDQGVLWHSHUV RQQHOZLOOEHPDVNHGWR
WUHDWPHQWDVVLJQPHQW
'XULQJWKHVFUHHQLQJSHUL RGWZR H[SRVXUHVWRWKH&$(ÂŠZLOOEHFRQGXFWHGWR
DVFHUWDLQHOLJLELOLW\WRHQWHUWKHVWXG\7KRVHZKRTXDOLI\ZLO OEHUDQGRPL]HGWRUHFHLYH
VWXG\GUXJLQDGRXEOHPDVNHGI DVKLRQIRUGD\V6XEMHFWVZLO OVHOIDGPLQLVWHUGURSV
%,'DQGZLOOFRPSOHWHGDLO\V\PSW RPGLDU\DVVHVVPHQWVDVLQVWUX FWHG
$W9LVLWV'D\'D\DQG'D\&$(ÂŠH[SRVXUHZLOORFFXUZLWKSUH
&$(ÂŠGXULQJ&$(ÂŠV\PSWRPVRQO\DQGSRVW&$(ÂŠDVVHVVPHQWVRIRFXODUVLJQVDQG
V\PSWRPV$W9LVLWRQO\QR&$(ÂŠH[SRVXUHZLOORFFXUEXWVLJQVDQGV\PSWRPVZLOOEH
DVVHVVHGHL036 Ophthalmic Solution 
Clinical Study Protocol HL036-DED-US-P301Sponsor: HanAll Biopharma, Co., Ltd. 
24 January 2019
Confidential Page 17
7KHWRWDOQXPEHURIH[SHFWHGSDU WLFLSDQWVLQFOXGLQJVFUHHQIDL OXUHVLVDSSUR[LPDWHO\
VXEMHFWV
$VWXG\IORZFKDUWDSSHDUVEHORZ
9LVLW
'D\Â“
&$(ÂŠ6FUHHQLQJ ,QIRUPHG&RQVHQW
'HPRJUDSKLFV0HGLFDO0H GLFDWLRQ	2FXODU+LVWRU\
5HYLHZRI4XDOLILF DWLRQ&ULWHULD
$GYHUVH(YHQW4XHU\
8ULQH3UHJQDQF\7HVWLQJ
6\PSWRP4XHVWLRQQDLUHV9LVXDO$FXLW\
3UH&$(ÂŠ(\H(YDOXDWLRQV
&$(ÂŠ([SRVXUHZLWKGLVFRPI[INVESTIGATOR_13318]JUDGLQJ
3RVW&$(ÂŠ'LVFRPI[INVESTIGATOR_13318]4XHVWLRQQDLUHV
3RVW&$(ÂŠ(\H(YDOXDWLRQV
6DIHW\$VVHVVPHQWV,QWUDRFXOD U3UHVVXUH>,2 3@DQG'LODWHG
)XQGRVFRS\
5HYLHZRI4XDOLILFDWLRQ& ULWHULDDQG$(4XHU\
5XQLQ	6XEMHFW'DLO\V \PSWRPGLDU\'LVSHQVHG
3ODFHER5XQLQ3HULRGÂ“GD\
9LVLW
'D\
&$(ÂŠ&RQILUPDWLRQ
%DVHOLQH&ROOHFWLRQRI5XQLQ'LDU\
0HGLFDO0HGLFDWLRQ8SGDWH$(4XHU\
5HYLHZRI4XDOLILF DWLRQ&ULWHULD
6\PSWRP4XHVWLRQQDLUHV9LVXDO$FXLW\
3UH&$(ÂŠ(\H(YDOXDWLRQV
&$(ÂŠ([SRVXUHZLWKGLVFRPI[INVESTIGATOR_13318]JUDGLQJ
3RVW&$(ÂŠ'LVFRPI[INVESTIGATOR_13318]4XHVWLRQQDLUHV
3RVW&$(ÂŠ(\H(YDOXDWLRQV
5HYLHZRI4XDOLILFDWLRQ& ULWHULDDQG$(4XHU\
5DQGRPL]DWLRQ
%ORRGVDPSOLQJIRU,PPXQRJHQLFLW\WHVWLQJ
,Q2IILFH'RVH	'URS&RPI[INVESTIGATOR_13318]4XHVWLRQQDLUH
6WXG\'UXJ	6XEMHFW'DLO\ V\PSWRPGLDU\'LVSHQVHG
9LVLW
'D\Â“
:HHN)ROORZ8S&ROOHFWLRQRI6WXG\'UXJ'LDU\
0HGLFDO0HGLFDWLRQ8SGDWH$(4XHU\
6\PSWRP4XHVWLRQQDLUHV9LVXDO$FXLW\
(\H(YDOXDWLRQV
,QRIILFH'RVH
6WXG\'UXJ'LVSHQVDWLRQ
'DLO\V\PSWRPGLDU\'LVSHQVHGHL036 Ophthalmic Solution 
Clinical Study Protocol HL036-DED-US-P301Sponsor: HanAll Biopharma, Co., Ltd. 
24 January 2019
Confidential Page 18
9LVLW
'D\Â“
:HHN&$(ÂŠ
)ROORZ8S &ROOHFWLRQRI6WXG\'UXJ'LDU\
0HGLFDO0HGLFDWLRQ8SGDWH$(4XHU\
6\PSWRP4XHVWLRQQDLUHV9LVXDO$FXLW\
3UH&$(ÂŠ(\H(YDOXDWLRQV
&$(ÂŠ([SRVXUHZLWKGLVFRPI[INVESTIGATOR_13318]JUDGLQJ
3RVW&$(ÂŠ'LVFRPI[INVESTIGATOR_13318]4XHVWLRQQDLUHV
3RVW&$(ÂŠ(\H(YDOXDWLRQV
$(4XHU\
6WXG\'UXJ	6XEMHFW'DLO\ V\PSWRPGLDU\'LVSHQVHG

9LVLW
'D\Â“
:HHN&$(ÂŠ
)ROORZ8S &ROOHFWLRQRI6WXG\'UXJ'LDU\
0HGLFDO0HGLFDWLRQ8SGDWH$(4XHU\
6\PSWRP4XHVWLRQQDLUHV9LVXDO$FXLW\
3UH&$(ÂŠ(\H(YDOXDWLRQV
&$(ÂŠ([SRVXUHZLWKGLVFRPI[INVESTIGATOR_13318]JUDGLQJ
3RVW&$(ÂŠ'LVFRPI[INVESTIGATOR_13318]4XHVWLRQQDLUHV
%ORRGVDPSOLQJIRU,PPXQRJHQLFLW\WHVWLQJ
3RVW&$(ÂŠ(\H(YDOXDWLRQV
$(4XHU\
6WXG\'UXJ	6XEMHFW'DLO\ V\PSWRPGLDU\'LVSHQVHG
 
9LVLW
'D\Â“
:HHN&$(ÂŠ  )ROORZ
8SDQG6WXG\([LWIRU
6XEMHFWVZLWK1HJDWLYH
,PPXQRJHQLFLW\5HVXOWV&ROOHFWLRQRI6WXG\'UXJ'LDU\
0HGLFDO0HGLFDWLRQ8SGDWH$(4XHU\
8ULQH3UHJQDQF\7HVWLQJ
6\PSWRP4XHVWLRQQDLUHV9LVXDO$FXLW\
3UH&$(ÂŠ(\H(YDOXDWLRQV
&$(ÂŠ([SRVXUHZLWKGLVFRPI[INVESTIGATOR_13318]JUDGLQJ
3RVW&$(ÂŠ'LVFRPI[INVESTIGATOR_13318]4XHVWLRQQDLUHV
%ORRGVDPSOLQJIRU,PPXQRJHQLFLW\WHVWLQJ
3RVW&$(ÂŠ(\H(YDOXDWLRQV
6DIHW\$VVHVVPHQWV,2 3DQG'LODWHG)XQGRVFRS\
$(4XHU\
6WXG\([LW
7RZRPHQRIFKLOGEHDULQJSRWHQWLDODVGHILQHG
7KH9LVLWVWXG\GUXJNLWLVUHGLVSHQVHGDW9LVLW
)RUVXEMHFWVZLWKQHJDWLYHLPPXQRJHQLFLW\UHVXOWVDWSUHYLRXVY LVLWV9LVLWVRU
6XEMHFWVZKRWHUPLQDWHHDUO\GXUL QJWKHWUHDWPHQWSHULRGZLOOE HDVNHGWRFRPSOHWHVDIHW\
DVVHVVPHQWVSULRUWRFRPPHQFHPHQ WRIDQ\DOWHUQDWLYHGU\H\HWK HUDS\LIDWDOOSRVVLEOH
6XEMHFWVZKRDUHWHUPLQDWHGHDUO\ IURPWKHVWXG\ZLOOQRWEHUH SODFHGHL036 Ophthalmic Solution 
Clinical Study Protocol HL036-DED-US-P301Sponsor: HanAll Biopharma, Co., Ltd. 
24 January 2019
Confidential Page 19
678'<3238/$7,21
1XPEHURI6XEMHFWV
,WLVHVWLPDWHGWKDWDSSUR[LPD WHO\VXEMHFWVZLOOEHVFUHHQ HGWRHQUROODSSUR[LPDWHO\
UDQGRPL]HGVXEMHFWVLQHDF KDUP6XEMHFWVZLOOEHUDQ GRPL]HGLQDUDWLRRI
+/2SKWKDOPLF6ROX WLRQWRSODFHER6ROXWLRQ 
6WXG\3RSXODWLRQ&KDUDFWHULVWLFV
$OOVXEMHFWVPXVWEHDWOHDVW \HDUVRIDJHRIHLWKHUJHQGHU DQGRIDQ\UDFHDQGPXVW
PHHWDOOLQFOXVLRQFULWHULDD QGQRQHRIWKHH[FOXVLRQFULWHULD 
,QFOXVLRQ&ULWHULD
,QGLYLGXDOVHOLJLEOHWRSDUWLFLSDW HLQWKLVVWXG\PXVWPHHWDOO RIWKHIROORZLQJFULWHULD
%HDWOHDVW\HDUVRIDJH
3URYLGHZULWWHQLQIRUPHGFRQVHQW
%HZLOOLQJDQGDEOHWRFRPSO\ ZLWKDOOVWXG\SURFHGXUHV
+DYHDSDWLHQWUHSRU WHGKLVWRU\RIGU\H\HIRUDWOHDVWPRQWK VSULRUWR9LVLW
+DYHDKLVWRU\RIXVHRUGHVLUH WRXVHH\HGURSVIRUGU\H\HV\ PSWRPVZLWKLQ 
RI9LVLW
+DYHDEHVWFRUUHFWHGYLVXDODFX LW\%&9$RI 0LQLPXP$QJOHRI 5HVROXWLRQ
ORJ0$5RUEHWWHU6 QHOOHQHTXLYDOHQWVFR UHRI LQHDFKH\HD W9LVLW

5HSRUWDVFRUHRI DFFRUG LQJWRWKH2UD&DOLEUDÂŠ2FXODU'LVFRPI[INVESTIGATOR_13318]	6\PSWRP
4XHVWLRQQDLUHLQDWOHDVWRQHRIW KHGU\H\HV\PSWRPVDW9LVLWV DQG
+DYHD6FKLUPHUÂ¶V7HVWVFRUH RIÂ”PPDQGÂ•PPDW9LVLWV DQG
+DYHDFRUQHDOIOXRUHVFHLQVWDLQLQ JVFRUHRI DFFRUGLQJWRWKH 2UD&DOLEUDÂŠ
&RUQHDODQG&RQMXQFWLYDO6WDLQLQJ6 FDOHIRU*UDGLQJRI)OXRUHVF HLQ6WDLQLQJLQDW
OHDVWRQHH\HDW9LVLWVDQG
+DYHDFRQMXQFWLYDOUHGQHVVVFRUH DFFRUGLQJWRWKH2UD&DOLEUDÂŠ&RQMXQFWLYDO
5HGQHVVIRU'U\(\H6FDOHLQD WOHDVWRQHH\HDW9LVLWVDQG SUH&$(ÂŠ
'HPRQVWUDWHLQWKHVDPHH\ HVDUHVSRQVHWRWKH&$(ÂŠDW9LVLWVDQGDVGHILQHG
E\






HL036 Ophthalmic Solution 
Clinical Study Protocol HL036-DED-US-P301Sponsor: HanAll Biopharma, Co., Ltd. 
24 January 2019
Confidential Page 20
+DYHDWOHDVWRQHH\HWKHVDPH H\HVDWLVI\DOOFULWHULDIRU DQGDERYH
$QHJDWLYHXULQHSUHJQDQF\WHVWLIIHPDOHRIFKLOGEHDULQJSRWHQ WLDOWKRVHZKRDUHQRW
VXUJLFDOO\VWHULOL]HG>ELODWHUD OWXEDOOLJDWLRQK\VWHUHFWRP\R UELODWHUDORRSKRUHFWRP\@
RUSRVWÂ±PHQRSDXVDO>PRQWKVDIWHU ODVWPHQVHV@DQGPXVWXVH DGHTXDWHELUWK
FRQWUROWKURXJKWKHVWXG\SHUL RG)RUQRQVH[XDOO\DFWLYHIHPDO HVDEVWLQHQFHPD\EH
UHJDUGHGDVDQDGHTXDWHPHWKRGRIELUWKFRQWURO
([FOXVLRQ&ULWHULD
,QGLYLGXDOVZKRPHHWDQ\RIWKHI ROORZLQJH[FOXVLRQFULWHULDZL OOQRWEHHOLJLEOHWR
SDUWLFLSDWHLQWKHVWXG\
+DYHDQ\FOLQLFDOO\VLJQLILFDQW VOLWODPSILQGLQJVDW9LVLWW KDWPD\LQFOXGHDFWLYH
EOHSKDULWLVPHLERPLDQJODQGG\V IXQFWLRQOLGPDUJLQLQIOD[COMPANY_003]WL RQRUDFWLYHRFXODU
DOOHUJLHVWKDWUHTXL UHWKHUDSHXWLFWUHD WPHQWDQGRULQWKHRSL QLRQRIWKHLQYHVWLJDWRU
PD\LQWHUIHUHZLWKVWXG\SDUDPHWHUV
%HGLDJQRVHGZLWKDQRQJRLQJRFXO DULQIHFWLRQEDFWHULDOYLUDO RUIXQJDORUDFWLYH
RFXODULQIOD[COMPANY_003]WL RQDW9LVLW
+DYHZRUQFRQWDFWOHQVHVZLWKL QGD\VRI9LVLWRUDQWLFLSDWH XVLQJFRQWDFWOHQVHV
GXULQJWKHVWXG\
+DYHSUHYLRXVO\KDGODVHUDVVLVWHG LQVLWXNHUDWRPLOHXVLV/$6,.VXUJHU\ZLWKLQWKH
ODVWPRQWKV
+DYHXVHG5HVWDVLVÂŠ;LLGUDÂŠRU&HTXDÂŠZLWKLQGD\VRI9LVLW
+DYHDQ\SUHYLRXVH[SHULHQFHXVLQJ+/
+DYHKDGDQ\RFXODUDQGRUOL GVXUJHULHVLQWKHSDVWPRQWKVR UKDYHDQ\SODQQHG
RFXODUDQGRUOLGVXUJHUL HVRYHUWKHVWXG\SHULRG
%HXVLQJRUDQWLFLSDWHXVLQJWH PSRUDU\SXQFWDOSOXJVGXULQJWKH VWXG\WKDWKDYHQRW
EHHQVWDEOHZLWKLQGD\VRI9LVLW
%HFXUUHQWO\WDNLQJDQ\WRSL FDORSKWKDOPLFSUHVFULSWLRQLQFOXG LQJPHGLFDWLRQVIRU
JODXFRPDRURYHUWKHFRXQWHUVRO XWLRQVDUWLILFLDOWHDUVJHOV RUVFUXEVDQGFDQQRW
GLVFRQWLQXHWKHVHPHGLFDWLRQVI RUWKHGXUDWLRQRIWKHWULDOH[ FOXGLQJPHGLFDWLRQV
DOORZHGIRUWKHFRQGXFW RIWKHVWXG\WKHUHVSHFWLYHZDVKRXW SHULRGVDUHUHTXLUHGIRU
WKHIROORZLQJPHGLFDWLRQV
D$QWLKLVWDPLQHVLQFOXGLQJRFXODUKRXUVSULRUWR9LVLW
E2UDODVSLULQRUDVSLULQÂ±FRQWDL QLQJSURGXFWVDOORZHGLIGRVHKDV EHHQVWDEOH
RYHUSDVWGD\VSULRUWR9LV LWDQGQRFKDQJHLQGRVHDQWLFL SDWHGGXULQJ
WKHVWXG\SHULRG
F&RUWLFRVWHURLGVRUPDVWFHOOVW DELOL]HUVLQFOXGLQJRFXODU GD\VSULRU
WR9LVLWHL036 Ophthalmic Solution 
Clinical Study Protocol HL036-DED-US-P301Sponsor: HanAll Biopharma, Co., Ltd. 
24 January 2019
Confidential Page 21
G$Q\PHGLFDWLRQRUDORUWRSLFDONQRZQWRFDXVHRFXODUGU\LQJW KDWKDVQRW
EHHQDGPLQLVWHUHGDVDVWDEOH GRVHIRUDWOHDVWGD\VSULRUW R9LVLWDQG
GXULQJWKHVWXG\
H$OORWKHUWRSLFDORSKWKDOPLFSUHSDU DWLRQVLQFOXGL QJDUWLILFLDO WHDU
VXEVWLWXWHVRWKHUWKDQWKHVWX G\GURSVKRXUVSULRUWR9LVL W
+DYHDQXQFRQWUROOHGV \VWHPLFGLVHDVH
%HDZRPDQZKRLVSUHJQDQWQXUVL QJRUSODQQLQJDSUHJQDQF\
%HXQZLOOLQJWRVXEPLWDXULQHSUHJ QDQF\WHVWDW9LVLWDQG9L VLWRUHDUO\
WHUPLQDWLRQYLVLWLI RIFKLOGEHDULQJSRWHQWLDO1RQFKLOGEHDU LQJSRWHQWLDOLVGHILQHG
DVDZRPDQZKRLVSHUPDQHQWO\VW HULOL]HGHJKD VKDGDK\VWHU HFWRP\RUWXEDO
OLJDWLRQRULVSRVWPHQRSDXVDO ZLWKRXWPHQVHVIRUFRQVHFX WLYHPRQWKV
%HDZRPDQRIFKLOGEHDULQJSRWHQWLDOZKRLVQRWXVLQJDQDFFHSW DEOHPHDQVRIELUWK
FRQWURODFFHSWDEOHPHWKRGVRIF RQWUDFHSWLRQLQFOXGHKRUPRQDO Â±RUDOLPSODQWDEOH
LQMHFWDEOHRUWUDQVGHUPDOFRQWU DFHSWLYHVPHFKDQLFDOÂ±VSHUPLF LGHLQFRQMXQFWLRQ
ZLWKDEDUULHUVXFKDVDGLDSKUDJ PRUFRQGRPLQWUDXWHULQHGHYL FHRUVXUJLFDO
VWHULOL]DWLRQRISDUWQHU)RUQRQ VH[XDOO\DFWLYHIHPDOHVDEV WLQHQFHPD\EH
UHJDUGHGDVDQDGHTXDWHPHW KRGRIELUWKFRQWUROKRZHYHULIWK HVXEMHFWEHFRPHV
VH[XDOO\DFWLYHGXULQJWKHVWXG\ VKHPXVWDJUHHWRXVHDGHTXDW HELUWKFRQWURODV
GHILQHGDERYHIRUWKHUH PDLQGHURIWKHVWXG\
+DYHDNQRZQDOOHUJ\DQGRUVHQV LWLYLW\WRWKHWHVWDUWLFOHRU LWVFRPSRQHQWV
+DYHDFRQGLWLRQRUEHLQDVLWXD WLRQZKLFKWKHLQYHVWLJDWRUIH HOVPD\SXWWKHVXEMHFW
DWVLJQLILFDQWULVNPD\FRQIRXQGWKHVWXG\UHVXOWVRUPD\LQW HUIHUHVLJQLILFDQWO\ZLWK
WKHVXEMHFWÂ¶VSDUWLFLSDWLRQLQWKHVWXG\
%HFXUUHQWO\HQUROOHGLQDQLQYHV WLJDWLRQDOGUXJRUGHYLFHVWXG \RUKDYHXVHGDQ
LQYHVWLJDWLRQDOGUXJRUGHY LFHZLWKLQGD\VRI9LVLW
%HXQDEOHRUXQZLOOLQJWRIROORZLQ VWUXFWLRQVLQFOXGLQJSDUWLF LSDWLRQLQDOOVWXG\
DVVHVVPHQWVDQGYLVLWV
:LWKGUDZDO&ULWHULD 
6XEMHFWVPD\ZLWKGUDZWKHLUFRQV HQWWRSDUWLFLSDWHLQWKHVWXG\ DWDQ\WLPHZLWKRXW
SUHMXGLFH7KH,QYHVWLJDWRUPXVW ZLWKGUDZIURPWKHVWXG\DQ\VX EMHFWZKRUHTXHVWVWREH
ZLWKGUDZQ$VXEMHFWÂ¶VSDUWLFLSD WLRQLQWKHVWXG\PD\EHGLVFRQ WLQXHGDWDQ\WLPHDWWKH
GLVFUHWLRQRIWKH,QYHVWLJDWRU DQGRU6SRQVRUDQGLQDFFRUGDQFH ZLWKKLVKHUFOLQLFDO
MXGJPHQW+RZHYHULWLVHQFRXUDJ HGWKDWWKH,QYHVWLJDWRUFRQWD FWWKH6SRQVRUZKHQ
SRVVLEOHWRGLVFXVVSRVVLEOHU HDVRQVIRUGLVFRQWLQXDWLRQSULRU WRZLWKGUDZLQJDVXEMHFW
IURPWKHVWXG\:KHQSRVVLEOHWKH WHVWVDQGHYDOXDWLRQVOLVWHG IRUWKHWHUPLQDWLRQYLVLW
VKRXOGEHFDUULHGRXW
+DQ$OO%LRSKDUPD&R/WGDQG2U DPXVWEHQRWLILHGRIDOOVXE MHFWZLWKGUDZDOVDVVRRQ
DVSRVVLEOH+DQ$OO%LRSKDUPD& R/WGDOVRUHVHUYHVWKHULJK WWRGLVFRQWLQXHWKHVWXG\
DWDQ\WLPHIRUHLWKHU FOLQLFDORUDGPLQLV WUDWLYHUHDVRQVDQGW RGLVFRQWLQXHSD UWLFLSDWLRQ
E\DQLQGLYLGXDO,QYHVWLJDWRURU VLWHIRUSRRUHQUROOPHQWRUQR QFRPSOLDQFHHL036 Ophthalmic Solution 
Clinical Study Protocol HL036-DED-US-P301Sponsor: HanAll Biopharma, Co., Ltd. 
24 January 2019
Confidential Page 22
5HDVRQVIRUZKLFKWKH,QYHVWLJD WRURU+DQ$OO%LRSKDUPD&R/W GPD\ZLWKGUDZD
VXEMHFWIURPWKHVWXG\LQFO XGHEXWDUHQRWOLPLWH GWRWKHIRO ORZLQJ
x6XEMHFWH[SHULHQFHVDVHU LRXVRULQWROHUDEOH$(
x6XEMHFWUHTXLUHVPHGLFDWLRQSU RKLELWHGE\WKHSURWRFRO
x6XEMHFWGRHVQRWDGKHUHWRVWXG\U HTXLUHPHQWVVSHFLILHGLQWKH SURWRFRO
x6XEMHFWZDVHUURQHRXVO\DGPLWWHGL QWRWKHVWXG\RUGRHVQRWPHH WHQWU\FULWHULD
x6XEMHFWLVORVWWRIROORZÂ±XS
x6XEMHFWEHFRPHVSUHJQDQW 
,IDVXEMHFWIDLOVWRUHWXUQIR UVFKHGXOHGYLVLWVDGRFXPHQWHG HIIRUWPXVWEHPDGHWR
GHWHUPLQHWKHUHDVRQ,IWKHVXEM HFWFDQQRWEHUHDFKHGE\WHOHS KRQHDIWHUWZRDWWHPSWVD
FHUWLILHGOHWWHUVKRXOGEHVHQWW RWKHVXEMHFWRUWKHVXEMHFWÂ¶ VOHJDOO\DXWKRUL]HG
UHSUHVHQWDWLYHLIDSSURSULDWH UHTXHVWLQJFRQWDFWZLWKWKH,QY HVWLJDWRU7KLVLQIRUPDWLRQ
VKRXOGEHUHFRUGHGLQWKHVWXG\UHFRUGV
7KH,QYHVWLJDWRURUGHVLJQHH PXVWH[SODLQWRHDFKVXEMHFWEHIR UHHQUROOPHQWLQWRWKH
VWXG\WKDWIRUHYDOXDWLRQRIV WXG\UHVXOWVWKHVXEMHFWÂ¶VSURW HFWHGKHDOWKLQIRUPDWLRQ
REWDLQHGGXULQJWKHVWXG\PD\EH VKDUHGZLWKWKHVWXG\VSRQVRU UHJXODWRU\DJHQFLHVDQG
,QYHVWLJDWLRQDO5HYLHZ%RDUG,5%,QGHSHQGHQW(WKLFV&RPPLWWH H,(&,WLVWKH
,QYHVWLJDWRUÂ¶VRUGHVLJQHHÂ¶V UHVSRQVLELOLW\WRREWDLQZULWWHQ SHUPLVVLRQWRXVHSURWHFWHG
KHDOWKLQIRUPDWLRQSHUFRXQWU\Â±V SHFLILFUHJXODWLRQVVXFKDV+H DOWK,QVXUDQFH3RUWDELOLW\
DQG$FFRXQWDELOLW\$FW+,3$$LQW KH8QLWHG6WDWHVIURPHDFK VXEMHFWRULI
DSSURSULDWHWKHVXEMHFWÂ¶VOHJDOO\ DXWKRUL]HGUHSUHVHQWDWLYH, ISHUPLVVLRQWRXVHSURWHFWHG
KHDOWKLQIRUPDWLRQLVZLWKGUDZQ LWLVWKH,QYHVWLJDWRUÂ¶VUHVSR QVLELOLW\WRREWDLQDZULWWHQ
UHTXHVWWRHQVXUHWKDWQRIXUWK HUGDWDZLOOEHFROOHFWHGIURP WKHVXEMHFWDQGWKHVXEMHFW
ZLOOEHUHPRYHGIURPWKHVWXG\
678'<3$5$0(7(56
(IILFDF\0HDVXUHV 
3ULPDU\(IILFDF\(QGSRLQWV
7KHSULPDU\HIILFDF\HQGSRL QWVRIWKHVWXG\DUH
x,QIHULRUFRUQHDOVWDLQLQJ VLJQ3UHWR3RVW&$(ÂŠDW'D\:HHN
DQG
x2FXODUGLVFRPI[INVESTIGATOR_13318]V\PSWRP3UH&$(ÂŠDW'D\:HHN
6HFRQGDU\(IILFDF\(QGSRLQWV
x)OXRUHVFHLQVWDLQLQJE\UHJLRQ FHQWUDOVXSHULRULQIHULRUWH PSRUDOQDVDOFRUQHDO
VXPFRQMXQFWLYDOVXPDQGWRWDOVWDLQLQJ
x&RQMXQFWLYDOOLVVDPLQHJUHHQVWDLQ LQJE\UHJLRQFHQWUDOVXSHU LRULQIHULRU
WHPSRUDOQDVDOFRUQHDOVXPF RQMXQFWLYDOVXPDQGWRWDOVWDLQL QJHL036 Ophthalmic Solution 
Clinical Study Protocol HL036-DED-US-P301Sponsor: HanAll Biopharma, Co., Ltd. 
24 January 2019
Confidential Page 23
x&RQMXQFWLYDOUHGQHVV
x6FKLUPHUÂ¶V7HVW
x7HDUILOPEUHDNXSWLPH7)%87
x2FXODU6XUIDFH'LVHDVH,QGH[Â‹26',Â‹
x9LVXDO$QDORJ6FRUH9$6
x'DLO\ V\PSWRP GLDU\ 2UD &DOLEUD 2FXODU 'LVFRPI[INVESTIGATOR_13318] 	 6\PSWRP
4XHVWLRQQDLUH2FXODU'LVFRPI[INVESTIGATOR_13318]6FRUH
x'DLO\V\PSWRPGLDU\E\&$(ÂŠ4XDOLILFDWLRQ7LPH
&ULWHULDIRU(IIHFWLYHQHVV
7KHVSHFLILFFULWHULDIRUHIIHFWLYHQHVVIRUWKHHQGSRLQWVGHULY HGIURPWKHPHDVXUHV
GHVFULEHGDERYHDUH
x0HDQFKDQJHIURPEDVHOLQHWR'D\ :HHNLQLQIHULRUFRUQHD OVWDLQLQJ3UH
WR3RVW&$(ÂŠLQWKHGHVLJQDWHGVWXG\H\HD VDVVHVVHGE\WKH2UD&DOLEUDÂŠ&RUQHDO
DQG&RQMXQFWLYDO6WDLQLQJ6FDOHIR U*UDGLQJRI)OXRUHVFHLQ6WDL QLQJ
DQG
x0HDQFKDQJHIURPEDVHOLQHWR'D\ :HHNLQRFXODUGLVFRPIR UW3UH&$(ÂŠ
LQWKHGHVLJQDWHGVWXG\H\HD VDVVHVVHGE\WKH2UD&DOLEUDÂŠ2FXODU'LVFRPI[INVESTIGATOR_13318]
6FDOH
6DIHW\0HDVXUHV
x9LVXDODFXLW\
x6OLWODPSHYDOXDWLRQ
x$GYHUVHHYHQWTXHU\
x,23
x'LODWHGIXQGRVFRS\
x,PPXQRJHQLFLW\WR+/LQ6HUXP
678'<0$7(5,$/6
6WXG\7UHDWPHQWV
6WXG\7UHDWPHQWV
6XEMHFWVZLOOUHFHLYHGRVHV%, 'RIHLWKHU+/2SKWKDOPL F6ROXWLRQRUSODFHER
DGPLQLVWHUHGWRWKHRFXODUVXUIDFHDVDQH\HGURS
+/RSKWKDOPLFVROXWLRQLVDPROHFXODUO\HQJLQHHUHG71)5IUD JPHQW+/
0ROHFXOHIUDJPHQWDWLRQDQGHQJLQ HHULQJWHFKQLTXHVDUHDSSOLHGI RUHQKDQFHGWLVVXH
GLVWULEXWLRQLQFUHDVHGVWDELOLW\DQGSRWHQF\HL036 Ophthalmic Solution 
Clinical Study Protocol HL036-DED-US-P301Sponsor: HanAll Biopharma, Co., Ltd. 
24 January 2019
Confidential Page 24
'HVFULSWLRQDQG-XVWLILFDWLRQIRU WKH5RXWHRI$GPLQLVWUDWLRQ 'RVDJH'RVDJH
5HJLPHQDQG7UHD WPHQW3HULRG
7RSLFDORSKWKDOPLFGRVLQJLVWKHRS WLPDOURXWHRID GPLQLVWUDWLR QIRUGU\H\HWUHDWPHQWV
7KHGRVDJHDQGGRVDJHUHJLPHQ ZDVVHOHFWHGEDVHGRQQRQFOLQLFDO VWXGLHVGHVFULEHGLQ
6HFWLRQ 7KHSURSRVHGWUHDWPHQWSHUL RGRIZHHNVLVDOVREDVHGRQQRQF OLQLFDODQG
FOLQLFDOVWXGLHVDQGRQWKHDQWLLQ IOD[COMPANY_003]WRU\PHFKDQLVPRIDFWL RQRIWKHGUXJ
,QVWUXFWLRQVIRU8VH DQG$GPLQLVWUDWLRQ
x6WXG\GUXJZLOOEHVXSSOLHGDVD VWHULOHFOHDUFRORUOHVVOLTX LGVROXWLRQFRQWDLQLQJ
$FWLYH3KDUPDFHXWLFDO,QJUHGLHQW$3,+/FDYLW\ P/ORZÂ±
GHQVLW\SRO\HWK\OHQH/'3(XQLWGRVHYLDOVZLWKDILOOYROXPH RIDSSUR[LPDWHO\
P/(DFKP/RIWKHVROXWLRQFRQWDLQVPJRIWKH$ 3,,QDGGLWLRQ
WR+/WKHFRPSRQHQWVRIWKH GUXJSURGXFWVROXWLRQDUHVRGL XPFKORULGH
WRQLFLW\DGMXVWLQJDJHQWFLWULFDFLGPRQRK\GUDWHEXIIHULQJ VROXWLRQVRGLXP
K\GUR[LGHVROXWLRQDQGK\GURFKORU LFDFLGERWKIRUS+DGMXVW PHQWVDQG
VWHULOHZDWHUIRULQMHF WLRQDVDVROYHQW
x7KHSODFHERVROXWLRQFRQVLVWVRI DOOFRPSRQHQWVRIWKHGUXJSUR GXFWVROXWLRQZLWK
WKHH[FHSWLRQRI+/
x$WWKHVWXG\VLWHDOOLQYHVWLJD WLRQDOSURGXFW,3PXVWEHVWR UHGXQGHUWKH
FRQGLWLRQVVSHFLILHGLQWKH,QYHVW LJDWRUÂ¶V%URFKXUHLQDVHFXUH DUHDDFFHVVLEOH
RQO\WRWKHGHVLJQDWHGTXDOLILH GFOLQLFDOVLWHSHUVRQQHO$OO, 3PXVWEHVWRUHG
LQYHQWRULHGDQGWKHL QYHQWRULHVFDUHIXOO\DQGDFFXUDWHO\GRFXPH QWHGDFFRUGLQJWR
DSSOLFDEOHVWDWHIHGHUDODQGOR FDOUHJXODWLRQV,QWHUQDWLRQDO &RQIHUHQFHRQ
+DUPRQL]DWLRQ,&+*RRG&OLQLFDO 3UDFWLFHV*&3VDQGVWXG\SU RFHGXUHV
x+/DQGSODFHERVROXWLRQVVKRXO GEHVWRUHGUHIULJHUDWHGÂ±Âƒ &6XEMHFWVZLOO
EHLQVWUXFWHGWRVWRUH+/D QGSODFHERVROXWLRQVLQDUHIULJH UDWRUÂ±Âƒ&,WLV
UHFRPPHQGHGWKDW+/DQGSODFHERV ROXWLRQVEHSODFHGDWURRP DPELHQW
WHPSHUDWXUHDWOHDVWÂ“KRXUV SULRUWRDGPLQLVWUDWLRQWRV XEMHFWV6WHULOHGUXJ
SURGXFWDQGSODFHERVROXWLRQVDUH SDFNDJHGLQWRVLQJOHÂ±XVH P//'3(XQLW
GRVHYLDOVWKDWGHOLYHUDQD SSUR[LPDWHSHUGU RSYROXPHRIÈ/ 7ZRFDYLW\XQLW
GRVHYLDOVDUHSDFNDJHGLQDOX PLQXPIRLOSRXFKHVXQGHUQLWURJHQ 8QLWGRVHYLDOV
DUHIRU6,1*/(86(21/<
x$WDPLQLPXPWKHLPPHGLDWHRUVHFRQGDU\VWXG\GUXJSDFNDJLQJZ LOOSURYLGHWKH
IROORZLQJLQIRUPDWLRQVWXG\V SRQVRULGHQWLILF DWLRQEDWFKQXPE HUGLUHFWLRQVIRU
XVHUHTXLUHGVWRUDJHFRQGLWLRQV FDXWLRQVWDWHPHQWVLQFOXGLQJ Â³1HZ'UXJÂ±
/LPLWHGE\)HGHUDO/DZWR,QYHVWLJDWLRQDO8VHÂ´ODQJXDJHVWXG\ LGHQWLILFDWLRQ
DQGSURGXFWUHWHVWGDWH
2WKHU6WXG\6XSSOLHV
8ULQHSUHJQDQF\WHVWV6FKLUPHUÂ¶V WHVWVWULSVVRGLXPIOXRUHVFH LQOLVVDPLQHJUHHQ)OXUHVV
EORRGGUDZVXSSOLHVHL036 Ophthalmic Solution 
Clinical Study Protocol HL036-DED-US-P301Sponsor: HanAll Biopharma, Co., Ltd. 
24 January 2019
Confidential Page 25
678'<0(7+2'6$1'352&('85(6
6XEMHFW(QWU\3URFHGXUHV
2YHUYLHZ
6XEMHFWVDVGHILQHGE \WKHFULWHULDLQ 6HFWLRQV DQGZLOOEHFRQVLGHUHGIRU
HQWU\LQWRWKLVVWXG\
,QIRUPHG&RQVHQW
3ULRUWRDVXEMHFWÂ¶VSDUWLFLSD WLRQLQWKHWULDOLHSULRUWR FKDQJHVLQDVXEMHFWÂ¶VPHGLFDO
WUHDWPHQWDQGRUSULRUWRVWXG\U HODWHGSURFHGXUHVWKHVWXG\ ZLOOEHGLVFXVVHGZLWKHDFK
VXEMHFWDQGVXEMHFWVZLVKLQJWRSD UWLFLSDWHPXVWJLYHZULWWHQ LQIRUPHGFRQVHQWXVLQJDQ
,&)7KH,&)PXVWEHWKHPRVWU HFHQWYHUVLRQWKDWKDVUHFHLYHG DSSURYDOIDYRUDEOH
UHYLHZE\DSURSHUO\FRQVWLWXWHG,QVWLWXWLRQDO5HYLHZ%RDUG,5 %
:DVKRXW,QWHUYDOV
3URKLELWHGPHGLFDWLRQVWUHDWPHQWVDQGDFWLYLWLHVDUHRXWOLQHG LQWKH([FOXVLRQ&ULWHULD
6HFWLRQ 
3URFHGXUHVIRU)LQDO6WXG\(QWU\
6XEMHFWVPXVWPHHWDOOLQFOXVL RQDQGQRQHRIWKHH[FOXVLRQFULW HULD
0HWKRGVIRU$VVLJQPHQW WR7UHDWPHQW*URXSV
3ULRUWRLQLWLDWLRQRIVWXG\UXQ LQDW9LVLWHDFKVXEMHFW ZKRTXDOLILHVIRUHQWU\ZLOOEH
DVVLJQHGDVFUHHQLQJQXPEHU$ OOVFUHHQLQJQXPEHUVZLOOEHDVVL JQHGLQVWULFWQXPHULFDO
VHTXHQFHDWDVLWHDQGQRQXPEH UVZLOOEHVNLSSHGRURPLWWHG, IDOOLQFOXVLRQDQG
H[FOXVLRQFULWHULDDUHPHW DW9LVLWVDQGHDFKTXDOLI\LQJV XEMHFWZLOOWKHQEHDVVLJQHG
DUDQGRPL]DWLRQQXPEHUDWWKHH QGRI9LVLWXVLQJDQLQWHUDFWL YHZHEUHVSRQVHV\VWHP
7KHUDQGRPL]DWLRQQXPEHUZLOOEH UHFRUGHGRQWKHSDWLHQWÂ¶VVRXU FHGRFXPHQWDQG
HOHFWURQLFFDVHUHSRUWIRUPH&5) $QHZNLWZLOOEHGLVSHQVHG DW9LVLWVDQG
EDVHGRQWKHVXEMHFWÂ¶VU DQGRPL]DWLRQ7KHYLVLWNLWZLOOEHU HGLVSHQVHGDW9LVLW7KH
6SRQVRU,QYHVWLJDWRUVDQGVWX G\VWDIIZLOOEHPDVNHGGXULQJW KHUDQGRPL]DWLRQSURFHVV
DQGWKURXJKRXWWKHVWXG\
&RQFXUUHQW7KHUDSLHV
7KHXVHRIDQ\FRQFXUUHQWPHG LFDWLRQSUHVFULSWLRQRURYHUWKH FRXQWHULVWREHUHFRUGHG
RQWKHVXEMHFWÂ¶VVRXUFHGRFXPHQW DQGFRUUHVSRQGLQJH&5)DORQJZ LWKWKHUHDVRQWKH
PHGLFDWLRQZDVWDNHQ
&RQFXUUHQWHQUROOPHQWLQDQRWKHULQYHVWLJDWLRQDOGUXJRUGHYLFH VWXG\LVQRWSHUPLWWHG
3URKLELWHG0HGLFD WLRQV7UHDWPHQWV
'LVDOORZHGPHGLFDWLRQVWUHDWPHQW VGXULQJWKHVWXG\DUHRXWOLQHG LQWKH([FOXVLRQ&ULWHULD
6HFWLRQ 
(VFDSH0HGLFDWLRQV
1RHVFDSHPHGLFDWLRQVDUHU HTXLUHGIRUWKLVVWXG\HL036 Ophthalmic Solution 
Clinical Study Protocol HL036-DED-US-P301Sponsor: HanAll Biopharma, Co., Ltd. 
24 January 2019
Confidential Page 26
6SHFLDO'LHWRU$FWLYLWLHV
1RVSHFLDOGLHWVRUDFWLYLWLHVDUHUHTXLUHGIRUWKLVVWXG\
([DPLQDWLRQ3URFHGXUHV
$Q,&)PXVWEHVLJQHGDQGGDWHGE \WKHVXEMHFWWKHSULQFLSDOL QYHVWLJDWRU3,RU
GHVLJQHHDQGZLWQHVVLIUHTXLUH GEHIRUHDQ\VWXG\Â±UHODWHGSUR FHGXUHVDUHSHUIRUPHG
3URFHGXUHVOLVWHGEHORZVKRXOGEH SHUIRUPHGLQWKHJLYHQRUGHU 6HH$SSHQGL[
([DPLQDWLRQ3URFHGXUHV7HV WV(TXLSPHQWDQG7HFKQLTXHV IRUGHWDLOVRQPHWKRGRORJLHV
DQGJUDGLQJV\VWHPV
9LVLW'D\Â±Â“Â±&$(ÂŠ6FUHHQLQJ
$OOVXEMHFWVZLOOXQGHUJRWKHIROORZLQJVFUHHQLQJDVVHVVPHQWV
3UHÂ±&$(ÂŠ
x,QIRUPHG&RQVHQW+,3$$3ULRUWRD Q\FKDQJHVLQDVXEMHFWÂ¶VPHGL FDOWUHDWPHQW
DQGRULQYDVLYHSURFHGXUHVHJ&$(ÂŠWKHVWXG\ZLOOEHGLVFXVVHGZLWKHDFK
VXEMHFWDQGVXEMHFWVZLVKLQJWRSD UWLFLSDWHPXVWJLYHZULWWHQL QIRUPHGFRQVHQW
DQGVLJQD+,3$$IRUP
x'HPRJUDSKLF'DWDDQG0HGLFDO0HGL FDWLRQ2FXODU+LVWRU\&ROOHFW DQGUHFRUGDOO
GHPRJUDSKLFGDWDPHGLFDOKLVW RU\DQ\PHGLFDWLRQVDQGDQ\XQGH UO\LQJ
FRQGLWLRQV6LJQLILFDQWQRQÂ±RFXODU PHGLFDOKLVWRU\RQO\ZLWKL QWKHSDVW\HDUDQG
PHGLFDWLRQVZLWKLQWKHSDVWGD\VZLOOEHFDSWXUHG5HFRUGDQ \PHGLFDWLRQVWKH
VXEMHFWLVWDNLQJDVZHOODVWKRV HWKHVXEMHFWPD\KDYHWDNHQ EXWGLVFRQWLQXHG
ZLWKLQGD\VSULRUWRVFUHHQLQJ
x5HYLHZRI,QFOXVLRQ([FOXVLRQ&ULWHULD
x8ULQH3UHJQDQF\7HVWIRUIHPDOH VRIFKLOGEHDULQJSRWHQWLDO:R PHQRI
FKLOGEHDULQJSRWHQWLDOPXVWKDYHD QHJDWLYHXULQHSUHJQDQF\WHV WWRFRQWLQXHLQWKH
VWXG\
x2UD&DOLEUDÂŠ2FXODU'LVFRPI[INVESTIGATOR_13318]6FDOH
x2UD&DOLEUDÂŠ2FXODU'LVFRPI[INVESTIGATOR_13318]	6\PSWRP4 XHVWLRQQDLUH2FXO DU'LVFRPI[INVESTIGATOR_13318]
6FRUH
x2FXODUGLVFRPI[INVESTIGATOR_13318]XVLQJD9$6
x26',Â‹
x%&9$8WLOL]LQJDQ(DUO\ 7UHDWPHQWRI'LDEHWLF 5HWLQRSDWK\6WXG\ (7'56
&KDUW6XEMHFWVPXVWKDYHDVFRUH RI ORJ0$5RUEHWWHU6QHOOHQ HTXLYDOHQW
VFRUHRI LQHDFKH\HDW9LVLW
x6OLW/DPS%LRPLFURVFRS\$VOLWODPSH[DPZLOOEHSHUIRUPHGDWW KHEHJLQQLQJRI
WKHYLVLWDQGDJDLQ3RVWÂ±&$(ÂŠWRH[FOXGHVXEMHFWVZ LWKGLVDOORZHGRFXODU
FRQGLWLRQVHL036 Ophthalmic Solution 
Clinical Study Protocol HL036-DED-US-P301Sponsor: HanAll Biopharma, Co., Ltd. 
24 January 2019
Confidential Page 27
x&RQMXQFWLYDO5HGQHVV6F RUH$QREMHFWLYHPHDVXUHXVHGWRVFRUH UHGQHVVRQWKH
2UD&DOLEUDÂŠ&RQMXQFWLY DO5HGQHVV6FDOHIRU 'U\(\H+DOISRLQW LQFUHPHQWV
PD\EHXVHG
x7)%87
x&RUQHDODQG&RQMXQFWLYDO6WDLQLQ JIOXRUHVFHLQDVDVVHVVHGE\ WKH2UD&DOLEUDÂŠ
&RUQHDODQG&RQMXQFWLYDO6WDLQLQJ6 FDOHIRU*UDGLQJRI)OXRUHVF HLQ6WDLQLQJ
x&RUQHDODQG&RQMXQFWLYDO6WDLQLQJ OLVVDPLQHJUHH QDVDVVHVVHG E\WKH2UD
&DOLEUDÂŠ&RUQHDODQG&RQMXQFWLYDO6 WDLQLQJ6FDOHIRU*UDGLQJRI /LVVDPLQH
*UHHQ6WDLQLQJ
x0RQLWRULQJDQG4XHU\$(V5HSRUWDQ\$(VWKDWRFFXUDIWHUVLJQLQ JWKH,&)
6FUHHQLQJ&KDOOHQJH&$(ÂŠ
6XEMHFWVPHHWLQJDOORIWKH DERYHHYDOXDWLRQ3UHÂ±&$(ÂŠFULWHULDZLOO XQGHUJRIXUWKHU
VFUHHQLQJHYDOXDWLRQLQWKH&$(ÂŠ6XEMHFWVZLOOEHH[SRVHGWRWKH&$(ÂŠIRU 
2FXODUGLVFRPI[INVESTIGATOR_13318]VHOIDVVHVVP HQWVFRUHV2'6ZLOOEHREWDLQ HGMXVWSULRUWR
HQWHULQJGXULQJDQGMXVWDIWHUWKH&$(ÂŠH[SRVXUH'XULQJWKH&$(ÂŠH[SRVXUH2'6ZLOO
EHFROOHFWHGDW 
3RVWÂ±&$(ÂŠ
x2UD&DOLEUDÂŠ2FXODU'LVFRPI[INVESTIGATOR_13318]6FDOH
x2UD&DOLEUDÂŠ2FXODU'LVFRPI[INVESTIGATOR_13318]	6\PSWRP4 XHVWLRQQDLUH2FXO DU'LVFRPI[INVESTIGATOR_13318]
6FRUH
x9$6GLVFRPI[INVESTIGATOR_13318]VFDOH
x6OLWODPSELRPLFURVFRS\
x&RQMXQFWLYDOUHGQHVV
x7)%87
x&RUQHDODQG&RQMXQFWLYDO6WDLQLQJIOXRUHVFHLQ
x&RUQHDODQG&RQMXQFWLYDO6WDLQ LQJOLVVDPLQHJUHHQ
x6FKLUPHUÂ¶VWHVW
x,23
x'LODWHG)XQGRVFRS\
x5HYLHZRI,QFOXVLRQ([FOXVLRQ&ULWHULD
R(OLJLEOHVXEMHFWVPXVWKDYHDSRV LWLYHUHVSRQVHLQDWOHDVWRQH H\H$SRVLWLYH
UHVSRQVHLVGHILQHGDVPHHWLQJ$/ /RIWKHIROORZLQJFULWHULDLQ WKHVDPHH\H
Â¾+DYLQJDWOHDVWD SRLQWLQFUHDVH LQIOXRUHVFHLQVWDLQLQJLQWK H
LQIHULRUUHJLRQLQDWOHDVWRQHH\HIROORZLQJ&$(ÂŠH[SRVXUHHL036 Ophthalmic Solution 
Clinical Study Protocol HL036-DED-US-P301Sponsor: HanAll Biopharma, Co., Ltd. 
24 January 2019
Confidential Page 28
Â¾5HSRUWLQJDQ2FXODU'LVFRPI[INVESTIGATOR_13318]V FRUH DWRUPRUHFRQVHFXWLYH
WLPHSRLQWVLQDWOHDVWRQHH\HGXULQJ&$(ÂŠH[SRVXUH 



Â¾,IERWKH\HVDUHHTXDOWKHULJ KWH\H2'ZLOOEHGHVLJQDWHGD VWKH
VWXG\H\H
R)ROORZLQJWKHVFUHHQLQJSURFHGXUHVDWWKLVYLVLWDOOVXEMHFWV ZKRPHHWDOO
HOLJLELOLW\FULWHULDDQGKDYHD SRVLWLYHUHVSRQVHDVGHILQHGD ERYHZLOOVHOI
DGPLQLVWHUWKHLULQLWLDOGRVHRI SODFHERGURSVWRERWKH\HV28 RSHQÂ±ODEHO
VLQJOHGURSIRUWUDLQLQJSXU SRVHVDWWKHVWXG\VLWHXQGHUVX SHUYLVLRQRI
WUDLQHGVWXG\ SHUVRQQHOIROORZLQJWKHODVW3RVWÂ±&$(ÂŠVWXG\DVVHVVPHQW
2QO\DVLQJOHGRVHRISODFHERGU RSVZLOOEHDGPLQLVWHUHG28RQ 'D\Â±
x3ODFHERDQG'LDU\'LVSHQVDWLRQD QG$GPLQLVWUDWLRQ3ULRUWRGLV FKDUJHIURPWKH
VWXG\VLWHRQ'D\Â±VXEMHFWVZ LOOEHGLVSHQVHGVXIILFLHQWSO DFHERVXSSO\WRODVW
XQWLO9LVLWDQGZLOOEHHGXFDWHGLQVWXG\GUXJGLDU\UHFRUGLQ JDQGVHOIÂ±
DGPLQLVWUDWLRQRISODFHER6XEMHFW VZLOOEHLQVWUXFWHGWRVHOIÂ± DGPLQLVWHURQHGURS
%,'LQHDFKH\HLQWKHPRUQLQJDQGWKHHYHQLQJXQWLOVFUHHQLQJ 9LVLW7KH
LQLWLDOVHOIDGPLQLVWHUHGGRVH WDNHQLQRIILFHDW9LVLWZLOO EHFRXQWHGDVD
PRUQLQJGRVHUHJDUGOHVVRIYL VLWWLPHDQGVXEMHFWVZLOOEHLQV WUXFWHGWRDGPLQLVWHU
DQHYHQLQJGRVHWKDWQLJKW6XEM HFWVZLOOEHLQVWUXFWHG127WR LQVWLOOVWXG\GUXJ
RQWKHPRUQLQJRIWKHLUQH[WVF KHGXOHGVWXG\YLVLW9LVLW'D \
x0RQLWRULQJDQG4XHU\RI$(V5HSRUWDQ\$(VWKDWRFFXUDIWHUVLJ QLQJWKH,&)
x6FKHGXOH1H[W9LVLW6XEMHFWVZ LOOEHVFKHGXOHGIRU9LVLW
9LVLW'D\Â±&$(ÂŠ&RQILUPDWLRQDQG%DVHOLQH
3UHÂ±&$(ÂŠ
x6WXG\'LDU\3ODFHER&ROOHFWLRQ6 XEMHFWVWXG\GLDULHVDQGDOOXV HGXQXVHGSODFHER
YLDOVGLVSHQVHGIRU'D\VÂ±W RVKRXOGEHFROOHFWHGDQGUHYLH ZHGE\DWUDLQHG
VWXG\WHFKQLFLDQ
x6LWHVWDIIPXVWFRQILUPVXEMHFWV KDYH127DGPLQLV WHUHGWKHLUPR UQLQJSODFHER
GRVHDWKRPH
x5HYLHZRI,QFOXVLRQ([FOXVLRQ&ULWHULD
x0RQLWRULQJDQG4XHU\RI$(V5HSRUWDQ\$(VWKDWRFFXUDIWHUVLJ QLQJWKH,&)
x5HFRUGDOO&KDQJHVLQ&RQFRPLWDQW0HGLFDWLRQV
x2UD&DOLEUDÂŠ2FXODU'LVFRPI[INVESTIGATOR_13318]6FDOH
x2UD&DOLEUDÂŠ2FXODU'LVFRPI[INVESTIGATOR_13318]	6\PSWRP4 XHVWLRQQDLUH2FXO DU'LVFRPI[INVESTIGATOR_13318]
6FRUH
x9$6GLVFRPI[INVESTIGATOR_13318]VFDOHHL036 Ophthalmic Solution 
Clinical Study Protocol HL036-DED-US-P301Sponsor: HanAll Biopharma, Co., Ltd. 
24 January 2019
Confidential Page 29
x26',Â‹
x%&9$8WLOL]LQJDQ(7'56&KDUW
x6OLW/DPS%LRPLFURVFRS\
x&RQMXQFWLYDOUHGQHVV
x7)%87
x&RUQHDODQG&RQMXQFWLYDO6WDLQLQJIOXRUHVFHLQ
x&RUQHDODQG&RQMXQFWLYDO6WDLQ LQJOLVVDPLQHJUHHQ
&RQILUPDWRU\6FUHHQLQJ&KDOOHQJH&$(ÂŠ
6XEMHFWVZLOOEHH [SRVHGWRWKH&$(ÂŠIRU 2FXODUGLVFRPI[INVESTIGATOR_13318]VHOIÂ±
DVVHVVPHQWVFRUHV2'6ZLOOEHREW DLQHGMXVWSULRUWRHQWHULQJ GXULQJDQGMXVWDIWHUWKH
&$(ÂŠH[SRVXUH'XULQJWKH&$(ÂŠH[SRVXUH2'6ZLOO EHFROOHFWHGDW 

3RVWÂ±&$(ÂŠ
x2UD&DOLEUDÂŠ2FXODU'LVFRPI[INVESTIGATOR_13318]6FDOH
x2UD&DOLEUDÂŠ2FXODU'LVFRPI[INVESTIGATOR_13318]	6\PSWRP4 XHVWLRQQDLUH2FXO DU'LVFRPI[INVESTIGATOR_13318]
6FRUH
x9$6GLVFRPI[INVESTIGATOR_13318]VFDOH
x6OLW/DPS%LRPLFURVFRS\
x&RQMXQFWLYDOUHGQHVV
x7)%87
x&RUQHDODQG&RQMXQFWLYDO6WDLQLQJIOXRUHVFHLQ
x&RUQHDODQG&RQMXQFWLYDO6WDLQ LQJOLVVDPLQHJUHHQ
x6FKLUPHUÂ¶VWHVW
x5HYLHZRI,QFOXVLRQ([FOXVLRQ&ULWHULD
R(OLJLEOHVXEMHFWVPXVWUHSOLFDW HDSRVLWLYHUHVSRQVHDWWKLVYL VLWLQWKHVDPH
H\HDVZDVHOLFLWHGLQ9LVLW$ SRVLWLYHUHVSRQVHLVGHILQHG DVPHHWLQJ
$//RIWKHIROORZLQJFUL WHULDLQWKHVDPHH\H
Â¾+DYLQJDWOHDVWD SRLQWLQFUHDVH LQIOXRUHVFHLQVWDLQLQJLQWK H
LQIHULRUUHJLRQLQDWOHDVWRQHH\HIROORZLQJ&$(ÂŠH[SRVXUH
Â¾5HSRUWLQJDQ2FXODU'LVFRPI[INVESTIGATOR_13318]V FRUH DWRUPRUHFRQVHFXWLYH
WLPHSRLQWVLQDWOHDVWRQHH\HGXULQJ&$(ÂŠH[SRVXUH 


HL036 Ophthalmic Solution 
Clinical Study Protocol HL036-DED-US-P301Sponsor: HanAll Biopharma, Co., Ltd. 
24 January 2019
Confidential Page 30
Â¾,IERWKH\HVDUHHTXDOWKHULJ KWH\H2'ZLOOEHGHVLJQDWHGD VWKH
VWXG\H\H
5DQGRPL]DWLRQ
x%ORRG6DPSOLQJIRU,PPXQRJHQLFLW\7HVWLQJ%ORRGVDPSOHVZLOOEH FROOHFWHG
IURPDOOVXEMHFWVIRULPPXQRJHQLFLW\WHVWLQJSULRUWRVWXG\GUX JLQVWLOODWLRQ
x6WXG\'UXJ,QVWLOODWLRQDWWKH6W XG\6LWH$OOVXEMHFWVKDYLQJD SRVLWLYHUHVSRQVH
DVGHILQHGDERYHDQGPHHWLQJ DOORWKHUVFUHHQLQJHOLJLELOLW\ FULWHULDDIWHU9LVLW
ZLOOEHUDQGRPL]HGWRRQH RIWZRWUHDWPHQWD UPV5DQGRPL]HGVXE MHFWVZLOOVHOI
DGPLQLVWHUWKHLULQLWLDOVWXG\GU XJGRVHELODWHUDOO\DWWKHVWX G\VLWH
x'URS&RPI[INVESTIGATOR_13318]$VVHVVPHQW$GURSF RPI[INVESTIGATOR_13318]HYDOXDWLRQZLOOEHSHUIR UPHG
LPPHGLDWHO\DQGWKHQDWDQG PLQXWHVIROORZLQJLQLWLDOG RVLQJ
x0RQLWRULQJDQG4XHU\RI$(V
x6WXG\'UXJ'LDU\6WXG\'UXJ'LVSHQVDWLRQ3ULRUWRGLVFKDUJHIUR PWKHVWXG\VLWH
RQ9LVLW'D\UDQGRPL]HGV XEMHFWVZLOOEHHGXFDWHGLQVWX G\GUXJGLDU\
UHFRUGLQJDQGVHOIÂ±DGPLQLVWUD WLRQRIVWXG\GUXJ7KHLQLWLDOV HOIDGPLQLVWHUHG
GRVHWDNHQLQRIILFHDW9LVLWZ LOOEHFRXQWHGDVDPRUQLQJGR VHUHJDUGOHVVRI
YLVLWWLPHDQGVXEMHFWVZLOOEHLQV WUXFWHGWRDGPLQ LVWHUDQHYHQLQJGRVHWKDWQLJKW
6XEMHFWVZLOOUHFHLYHWKHLUDVVLJQ HGVWXG\GUXJNLWZLWKVXIILF LHQWVXSSO\WRODVW
XQWLO9LVLWDQGZLOOEHLQVWUXFWH G127WRVHOIÂ±DGPLQLVWHUVWX G\GUXJRQWKH
PRUQLQJRIWKHLUQH[WVFKHGXOH GVWXG\YLVLW9LVLW'D\
x6FKHGXOH1H[W9LVLW6XEMHFWVZ LOOEHVFKHGXOHGIRU9LVLW
9LVLW'D\
7KHUHLVQR&$(ÂŠHYDOXDWLRQDW'D\9LVLW 
x6WXG\'UXJ'LDU\6WXG\'UXJ&R OOHFWLRQ6LWHVWD IIPXVWFRQILUP WKDWVXEMHFWV
KDYH127DGPLQLVWHUHGWKHLUPRU QLQJVWXG\GUXJGRVHDWKRPH6X EMHFWVZLOO
XQGHUJRUHSHDWDVVHVVPHQWVDVIROORZV
x0RQLWRULQJDQG4XHU\$(V
x5HFRUGLQJRIDOO&KDQJHVLQ&RQFRPLWDQW0HGLFDWLRQV
x2UD&DOLEUDÂŠ2FXODU'LVFRPI[INVESTIGATOR_13318]6FDOH
x2UD&DOLEUDÂŠ2FXODU'LVFRPI[INVESTIGATOR_13318]	6\PSWRP4XHVWLRQQDLUH
x9$6GLVFRPI[INVESTIGATOR_13318]VFDOH
x26',Â‹
x%&9$8WLOL]LQJDQ(7'56&KDUW
x6OLW/DPS%LRPLFURVFRS\
x&RQMXQFWLYDOUHGQHVV
x7)%87HL036 Ophthalmic Solution 
Clinical Study Protocol HL036-DED-US-P301Sponsor: HanAll Biopharma, Co., Ltd. 
24 January 2019
Confidential Page 31
x&RUQHDO6WDLQLQJDQG&RQMXQFWLYDOIOXRUHVFHLQ
x&RUQHDODQGDQG&RQMXQFWLYDO6WDLQLQJOLVVDPLQHJUHHQ
x6WXG\'UXJ,QVWLOODWLRQDWWKH6W XG\6LWH6XEMHFWVZLOOVHOIDG PLQLVWHUWKHLUILUVW
VWXG\GUXJGRVHELODWHUDOO\IRU 'D\DWWKHVWXG\VLWHIROORZL QJWKHODVWVWXG\
DVVHVVPHQW7KHHYHQLQJGRVHZ LOOEHDGPLQLVWHUHGDWKRPHE\W KHVXEMHFW
x0RQLWRULQJDQG4XHU\$(V
x6WXG\'UXJ5H'LVSHQVDWLRQ3ULRU WRGLVFKDUJHIURPWKHVWXG\V LWHRQ9LVLW
'D\VWXG\GUXJNLWVIURP'D\ZLOOEHUHGLVSHQVHGWRVXE MHFWVZLWKWKH
UHPDLQLQJVWXG\GUXJWRFRPS OHWHXSWR'D\6XEMHFWVZLOODJ DLQEHHGXFDWHG
LQVWXG\GUXJGLDU\UHFRUGLQJDQGVHOIÂ±DGPLQLVWUDWLRQRIVWXG\ GUXJ6XEMHFWVZLOO
EHLQVWUXFWHGWR127VHOIÂ±DGPLQLV WHUVWXG\GUXJRQWKHPRUQLQJ RIWKHLUQH[W
VFKHGXOHGVWXG\YLVLW9LVLW'D\
x6FKHGXOH1H[W9LVLW6XEMHFWVZ LOOEHVFKHGXOHGIRU9LVLW
9LVLW'D\Â“
3UH&$(ÂŠ
x6WXG\'UXJ'LDU\6WXG\'UXJ&ROOHFWLRQ6XEMHFWVWXG\GUXJGLDUL HVDQGDOO
XVHGXQXVHGVWXG\GUXJYLDOVGLVSHQVHGIRU'D\VWRVKRXOG EHFROOHFWHGDQG
UHYLHZHGE\DWUDLQHGVWXG\WHFKQLFLDQ
x6LWHVWDIIPXVWFRQILUPVXEMHFWV KDYH127DGPLQLV WHUHGWKHLUPR UQLQJVWXG\GUXJ
GRVHDWKRPH
x0RQLWRUDQG4XHU\$(V
x5HFRUGDOO&KDQJHVLQ&RQFRPLWDQW0HGLFDWLRQV
x2UD&DOLEUDÂŠ2FXODU'LVFRPI[INVESTIGATOR_13318]6FDOH
x2UD&DOLEUDÂŠ2FXODU'LVFRPI[INVESTIGATOR_13318]	6\PSWRP4XHVWLRQQDLUH
x9$6GLVFRPI[INVESTIGATOR_13318]VFDOH
x26',Â‹
x%&9$8WLOL]LQJDQ(7'56&KDUW
x6OLW/DPS%LRPLFURVFRS\
x&RQMXQFWLYDOUHGQHVV
x7)%87
x&RUQHDODQG&RQMXQFWLYDO6WDLQLQJIOXRUHVFHLQ
x&RUQHDODQG&RQMXQFWLYDO6WDLQ LQJOLVVDPLQHJUHHQHL036 Ophthalmic Solution 
Clinical Study Protocol HL036-DED-US-P301Sponsor: HanAll Biopharma, Co., Ltd. 
24 January 2019
Confidential Page 32
&$(ÂŠ
'XULQJWKH&$(ÂŠH[SRVXUH2'6ZLOOEHFROOHFWHGDW 

3RVW&$(ÂŠ
x2UD&DOLEUDÂŠ2FXODU'LVFRPI[INVESTIGATOR_13318]6FDOH
x2UD&DOLEUDÂŠ2FXODU'LVFRPI[INVESTIGATOR_13318]	6\PSWRP4 XHVWLRQQDLUH2FXO DU'LVFRPI[INVESTIGATOR_13318]
6FRUH
x9$6GLVFRPI[INVESTIGATOR_13318]VFDOH
x6OLWODPSELRPLFURVFRS\
x&RQMXQFWLYDOUHGQHVV
x7)%87
x&RUQHDODQG&RQMXQFWLYDO6WDLQLQJIOXRUHVFHLQ
x&RUQHDODQG&RQMXQFWLYDO6WDLQ LQJOLVVDPLQHJUHHQ
x6FKLUPHUÂ¶VWHVW
x6WXG\'UXJ'LDU\6WXG\'UXJ'LVSHQVDWLRQ3ULRUWRGLVFKDUJHIUR PWKHVWXG\VLWH
RQ9LVLW'D\VXEMHFWVZ LOOEHHGXFDWHGLQVWXG\GUXJGL DU\UHFRUGLQJDQG
VHOIÂ±DGPLQLVWUDWLRQRI VWXG\GUXJ6XEMHFWVZLOOUHFHLYHWKHLU DVVLJQHGVWXG\GUXJ
NLWZLWKVXIILFLHQWVXSSO\WRODVWXQWLO9LVLWDQGZLOOEHLQ VWUXFWHGWR127VHOIÂ±
DGPLQLVWHUVWXG\GUXJRQWKHPRUQ LQJRIWKHLUQH[WVFKHGXOHGVW XG\YLVLW9LVLW
'D\
x6FKHGXOH1H[W9LVLW6XEMHFWVZ LOOEHVFKHGXOHGIRU9LVLW
9LVLW'D\Â“
3UH&$(ÂŠ
x6WXG\'UXJ'LDU\6WXG\'UXJ&ROOHFWLRQ6XEMHFWVWXG\GUXJGLDUL HVDQGDOO
XVHGXQXVHGVWXG\GUXJYLDOVGLVSHQVHGIRU'D\VWRVKRXOG EHFROOHFWHGDQG
UHYLHZHGE\DWUDLQHGVWXG\WHFKQLFLDQ
x6LWHVWDIIPXVWFRQILUPVXEMHFWV KDYH127DGPLQLV WHUHGWKHLUPR UQLQJVWXG\GUXJ
GRVHDWKRPH
x0RQLWRULQJDQG4XHU\RI$(V
x5HFRUGDOO&KDQJHVLQ&RQFRPLWDQW0HGLFDWLRQV
x2UD&DOLEUDÂŠ2FXODU'LVFRPI[INVESTIGATOR_13318]6FDOH
x2UD&DOLEUDÂŠ2FXODU'LVFRPI[INVESTIGATOR_13318]	6\PSWRP4XHVWLRQQDLUH
x9$6GLVFRPI[INVESTIGATOR_13318]VFDOH
x26',Â‹HL036 Ophthalmic Solution 
Clinical Study Protocol HL036-DED-US-P301Sponsor: HanAll Biopharma, Co., Ltd. 
24 January 2019
Confidential Page 33
x%&9$8WLOL]LQJDQ(7'56&KDUW
x6OLW/DPS%LRPLFURVFRS\
x&RQMXQFWLYDOUHGQHVV
x7)%87
x&RUQHDODQG&RQMXQFWLYDO6WDLQLQJIOXRUHVFHLQ
x&RUQHDODQG&RQMXQFWLYDO6WDLQ LQJOLVVDPLQHJUHHQ
&$(ÂŠ
'XULQJWKH&$(ÂŠH[SRVXUH2'6ZLOOEHFROOHFWHGDW 

3RVW&$(ÂŠ
x%ORRG6DPSOLQJIRU,PPXQRJHQLFLW\7HVWLQJ
x2UD&DOLEUDÂŠ2FXODU'LVFRPI[INVESTIGATOR_13318]6FDOH
x2UD&DOLEUDÂŠ2FXODU'LVFRPI[INVESTIGATOR_13318]	6\PSWRP4 XHVWLRQQDLUH2FXO DU'LVFRPI[INVESTIGATOR_13318]
6FRUH
x9$6GLVFRPI[INVESTIGATOR_13318]VFDOH
x6OLWODPSELRPLFURVFRS\
x&RQMXQFWLYDOUHGQHVV
x7)%87
x&RUQHDODQG&RQMXQFWLYDO6WDLQLQJIOXRUHVFHLQ
x&RUQHDODQG&RQMXQFWLYDO6WDLQ LQJOLVVDPLQHJUHHQ
x6FKLUPHUÂ¶VWHVW
x0RQLWRULQJDQG4XHU\RI$(V
x6WXG\'UXJ'LDU\6WXG\'UXJ'LVSHQVDWLRQ3ULRUWRGLVFKDUJHIUR PWKHVWXG\VLWH
RQ9LVLW'D\VXEMHFWVZ LOOEHHGXFDWHGLQVWXG\GUXJGL DU\UHFRUGLQJDQG
VHOIÂ±DGPLQLVWUDWLRQRI VWXG\GUXJ6XEMHFWVZLOOUHFHLYHWKHLU DVVLJQHGVWXG\GUXJ
NLWZLWKVXIILFLHQWVXSSO\WRO DVWXQWLO9LVLWDQGZLOOEHLQ VWUXFWHGWR127VHOIÂ±
DGPLQLVWHUVWXG\GUXJRQWKHPRUQ LQJRIWKHLUQH[WVFKHGXOHGVW XG\YLVLW9LVLW
'D\
x6FKHGXOH1H[W9LVLW6XEMHFWVZ LOOEHVFKHGXOHGIRU9LVLWHL036 Ophthalmic Solution 
Clinical Study Protocol HL036-DED-US-P301Sponsor: HanAll Biopharma, Co., Ltd. 
24 January 2019
Confidential Page 34
9LVLW'D\Â“
3UH&$(ÂŠ
x6WXG\'UXJ'LDU\6WXG\'UXJ&ROOHFWLRQ6XEMHFWVWXG\GUXJGLDUL HVDQGDOO
XVHGXQXVHGVWXG\GUXJYLDOVGLVSHQVHGIRU'D\VWRVKRXOG EHFROOHFWHGDQG
UHYLHZHGE\DWUDLQHGVWXG\WHFKQLFLDQ
x6LWHVWDIIPXVWFRQILUPVXEMHFWV KDYH127DGPLQLV WHUHGWKHLUPR UQLQJVWXG\GUXJ
GRVHDWKRPH
x0RQLWRULQJDQG4XHU\RI$(V
x5HFRUGDOO&KDQJHVLQ&RQFRPLWDQW0HGLFDWLRQV
x8ULQH3UHJQDQF\7HVWIRUIHPD OHVRIFKLOGEHDULQJSRWHQWLDO
x2UD&DOLEUDÂŠ2FXODU'LVFRPI[INVESTIGATOR_13318]6FDOH
x2UD&DOLEUDÂŠ2FXODU'LVFRPI[INVESTIGATOR_13318]	6\PSWRP4XHVWLRQQDLUH
x9$6GLVFRPI[INVESTIGATOR_13318]VFDOH
x26',Â‹
x%&9$8WLOL]LQJDQ(7'56&KDUW
x6OLW/DPS%LRPLFURVFRS\
x&RQMXQFWLYDOUHGQHVV
x7)%87
x&RUQHDODQG&RQMXQFWLYDO6WDLQLQJIOXRUHVFHLQ
x&RUQHDODQG&RQMXQFWLYDO6WDLQ LQJOLVVDPLQHJUHHQ
&$(ÂŠ
'XULQJWKH&$(ÂŠH[SRVXUH2'6ZLOOEHFROOHFWHGDW 

3RVW&$(ÂŠ
x%ORRG6DPSOLQJIRU,PPXQRJHQLFLW\7HVWLQJ
x2UD&DOLEUDÂŠ2FXODU'LVFRPI[INVESTIGATOR_13318]6FDOH
x2UD&DOLEUDÂŠ2FXODU'LVFRPI[INVESTIGATOR_13318]	6\PSWRP4 XHVWLRQQDLUH2FXO DU'LVFRPI[INVESTIGATOR_13318]
6FRUH
x9$6GLVFRPI[INVESTIGATOR_13318]VFDOH
x6OLWODPSELRPLFURVFRS\
x&RQMXQFWLYDOUHGQHVV
x7)%87
x&RUQHDODQG&RQMXQFWLYDO6WDLQLQJIOXRUHVFHLQHL036 Ophthalmic Solution 
Clinical Study Protocol HL036-DED-US-P301Sponsor: HanAll Biopharma, Co., Ltd. 
24 January 2019
Confidential Page 35
x&RUQHDODQG&RQMXQFWLYDO6WDLQ LQJOLVVDPLQHJUHHQ
x6FKLUPHUÂ¶VWHVW
x,QWUDRFXODU3UHVVXUH
x'LODWHGIXQGRVFRS\
x0RQLWRULQJDQG4XHU\RI$(V
x6WXG\([LWIRUVXEMHFWVZLWKQHJDWLYHLPPXQRJHQLFLW\UHVXOWVDW SUHYLRXVYLVLWV
9LVLWVRU
6FKHGXOHRI9LVLWV0HDVXUHPHQWVDQG'RVLQJ
6FKHGXOHG9LVLWV
5HIHUWR$SSHQGL[6FKHGXOHRI 9LVLWVDQG0HDVXUHPHQWV IRUDVFKHGXOHRIYLVLWVDQG
PHDVXUHPHQWV
8QVFKHGXOHG9LVLWV
6XEMHFWVPD\EHDVNHGWRUHWXU QIRU%ORRG6DPSOLQJIRU,PPXQRJH QLFLW\7HVWLQJLIWKH\
WHVWHGSRVLWLYHLPPXQRJHQLFLW\UHVX OWVDWSUHYLRXVYLVLWV9LVL WVRU7KLVYLVLWZLOO
RFFXUPRQWKVDIWHU9LVLW
8QVFKHGXOHGYLVLWVPD\DOVREHSH UIRUPHGLQRUGHUWRHQVXUHVXE MHFWVDIHW\$OO
SURFHGXUHVSHUIRUPHGDWDQXQVFK HGXOHGYLVLWZLOOEHUHFRUGHGL QWKHVRXUFHGRFXPHQWV
DQGRQWKH8QVFKHGXOHG9LVLWH&5) SDJHV$Q\SURFHGXUHLQGLFDWH GLQWKHH&5)WKDWLV
QRWSHUIRUPHGVKRXOGEHLQGL FDWHGDVÂ³1RWGRQHÂ´
(YDOXDWLRQVWKDWPD\EHFRQGXFWHGD WDQ8QVFKHGXOHG9LVLWLQFOX GH
x%ORRG6DPSOLQJIRU,PPXQRJHQLFLW\7HVWLQJ
x6OLWODPS%LRPLFURVFRS\
x9LVXDO$FXLW\
x,QWUDRFXODU3UHVVXUH
x8ULQH3UHJQDQF\7HVW
x'LODWHG)XQGRVFRS\
x$VVHVVPHQWRI$GYHUVH(YHQWV
x$VVHVVPHQWRIFRQFRPLWDQWPHGLFDWLRQVDQGRUWUHDWPHQWVDQG
x$Q\RWKHUDVVHVVPHQWVQHHGHGLQW KHMXGJPHQWRIWKHLQYHVWLJDWR UHL036 Ophthalmic Solution 
Clinical Study Protocol HL036-DED-US-P301Sponsor: HanAll Biopharma, Co., Ltd. 
24 January 2019
Confidential Page 36
(DUO\7HUPLQDWLRQ9LVLW
x&ROOHFWLRQRIVWXG\GUXJGRVLQJGLDU\
x0HGLFDWLRQPHGLFDOKLVWRU\XSGDWH
x$VVHVVPHQWRI$(Â¶V
x6OLWODPS%LRPLFURVFRS\
x9LVXDO$FXLW\
x8ULQH3UHJQDQF\7HVWLIDSSOLFDEOH
x%ORRGVDPSOLQJIRULPPXQRJHQLFLW\WHVWLQJLIDSSOLFDEOH
x$Q\RWKHUDVVHVVPHQWVQHHGHGLQW KHMXGJPHQWRIWKHLQYHVWLJDWR U
&RPSOLDQFHZLWK3URWRFRO
6XEMHFWVZLOOEHLQVWUXFWHGRQSURSH UXVHRIWKHVXEMHFWGDLO\ V\PSWRPGLDU\DQGSURSHU
LQVWLOODWLRQDQGVWRUDJHRIVWXG\ GUXJDWWKHHQGRI9LVLWV DQGDQGJLYHQ
ZULWWHQLQVWUXFWLRQV7KHVXEMHFWGD LO\GLDULHVDQGXQXVHGVWXG \GUXJYLDOVZLOOEH
FROOHFWHGDWHDFKYLVLWIURP 9LVLWXSWRDQGLQFOXGLQJ9LVLW WRDVVHVVGRVLQJDQG
V\PSWRPDVVHVVPHQWFRPSOLDQFH'RVLQJFRPSOLDQFHZLOOEHEDVHG RIIRIWKHXQXVHGYLDO
FRXQW,IWKHVXEMHFWLVOHVVW KDQRUPRUHWKDQFRPSOL DQWZLWKGRVLQJEDVHGRQ
WKHH[SHFWHGQXPEHURIXQXVHGYL DOVWKHQWKHVXEMHFWZLOOEHG HHPHGQRQFRPSOLDQWDQG
DGHYLDWLRQVKRXOGEHUHFRUGHG
,QWKHVXEMHFWGDLO\V\PSWRPGLDU\LIPRUHWKDQRI'RVH7D NHQER[HVDUHFKHFNHG
Â³QRÂ´OHIWEODQNRUPLVVLQJI RUDGLDU\SHULRGDVXEMHFWZLOO EHGHHPHGQRQFRPSOLDQW
DQGDGLDU\GHYLDWLRQZLOOEHUHFR UGHG,IPRUHWKDQRIWKH WRWDOGLDU\V\PSWRP
DVVHVVPHQWVIRUWKDWGRVLQJSH ULRGDUHPLVVHGWKHVHVXEMHFWVZ LOOEHGHHPHGQRQ
FRPSOLDQWDQGDGLDU\V\PSWRPD VVHVVPHQWGHYLDWLRQZLOOEHUHFR UGHG7KHVHJXLGHOLQHV
ZLOOEHXVHGE\WKH,QYHV WLJDWRUIRUGHWHUPLQLQJ WKHVXEMHFWÂ¶VQHFHVVDU\FRPSOLDQFHIRU
WKHVWXG\DQGIRUUHFRUGLQJGHYLDWLRQVIURPWKLVFRPSOLDQFH 
6XEMHFW'LVSRVLWLRQ
&RPSOHWHG6XEMHFWV
$FRPSOHWHGVXEMHFWLVRQHZKRKD VQRWEHHQGLVFRQWLQXHGIURPW KHVWXG\
'LVFRQWLQXHG6XEMHFWV
6XEMHFWVPD\EHGLVFRQWLQXHGSULR UWRWKHLUFRPSOHWLRQRIWKHV WXG\GXHWR
xDGYHUVHHYHQWV$(V
xXQPDVNLQJZKHQPHGLFDOO\QHFHVVDU\
xSURWRFROYLRODWLRQV
xDGPLQLVWUDWLYHUHDVRQVHJLQD ELOLW\WRFRQWLQXHORVWWRIR OORZXSHL036 Ophthalmic Solution 
Clinical Study Protocol HL036-DED-US-P301Sponsor: HanAll Biopharma, Co., Ltd. 
24 January 2019
Confidential Page 37
xVSRQVRUWHUPLQDWLRQRIVWXG\
xVXEMHFWFKRLFHHJZLWKGUDZDORIFRQVHQWDQG
xRWKHU
1RWH,QDGGLWLRQDQ\VXEMHFWP D\EHGLVFRQWLQXHGIRUDQ\VRXQ GPHGLFDOUHDVRQDW
WKHGLVFUHWLRQRIW KHLQYHVWLJDWRU
1RWLILFDWLRQRIDVXEMHFWGLVF RQWLQXDWLRQDQGWKHUHDVRQIRUGL VFRQWLQXDWLRQZLOOEHPDGH
WR2UDDQGRUVWXG\VSRQVRUD QGZLOOEHFOHDUO\GRFXPHQWHGRQW KHH&5)
'LVFRQWLQXHGVXEMHFWV ZLOOQRWEHUHSODFHG
6WXG\7HUPLQDWLRQ
7KHVWXG\PD\EHVWRSSHGDWDQ\WLPHE\WKHLQYHVWLJDWRUWKHV SRQVRUDQGRU2UDZLWK
DSSURSULDWHQR WLILFDWLRQ
6WXG\'XUDWLRQ
$QLQGLYLGXDOVXEMHFWÂ¶VSDUWLF LSDWLRQZLOOLQYROYHYLVLWVRYH UDSSUR[LPDWHO\DZHHN
aGD\VSHULRGGD\VRIWUHD WPHQWDQGGD\VSUHVFUHHQL QJ
0RQLWRULQJDQG4XDOLW\$VVXUDQFH
'XULQJWKHFRXUVHRIWKHVWXG\D PRQLWRURUGHVLJQHHZLOOPD NHURXWLQHVLWHYLVLWVWR
UHYLHZSURWRFROFRPSOLDQFHDVVH VVVWXG\GUXJGHYLFHDFFRXQWDEL OLW\DQGHQVXUHWKH
VWXG\LVEHLQJFRQGXFWHGDFFRUGLQJWRWKHSHUWLQHQWUHJXODWRU\ UHTXLUHPHQWV7KH
UHYLHZRIWKHVXEMHFWVÂ¶PHGLFDO UHFRUGVZLOOEHSHUIRUPHGLQD PDQQHUWKDWDGHTXDWHO\
PDLQWDLQVVXEMHFWFRQILGHQWLDOLW\)XUWKHUGHWDLOVRIWKHVWXG \PRQLWRULQJZLOOEH
RXWOLQHGLQDPRQLWRULQJSODQ
5HJXODWRU\DXWKRULWLHVRIGRP HVWLFDQGIRUHLJQDJHQFLHV TXDOLW\DVVXUDQFHDQGRULWV
GHVLJQHHVPD\FDUU\RXWRQVLWH LQVSHFWLRQVDQGRUDXGLWVZKLFK PD\LQFOXGHVRXUFHGDWD
FKHFNV7KHUHIRUHGLUHFWDFFHVV WRWKHRULJLQDOVRXUFHGDWDZLO OEHUHTXLUHGIRULQVSHFWLRQV
DQGRUDXGLWV$OOLQVSHFWLRQV DQGDXGLWVZLOOEHFDUULHGRXWJ LYLQJFRQVLGHUDWLRQWRGDWD
SURWHFWLRQDVZHOODVVXEMHFWFRQI LGHQWLDOLW\WRWKHH[WHQWWKD WORFDOVWDWHDQGIHGHUDOODZV
DSSO\
$'9(56((9(176
$Q$(LVGHILQHGDVDQ\XQWRZDU GPHGLFDORFFXUUHQFHDVVRFLDWHG ZLWKWKHXVHRIDQ,3LQ
KXPDQVZKHWKHURUQRWFRQVLGHUHG ,3UHODWHG$Q$(FDQEHDQ\ XQIDYRUDEOHDQG
XQLQWHQGHGVLJQHJDQDEQRUPDO ODERUDWRU\ILQGLQJV\PSWRP RUGLVHDVHWHPSRUDOO\
DVVRFLDWHGZLWKWKHXVHRIDQ ,3ZLWKRXWDQ\MXGJPHQWDERXWFD XVDOLW\$Q$(FDQDULVH
IURPDQ\XVHRIWKH,3HJRI IODEHOXVHXVHLQFRPELQDWLRQZ LWKDQRWKHUGUXJRUPHGLFDO
GHYLFHDQGIURPDQ\URXWHRIDGPLQLVWUDWLRQIRUPXODWLRQRUG RVHLQFOXGLQJDQRYHUGRVH
$Q$(FDQDULVHIURPDQ\GHOLYHU \LPSODQWDWLRQRUXVHRIDPH GLFDOGHYLFHLQFOXGLQJ
PHGLFDOGHYLFHIDLOXUHVXEMHFWFKDUDFWHULVWLFVWKDWPD\LPSDFW PHGLFDOGHYLFH
SHUIRUPDQFHHJDQDWRPLFDOOLPLWD WLRQVDQGWKHUD SHXWLFSDUDP HWHUVHJHQHUJ\DSSOLHG
VL]LQJGRVHUHOHDVHDVVRF LDWHGZLWKPHGLFDOGHYLFHHL036 Ophthalmic Solution 
Clinical Study Protocol HL036-DED-US-P301Sponsor: HanAll Biopharma, Co., Ltd. 
24 January 2019
Confidential Page 38
$OO$(VVSRQWDQHRXVO\UHSRUWHGE \WKHVXEMHFWDQGRULQUHVSRQV HWRDQRSHQTXHVWLRQ
IURPVWXG\SHUVRQQHORUUHYHDOHGE\REVHUYDWLRQSK\VLFDOH[DPL QDWLRQRURWKHU
GLDJQRVWLFSURFHGXUHVZLOOEHU HFRUGHGLQWKHVRXUFHGRFXPHQWD QGRQWKHDSSURSULDWH
SDJHVRIWKHH&5)$Q\FOLQLFDOO\ UHOHYDQWGHWHULRUDWLRQLQFOL QLFDOILQGLQJLVFRQVLGHUHG
DQ$(DQGPXVWEHUHFRUGHG:KH QSRVVLEOHVLJQVDQGV\PSWRPVL QGLFDWLQJDFRPPRQ
XQGHUO\LQJSDWKRORJ\VKRXOGEHQRW HGDVFRPSUHKHQVLYHHYHQW
'RFXPHQWDWLRQUHJDUGLQJWKH$( VKRXOGEHPDGHDVWRWKHQDWXUH GDWHRIRQVHWHQGGDWH
VHYHULW\UHODWLRQVKLSWR,3DF WLRQVWDNHQVHULRXVQHVVDQG RXWFRPHRIDQ\VLJQRU
V\PSWRPREVHUYHGE\WKHSK\VLFLD QRUUHSRUWHGE\WKHVXEMHFWXS RQLQGLUHFWTXHVWLRQLQJ
,IDIHPDOHKDVDSRV LWLYHSUHJQDQF\WHVWGXULQJWKHVWXG\WKH QWKHLQYHVWLJDWRUZLOOQRWLI\
2UDLPPHGLDWHO\7KHLQYHVWLJDWRUVKDOOUHTXHVWIURPWKHVXEMHF WDQGRUWKHVXEMHFWÂ¶V
SK\VLFLDQFRSLHVRID OOUHODWHGPHGLFDOUHSRUWVGXULQJWKHSUHJ QDQF\DQGVKDOOGRFXPHQW
WKHRXWFRPHRIWKHSUHJQDQF\7KH LQYHVWLJDWRUZLOOUHWDLQWKHV HUHSRUWVWRJHWKHUZLWKWKH
VXEMHFWÂ¶VVRXUFHGRFXPHQWVDQGZ LOOSURYLGHDFRS\RIDOOGRFXP HQWDWLRQWR2UD
1RWH$FOLQLFDOO\VLJQLILFDQWYLVXDODFXLW\GHFUHDVHGHILQHG DVDQLQFUHDVHRIRU
JUHDWHULQORJ0$5VFRUHIURP EDVHOLQH9LVLW ZLOOEHFRQVLG HUHGDQ$GYHUVH(YHQW
5HSRUWLQJDQ$GYHUVH(YHQ WRI6SHFLDO,QWHUHVW
)RUDOOFRQMXQFWLYLWLVDQGDOOHUJLFFRQMXQFWLYLWLV$(VWKH3, RUDVVLJQHGVWXG\SHUVRQQHO
PXVWFRPSOHWHDFRS\RIWKH &RQMXQFWLYLWLV$(V5HSRUW)RUP SURYLGHGE\WKHVSRQVRU
$SSHQGL[&RQMXQFWLYLWLV$GYHUVH(YHQWV5HSRUW)RUP $FRS\RIWKHIRUPZLWKD
SKRWRRIWKHVXEMHFWÂ¶VH\HVVKRXO GEHHPDLOHGWR 2UDDQGWKHV WXG\VSRQVRUZLWKLQ
KRXUVRI$(UHSRUWE\WKHVXEMHFW
6HYHULW\
6HYHULW\RIDQ$(LVGHILQHGD VDTXDOLWDWLYHD VVHVVPHQWRIWKH GHJUHHRILQWHQVLW\RIDQ
$(DVGHWHUPLQHGE\WKHLQYHVWLJDWRURUUHSRUWHGWRKLPKHUE\ WKHVXEMHFW7KH
DVVHVVPHQWRIVHYHULW\LVPDGH LUUHVSHFWLYHRIUHODWLRQVKLSWR ,3RUVHULRXVQHVVRIWKH
HYHQWDQGVKRXOGEHHYDOXDWHGDFFRU GLQJWRWKHIROORZLQJVFDOH 
x0LOG(YHQWLVQRWLFHDEOHWRWKHVXEMHFWEXWLVHDVLO\WROHUDWHGD QGGRHVQRW
LQWHUIHUHZLWKWKHVXEMHFWÂ¶VGDLO\DFWLYLWLHV
x0RGHUDWH(YHQWLVERWKHUVRPHSRVVLEO\ UHTXLULQJDGGLWLRQDOWKHUDS\D QGPD\
LQWHUIHUHZLWKWKHVXEMHFWÂ¶VGDLO\DFWLYLWLHV
x6HYHUH(YHQWLVLQWROHUDEOHQHFHVVLWDWHVDGGLWLRQDOWKHUDS\RUDOWH UDWLRQRI
WKHUDS\DQGLQWHUIHUH VZLWKWKHVXEMHFWÂ¶VGDLO\DFWLYLWLHVHL036 Ophthalmic Solution 
Clinical Study Protocol HL036-DED-US-P301Sponsor: HanAll Biopharma, Co., Ltd. 
24 January 2019
Confidential Page 39
5HODWLRQVKLSWR,QYH VWLJDWLRQDO3URGXFW
7KHUHODWLRQVKLSRIHDFK$(WRW KH,3VKRXOGEHGHWHUPLQHGE\W KHLQYHVWLJDWRUXVLQJ
WKHVHH[SODQDWLRQV
x6XVSHFWHG $UHDVRQDEOHSRVVLELOLW\H[LVWVWKDWWKH,3FDXVHGWKH$($V XVSHFWHG
$(FDQEHIXUWKHUGHILQHGDV
R'HILQLWH5HODWLRQVKLSH[LVWVZKHQWKH$ (IROORZVDUHDVRQDEOHVHTXHQFH IURP
WKHWLPHRI,3DGPLQLVWUDWLRQI ROORZVDNQRZQUHVSRQVHSDWWHUQ RIWKHGUXJ
FODVVLVFRQILUPHGE\LPSU RYHPHQWRQVWRSSLQJWKH,3DQGQRRW KHU
UHDVRQDEOHFDXVHH[LVWV
R3UREDEOH5HODWLRQVKLSH[LVWVZKHQWKH$ (IROORZVDUHDVRQDEOHVHTXHQFH
IURPWKHWLPHRI,3DGPLQLVWUD WLRQIROORZVDNQRZQUHVSRQVHSD WWHUQRIWKH
GUXJFODVVLVFRQILUPHGE\LPS URYHPHQWRQVWRSSLQJWKH,3DQG WKHVXVSHFW,3
LVWKHPRVWOLNHO\RIDOOFDXVHV
R3RVVLEOH5HODWLRQVKLSH[LVWVZKHQWKH$ (IROORZVDUHDVRQDEOHVHTXHQFH
IURPWKHWLPHRIDGPLQLVWUD WLRQEXWFRXOGDOVRKDYHEHHQSURGX FHGE\WKH
VXEMHFWÂ¶VFOLQLFDOVWDWHRUE\RW KHUGUXJVDGPLQLVWHUHGWRWKH VXEMHFW
x1RW6XVSHFWHG $UHDVRQDEOHSRVVLELOLW\GRHVQRWH[LVWWKDWWKH,3FDXVHGWKH $(
$QRWVXVSHFWHG$(FDQI XUWKHUEHGHILQHGDV
R1RW5HODWHG &RQFXUUHQWLOOQHVVFRQFXUUHQWP HGLFDWLRQRURWKHUNQRZQFDXV H
LV FOHDUO\ UHVSRQVLEOH IRU WKH $(  WKH DGPLQLVWUDWLRQ RI WKH ,3  DQG WKH
RFFXUUHQFHRIWKH$(DUHQRWUHDVRQDEO\UHODWHGLQWLPH25H[S RVXUHWR,3
KDVQRWRFFXUUHG
7\SHVRIHYLGHQFHWKDWZRXOGVXJJHVWDFDXVDOUHODWLRQVKLSEHWZ HHQWKH,3DQGWKH$(
LQFOXGHDVLQJOHRFFXUUHQFHRI DQHYHQWWKDWLVXQFRPPRQDQGN QRZQWREHVWURQJO\
DVVRFLDWHGZLWK,3H[SRVXUHHJ DQJLRHGHPDKHSDWLFLQMXU\6W HYHQV-RKQVRQ
6\QGURPHRQHRUPRUHRFFXUUHQFH VRIDQHYHQWWKDWLVQRWFRPP RQO\DVVRFLDWHGZLWK,3
H[SRVXUHEXWLVRWKHUZLVHXQF RPPRQLQWKHSRSXODWLRQH[SRVHGW RWKH,3HJWHQGRQ
UXSWXUHDQDJJUHJDWHDQDO\VLV RIVSHFLILFHYHQWVREVHUYHGLQ DFOLQLFDOWULDOVXFKDV
NQRZQFRQVHTXHQFHVRIWKHXQGHUO \LQJGLVHDVHRUFRQGLWLRQXQGHU LQYHVWLJDWLRQRURWKHU
HYHQWVWKDWFRPPRQO\RFFXUL QWKHVWXG\SRSXODWLRQLQGHSHQGHQW RIGUXJWKHUDS\WKDW
LQGLFDWHVWKRVHHYHQWVRFFXUPRUH IUHTXHQWO\LQWKH,3WUHDWPHQ WJURXSWKDQLQD
FRQFXUUHQWRUKLVWRULFDOFRQWUROJURXS
([SHFWHGQHVV
7KHH[SHFWHGQHVVRIDQ$(V KRXOGEHGHWHUPLQ HGEDVHGXSRQH[LVW LQJVDIHW\LQIRUPDWLRQ
DERXWWKH,3XVLQJWKHVHH[SODQDWLRQV
x8QH[SHFWHG DQ$(WKDWLVQRWOLVWHGLQWKH ,QYHVWLJDWRUÂ¶V%URFKXUH,% RULVQRW
OLVWHGDWWKHVSHFLILFLW\RUVHYHULW\WKDWKDVEHHQREVHUYHG
x([SHFWHGDQ$(WKDWLVOLVWHGLQWKH,% DWWKHVSHFLILFLW\DQGVHYHULW \WKDWKDVEHHQ
REVHUYHG
x1RWDSSOLFDEOH DQ$(XQUHODWHGWRWKH,3HL036 Ophthalmic Solution 
Clinical Study Protocol HL036-DED-US-P301Sponsor: HanAll Biopharma, Co., Ltd. 
24 January 2019
Confidential Page 40
$(VWKDWDUHPHQWLRQHGLQWKH, %DVRFFXUULQJZLWKDFODVVRIS URGXFWVRUDVDQWLFLSDWHG
IURPWKHSKDUPDFRORJLFDOPHFKDQ LFDORURWKHUSURSHUWLHVRIW KHSURGXFWEXWDUHQRW
VSHFLILFDOO\PHQWLRQHGD VRFFXUULQJZLWKWKHSDUWLFXODUSURGXFW XQGHULQYHVWLJDWLRQDUHWR
EHFRQVLGHUHGXQH[SHFWHG
7KHLQYHVWLJDWRUVKRXOGLQLWLDOO\ FODVVLI\WKHH[SHFWHGQHVVRI DQ$(EXWWKHILQDO
FODVVLILFDWLRQLVVXEM HFWWRWKH0HGLFDO0RQLWRUÂ¶VGHWHUPLQDWLR Q
6HULRXV$GYHUVH(YHQWV
$Q$(LVFRQVLGHUHGVHULRXVLI LQWKHYLHZRIH LWKHUWKHLQYHV WLJDWRURUVSRQVRULWUHVXOWV
LQDQ\RIWKHIROORZLQJRXWFRPHV
x'HDWK
x$OLIHWKUHDWHQLQJ$(
1RWH$Q$(LVFRQVLGHUHGÂ³OLIH WKUHDWHQLQJÂ´LILQWKHYLHZRI HLWKHUWKHLQYHVWLJDWRU
RUVSRQVRULWVRFFXUUHQFHSODFHV WKHVXEMHFWDWLPPHGLDWHULVN RIGHDWK,WGRHVQRW
LQFOXGHDQ$(WKDWKDGLWRFFXUUH GLQDPRUHVHYHUHIRUPPLJK WKDYHFDXVHGGHDWK
x,QSDWLHQWKRVSLWDOL]DWLRQRUSU RORQJDWLRQRIH[LVWLQJKRVSLWDOL ]DWLRQ
1RWH7KHWHUPÂ³LQSDWLHQWKRVSLWD OL]DWLRQÂ´UHIHUVWRDQ\LQSDWL HQWDGPLVVLRQHYHQLI
OHVVWKDQKRXUV)RUFKURQLF RUORQJWHUPLQSDWLHQWVLQSD WLHQWDGPLVVLRQ
LQFOXGHVWUDQVIHUZLWKLQWKHKRV SLWDOWRDQDFXWHLQWHQVLYHFDU HLQSDWLHQWXQLW
,QSDWLHQWKRVSLWDOL]DWLRQGRHVQRW LQFOXGHHPHUJHQF\URRPYLV LWVRXWSDWLHQWVDPH
GD\DPEXODWRU\SURFHGXUHVREVHU YDWLRQVKRUWVWD\XQLWVUHKDEL OLWDWLRQIDFLOLWLHV
KRVSLFHIDFLOLWLHVQXUVLQJKRPHV RUFOLQLFDOUHVHDUFKSKDVH XQLWV
1RWH7KHWHUPÂ³SURORQJDWLRQRIH [LVWLQJKRVSLWDOL]DWLRQÂ´UHIHU VWRDQ\H[WHQVLRQRI
DQLQSDWLHQWKRVSLWDOL]DWLRQEH\ RQGWKHVWD\DQWLFLSDWHGRUUHT XLUHGIRUWKHUHDVRQIRU
WKHLQLWLDODGPLVVLRQDVGHWHUPLQH GE\WKHLQYHVWLJDWRURUWUHD WLQJSK\VLFLDQ
x$SHUVLVWHQWRUVLJQLILFDQWLQ FDSDFLW\RUVXEVWDQWLDOGLVUXSWLR QRIWKHDELOLW\WR
FRQGXFWQRUPDOOLIHIXQFWLRQV
1RWH$Q6$(VSHFLILFDOO\UHODW HGWRYLVXDOWKUHDWZRXOGEHLQW HUSUHWHGDVDQ\
SRWHQWLDOLPSDLUPHQWRUGDPDJHW RWKHVXEMHFWÂ¶VH\HVHJKHPRU [LOCATION_006]DJHUHWLQDO
GHWDFKPHQWFHQWUDOFRUQHDOXO FHURUGDPDJHW RWKHRSWLFQHUYH 
x$FRQJHQLWDODQRPDO\ELUWKGHIHFW
,PSRUWDQWPHGLFDOHYHQWVWKDWP D\QRWUHVXOWLQGHDWKDUHOLIH WKUHDWHQLQJRUUHTXLUH
KRVSLWDOL]DWLRQPD\EHFRQVLGHU HGVHULRXVZKHQEDVHGXSRQDSSU RSULDWHPHGLFDO
MXGJPHQWWKH\PD\MHRSDUGL]HW KHVXEMHFWDQGPD\UHTXLUHPHGLF DORUVXUJLFDO
LQWHUYHQWLRQWRSUHYHQWRQHRIW KHRXWFRPHVOLVWHGLQWKLVGHIL QLWLRQ
3URFHGXUHVIRU5HSRUWLQJ$GYHUVH(YHQWV
$OO$(VDQGWKHLURXWFRPHVPXVWEH UHSRUWHGWR2UDWKHVWXG\V SRQVRUDQGWKH,5%,(&
DVUHTXLUHGE\WKH,5%,(&IHG HUDOVWDWHRUORFDOUHJXODWLRQ VDQGJRYHUQLQJKHDOWK
DXWKRULWLHVDQGU HFRUGHGRQWKHD SSURSULDWHH&5)HL036 Ophthalmic Solution 
Clinical Study Protocol HL036-DED-US-P301Sponsor: HanAll Biopharma, Co., Ltd. 
24 January 2019
Confidential Page 41
5HSRUWLQJD6XVSHFWHG8QH[SHFWHG$GYHUVH5HDFWLRQ
$OO$(VWKDWDUHÂµVXVSHFWHGÂ¶D QGÂµXQH[SHFWHGÂ¶DUHWREHUHSRUWH GWR2UDWKHVWXG\VSRQVRU
DQGWKH,5%,(&DVUHTXLUHGE\WK H,5%,(&IHGHUDOVWDWHRU ORFDOUHJXODWLRQVDQG
JRYHUQLQJKHDOWKDXWKRULWLHV
)RUDOOFRQMXQFWLYLWLVDQGDOOHUJLFFRQMXQFWLYLWLV$(VWKH3, RUDVVLJQHGVWXG\SHUVRQQHO
PXVWFRPSOHWHDFRS\RIWKH &RQMXQFWLYLWLV$(V5HSRUW)RUP SURYLGHGE\WKHVSRQVRU$
FRS\RIWKHIRUPZLWKDSKRWRRI WKHVXEMHFWÂ¶VH\HVVKRXOGEHH PDLOHGWR2UDDQGWKH
VWXG\VSRQVRUZLWKLQKRXUVRI$(UHSRUWE\WKHVXEMHFW
5HSRUWLQJD6HULRXV$GYHUVH(YHQW
7RHQVXUHVXEMHFWVDIHW\DOO6$ (VUHJDUGOHVVRIUHODWLRQVKLS WRWKHVWXG\GUXJPXVWEH
LPPHGLDWHO\UHSRUWHG$OOLQIRUPD WLRQUHOHYDQWWRWKH6$(PXVW EHUHFRUGHGRQWKH
DSSURSULDWHFDVHUHSRUWIRUPV7 KHLQYHVWLJDWRULVREOLJDWHGWR SXUVXHDQGREWDLQ
LQIRUPDWLRQUHTXHVWHGE\2UD DQGRUWKHVSRQVRULQDGGLWLRQWR WKDWLQIRUPDWLRQUHSRUWHG
RQWKHFDVHUHSRUWIRUP$OOVXEM HFWVH[SHULHQFLQJDQ6$(PXVW EHIROORZHGXSDQGWKH
RXWFRPHUHSRUWHG
,QWKHHYHQWRIDQ6$(WKHLQYHV WLJDWRUPXVWQRWLI\2UDDQGWK HVSRQVRULPPHGLDWHO\
REWDLQDQGPDLQWDLQLQKLVKHUILOH VDOOSHUWLQHQWPHGLFDOUHFR UGVLQIRUPDWLRQDQG
PHGLFDOMXGJPHQWVIURPFROOHDJXHV ZKRDVVLVWHGL QWKHWUHDWPHQW DQGIROORZXSRIWKH
VXEMHFWSURYLGH2UDDQGWKHVWXG \VSRQVRUZLWKDFRPSOHWHFDVH KLVWRU\ZKLFKLQFOXGHVD
VWDWHPHQWDVWRZKHWKHUWKHHYH QWZDVRUZDVQRWVXVSHFWHGWRE HUHODWHGWRWKHXVHRIWKH
VWXG\GUXJDQGLQIRUPWKH,5%RIWKHDGYHUVHHYHQWZLWKLQWKHL UJXLGHOLQHVIRUUHSRUWLQJ
VHULRXVDGYHUVHHYHQWV
&RQWDFWLQIRUPDWLRQIRU UHSRUWLQJ6$(V
1DPH
7LWOH&RPSDQ\
2IILFH7HOHSKRQH
$OWHUQDWLYH7HOHSKRQH2IILFH)DFVLPLOH
&OLQLFDO3URMHFW0DQDJHU'U\(\H2UD,QF


1DPH7LWOH2IILFH7HOHSKRQH
0RELOH3KRQH
2IILFH)DFVLPLOH
0HGLFDO0RQLWRU


3URFHGXUHVIRU8QPDVNLQJLIDSSOLFDEOH
$OOVXEMHFWVLQYHVWLJDWRUVD QGVWXG\SHUVRQQHOLQYROYHGZLWK WKHFRQGXFWRIWKHVWXG\
ZLOOEHPDVNHGZLWKUHJDUGWRWU HDWPHQWDVVLJQPHQWV:KHQPHGLF DOO\QHFHVVDU\WKH
LQYHVWLJDWRUPD\QHHGW RGHWHUPLQHZKDWWU HDWPHQWDUPKDVEHHQ DVVLJQHGWRDVXEMHFW
:KHQSRVVLEOHLHLQQRQHPHUJHQW VLWXDWLRQV2UDDQGRUWK HVWXG\VSRQVRUVKRXOGEHHL036 Ophthalmic Solution 
Clinical Study Protocol HL036-DED-US-P301Sponsor: HanAll Biopharma, Co., Ltd. 
24 January 2019
Confidential Page 42
QRWLILHGEHIRUHXQPDVNLQJVWXG\ GUXJ7KHXQPDVNHGVXEMHFWZLOO EHGLVFRQWLQXHGIURP
WKHVWXG\
7\SHDQG'XUDWLRQRIWKH)ROORZXSRI6XEMHFWVDIWHU$GYHUVH(Y HQWV
7KHLQYHVWLJDWRUZLOOIROORZXQU HVROYHG$(VWRUHVROXWLRQXQWLO WKHVXEMHFWLVORVWWR
IROORZXSRUXQWLOWKH$(LVRWKHUZ LVHFODVVLILHG5HVROXWLRQP HDQVWKHVXEMHFWKDV
UHWXUQHGWREDVHOLQHVWDWHRIK HDOWKRUWKH,QYHVWLJDWRUGRHVQ RWH[SHFWDQ\IXUWKHU
LPSURYHPHQWRUZRUVHQL QJRIWKH$(,IWKHSDWLHQWLVORVWWRI ROORZXSWKH,QYHVWLJDWRU
VKRXOGPDNHUHDVRQDEOHDWWHPSWV WRFRQWDFWWKHSDWLHQWYLDWH OHSKRQHSRVWRUFHUWLILHG
PDLO$OOIROORZXSZLOOEHGRFXPHQ WHGLQWKHVXEMHFWÂ¶VVRXUFH GRFXPHQW1RQVHULRXV
$(VLGHQWLILHGRQWKHODVWVFKHGXO HGFRQWDFWPXVWEHUHFRUGHGR QWKH$(H&5)ZLWKWKH
VWDWXVQRWHG
,IWKH,QYHVWLJDWRUEHFRPHVDZDUHRIDQ\QHZLQIRUPDWLRQUHJDUG LQJDQH[LVWLQJ6$(LH
UHVROXWLRQFKDQJHLQFRQGLWLRQRU QHZWUHDWPHQWDQHZ6$(8 QDQWLFLSDWHG5HSRUW
)RUPPXVWEHFRPSOHWHGDQGID[ HGWR2UDZLWKLQKRXUVRIWKH VLWHÂ¶VDZDUHQHVVRIWKH
QHZLQIRUPDWLRQ7KHRULJLQDO 6$(IRUPLVQRWWREHDOWHUHG7K HUHSRUWVKRXOGGHVFULEH
ZKHWKHUWKHHYHQWKDVUHVROYH GRUFRQWLQXHVDQGK RZWKHHYHQWZ DVWUHDWHG
67$7,67,&$/+<327+(6(6$1'0(7+2'62)$1$/<6(6
$QDO\VLV3RSXODWLRQV
7KHIROORZLQJDQDO\VLVSRSXODWLRQVZLOOEHFRQVLGHUHG
x,QWHQWWR7UHDW3RSXODWLRQÂ±7KH LQWHQWWRWUHDW,77SRSXODWL RQLQFOXGHVDOO
UDQGRPL]HGVXEMHFWV7KHSULPDU\ DQDO\VLVZLOOEHSHUIRUPHGRQ WKH,77SRSXODWLRQ
ZLWKWKH0DUNRY&KDLQ0RQWH&DUO R0&0&LPSXWDWLRQPHWKRGIRU PLVVLQJ
YDOXHV7KH,77SRSXODWLRQPD\DOV REHDQDO\]HGZLWK/DVW2EVHU YDWLRQ&DUULHG
)RUZDUG/2&)LPSXWDWLRQLPSXW DWLRQYLDSDWWHU QPL[WXUHPRGHO VDQGZLWK
REVHUYHGGDWDRQO\WRDVVHVVVHQV LWLYLW\6XEMHFWVLQWKH,77S RSXODWLRQZLOOEH
DQDO\]HGDVUDQGRPL]HG
x3HU3URWRFRO3RSXODWLRQÂ±7KHSH USURWRFRO33SRSXODWLRQLQFO XGHVVXEMHFWVLQWKH
,77SRSXODWLRQZKRGRQRWKDYHVLJQLIL FDQWSURWRFROGHYLDWLRQV DQGZKRFRPSOHWH
WKHVWXG\3URWRFROGHYLDWL RQVZLOOEHDVVHVVH GSULRUWRGDWDED VHORFNDQG
XQPDVNLQJ7KH33SRSXODWLRQZLOO EHDQDO\]HGXVLQJREVHUYHGGD WDRQO\IRU
HIILFDF\YDULDEOHV6XEMHFWVL QWKH33SRSXODWL RQZLOOEHDQDO\ ]HGDVWUHDWHG
x6DIHW\3RSXODWLRQÂ±7KHVDIHW\ SRSXODWLRQLQFOXGHVDOOUDQGRPL] HGVXEMHFWVZKR
KDYHUHFHLYHGDWOHDVWRQHGRVH RIWKH,37KHVDIHW\SRSXODWLR QZLOOEHDQDO\]HGIRU
DOOVDIHW\DVVHVVPHQWV6XEMHFWV LQWKH6DIHW\SRSXODWLRQZLOO EHDQDO\]HGDVWUHDWHG
7KHVWDWLVWLFDODQDO\VLVRIVDI HW\GDWDZLOOEHSHUIRUPHGIRUW KHVDIHW\SRSXODWLRQ7KH
DQDO\VLVRIEDVHOLQHDQGHIILFD F\GDWDZLOOEHSHUIRUPHGIRUWK H,77SRSXODWLRQ7KH
SULPDU\HIILFDF\DQDO\VLVZLOO DOVREHSHUIRUPHGRQWKH33SRSX ODWLRQDVVHQVLWLYLW\
DQDO\VHVHL036 Ophthalmic Solution 
Clinical Study Protocol HL036-DED-US-P301Sponsor: HanAll Biopharma, Co., Ltd. 
24 January 2019
Confidential Page 43
6WDWLVWLFDO+\SRWKHVHV
7KHVWDWLVWLFDOK\SRWKHVHVDUH VWDWHGLQWHUPVRIRQHVLGHGK\S RWKHVHVDOWKRXJKVWDWLVWLFDO
WHVWLQJZLOOEHWZRVLGHG7KH SULPDU\HQGSRLQWVZLOOEHWHVWHG LQDKLHUDUFKLFDOIL[HG
VHTXHQFHLQWKHIROORZLQJRUGHU
+7KHUHLVQRGLIIHUHQFHEHWZHH Q+/2SKWKDOPLF6ROXWLR QDQG
SODFHERLQWKHFKDQJHIURP EDVHOLQHRIWKHSUH&$(ÂŠWRSRVW&$(ÂŠFKDQJHLQ
LQIHULRUFRUQHDOIOXRUHVFHLQV WDLQLQJDW'D\9LVLWXVLQ JWKH2UD&DOLEUDÂŠ
VFDOH
+7KHFKDQJHIURPEDVHOLQHRIWKHSUH&$(ÂŠWRSRVW&$(ÂŠFKDQJHLQLQIHULRU
FRUQHDOIOXRUHVFHLQVWDLQLQJDW 'D\9LVLWXVLQJWKH2UD &DOLEUDÂŠVFDOHLV
OHVVZLWK+/2SKWKDOPLF 6ROXWLRQWKDQZLWKSODFHER
+7KHUHLVQRGLIIHUHQFHEHWZHH Q+/2SKWKDOPLF6ROXWLR QDQG
SODFHERLQWKHFKDQJHIURP EDVHOLQHRIWKHSUH&$(ÂŠRFXODUGLVFRPI[INVESTIGATOR_13318]HYDOXDWHG
DW9LVLWXVLQJWKH2UD&DOLEUDÂŠ2FXODU'LVFRPI[INVESTIGATOR_13318]6FDOH
+7KHFKDQJHIURPEDVHOLQHRIWKHSUH&$(ÂŠRFXODUGLVFRPI[INVESTIGATOR_13318]DW9LVLWXVLQJ
WKH2UD&DOLEUDÂŠ2FXODU'LVFRPI[INVESTIGATOR_13318]6FDOHLVO HVVZLWK+/2SKWKDOPLF
6ROXWLRQWKDQZLWKSODFHER
6DPSOH6L]H
7KHSULPDU\REMHFWLYHRIWKHVWXG\ LVWRGHPRQVWUDWHDVWDWLVWL FDOO\VLJQLILFD QWGLIIHUHQFH
EHWZHHQWKHDFWLYH WUHDWPHQWDQGSODFHER
7KLVVWXG\LVH[SHFWHGWRHQU ROOVXEMHFWVLQHDFKRIWKHWZ RWUHDWPHQWDUPVIRUDWRWDO
RIUDQGRPL]HGVXEMHFWV$VVX PLQJDGURSRXWUDWHV XEMHFWVSHUJURXSDUH
H[SHFWHGWRFRPSOHWHWKHVWXG\
$VVXPLQJDFRPPRQVWDQGDUGGHYLD WLRQLQWKHFKDQJHIURPEDVHOLQ HIRUWKHSUH&$(ÂŠWR
SRVW&$(ÂŠFKDQJHLQLQIHULRUFRUQHDOIOXRUHVFHLQVWDLQLQJRIXQLWV DVDPSOHVL]HRI
VXEMHFWVSHUJURXSZLOOKDYH SRZHUWRGHWHFWDGLIIHUHQ FHRIXQLWVEHWZHHQ
WKHDFWLYHWUHDWPHQWJURXSDQGW KHSODFHERJURXSDWDVLJQLILFD QFHOHYHORI$
VDPSOHVL]HRIVXEMHFWVSHU WUHDWPHQWDUPZ LOOKDYHSRZ HUWRGHWHFWDPHDQ
GLIIHUHQFHRIXQLWVLQWKHFKD QJHIURPEDVHOLQHIRUWKHSUH &$(ÂŠRFXODUGLVFRPI[INVESTIGATOR_13318]DV
DVVHVVHGE\WKH2UD&DOLEUDÂŠ2FXODU'LVFRPI[INVESTIGATOR_13318]6FDOHDVVX PLQJDVWDQGDUGGHYLDWLRQRI
XQLWV7KHSRZHUIRUERWKWKHV LJQDQGV\PSWRPHQGSRLQWVL VDVVXPLQJ
LQGHSHQGHQFHEHWZ HHQWKHHQGSRLQWV
6WDWLVWLFDO$QDO\VLV
*HQHUDO&RQVLGHUDWLRQV
7KHTXDQWLWDWLYHYDULDEOHVZLOO EHVX[COMPANY_003]UL]HGXVLQJQXPEHURIV XEMHFWVQPHDQ
PHGLDQVWDQGDUGGHY LDWLRQPLQLPXPDQGP D[LPXP7KHTXDOLWDWLY HYDULDEOHVZLOOEH
VX[COMPANY_003]UL]HGXVLQJFRXQWVDQGSHUFHQWDJHV
$OOVX[COMPANY_003]ULHVZLOOEHSUHVHQWHGE\WUHDWPHQWJURXS6X[COMPANY_003]ULHV ZLOOEHSURYLGHGIRU
GHPRJUDSKLFVEDVHOLQHPHGLFDOKL VWRU\FRQFXUUHQWWKHUDSLHVD QGVXEMHFWGLVSRVLWLRQHL036 Ophthalmic Solution 
Clinical Study Protocol HL036-DED-US-P301Sponsor: HanAll Biopharma, Co., Ltd. 
24 January 2019
Confidential Page 44
)RUWKHSXUSRVHRIVX[COMPANY_003]UL]DWL RQPHGLFDOKLVWRU\FRQFXUUHQWW KHUDSLHVDQG$(VZLOOEH
FRGHGWR0HGLFDO'LFWLRQDU\IRU5HJXODWRU\$XWKRULWLHV0HG'5$ DQG:RUOG+HDOWK
2UJDQL]DWLRQ'UXJGLFWLRQDULHVDVDSSURSULDWH
%DVHOLQHPHDVXUHVDUHGHILQHGDV WKHODVWPHDVXUHSULRUWRWKH LQLWLDWLRQRIVWXG\WUHDWPHQW
XVXDOO\DW9LVLW,IDPHDVXUHLVWDNHQERWKSUH&$(ÂŠDQGSRVW&$(ÂŠWKHEDVHOLQHZLOO
EHWKHWLPHSRLQWPDWFKHGYDOXH DW9LVLW)RUPHDVXUHVIURPG DLO\VXEMHFWGLDULHV
EDVHOLQHLVGHILQHGDVWKHDYHUD JHRIDOOGD\VGXULQJWKHUXQL QSHULRG)RUFKDQJHVIURP
SUH&$(ÂŠWRSRVW&$(ÂŠSRVWILUVWWUHDWPHQWW KHFKDQJHIURPSUH&$(ÂŠWRSRVW&$(ÂŠDW
9LVLWZLOOEHFRQVLGHUH GWKHEDVHOLQHYDOXH
$OOSULPDU\DQGVHFRQGDU\DQDO\VHV ZLOOEHVLGHGDWDVLJQLIL FDQFHOHYHORI
8QLWRI$QDO\VLV
6DIHW\HQGSRLQWVZLOOEH DQDO\]HGIRUERWKH \HV)RUHIILFDF\H QGSRLQWVWKHXQLWRI
DQDO\VLVZLOOEHWKHVWXG\H\HDVGHILQHGE\WKHIROORZLQJ
6WXG\(\H(\HVDUHHOLJLEOHIRU DQDO\VLVLIWKH\PHHWDOORIW KHLQFOXVLRQFULWHULD,QWKH
FDVHWKDWERWKH\HVDUHHOLJLEOHIRUDQDO\VLVWKHVWXG\H\HZL OOEHWKHH\HZLWKZRUVH
KLJKHULQIHULRUFRUQHDOVWDLQLQJSUH&$(ÂŠDW9LVLW,IWKHLQIHULRUFRUQHDOVWDLQLQJLV
WKHVDPHLQERWKH\HVWKHQWKHV WXG\H\HZLOOEHWKHH\HZLWK WKHKLJKHVWRFXODU
GLVFRPI[INVESTIGATOR_13318]SUH&$(ÂŠDW9LVLW,IWKHRFXODUGLVF RPI[INVESTIGATOR_13318]LVWKHVDPHLQERWKH\HV WKHQ
WKHULJKWH\HZLOOEHVHOHFWHGDVWKHVWXG\H\H
0LVVLQJ'DWD
7KHSULPDU\HIILFDF\DQDO\VHVZ LOOEHSHUIRUPHGXVLQJWKH0&0& PXOWLSOHLPSXWDWLRQ
PHWKRGIRUPLVVLQJYDOXHV$GGLWL RQDOO\/2&)LPSXWDWLRQPHWKRG RORJ\DQGLPSXWDWLRQ
YLDSDWWHUQPL[WXUHP RGHOVZLOODOVREHXVHGWRLPSXWHPLVVLQJ GDWDIRUWKHDQDO\VHVRI
WKHSULPDU\HIILFDF\YDULDEOHV) RU/2&)WKHODVWYDOXHIURPW KHSUHYLRXVYLVLWVZLOOEH
FDUULHGIRUZDUGPDWFKLQJSUH&$(ÂŠRUSRVW&$(ÂŠWLPHSRLQWV$SUH&$(ÂŠWLPHSRLQW
ZLOOQHYHUEHLPSXW HGIRUDSRVW&$(ÂŠYDOXHDQGYLFHYHUVD$QD QDO\VLVXVLQJREVHUYHG
GDWDRQO\ZLOODOVREHSH UIRUPHGIRUWKHSULPDU\HIILFDF\YDULD EOHV
1RVHFRQGDU\HIILFDF\HQGSRLQWV RUVDIHW\HQGSRLQWVZLOOEHLPS XWHG
0XOWLSOLFLW\&RQVLGHUDWLRQ
+LHUDUFKLFDOIL[HGVHTXHQFHWH VWLQJZLOOEHXVHGWRPDLQWDLQWK HW\SH,HUURUUDWH7KH
SULPDU\DQDO\VLVZLOOILUVWWHVWWKHGLIIHUHQFHLQWKHFKDQJHI URPEDVHOLQHRIWKHSUH&$(ÂŠ
WRSRVW&$(ÂŠFKDQJHLQLQIHULRUFRUQHDOIOXRUHVFHLQVWDLQLQJDW'D\,I WKHWHVWRIWKH
GLIIHUHQFHLVVWDWLVWLFDOO\VLJQLILFDQWDWWKHWZRVLGHGDOSKD  OHYHOLQIDYRURI+/
WKHQWKHVWXG\ZLOOEHFRQVLGH UHGDVXFFHVV+/ZLOOEHGHFO DUHGWREHVXSHULRUWR
SODFHERLQWKHFKDQJHIURP EDVHOLQHRIWKHSUH&$(ÂŠWRSRVW&$(ÂŠFKDQJHLQLQIHULRU
FRUQHDOIOXRUHVFHLQVWDLQLQJ DW'D\DQGWKHGLIIHUHQFHLQW KHFKDQJHIURPEDVHOLQHRI
WKHSUH&$(ÂŠRFXODUGLVFRPI[INVESTIGATOR_13318]DW'D\ZLOO EHWHVWHGDWWKHWZRVLGHGDO SKD 
OHYHO
,ILQDGGLWLRQWRDVWDWLVWLFDOO\V LJQLILFDQWWHVWRIWKHGLII HUHQFHLQFKDQJHIURPEDVHOLQHRI
WKHSUH&$(ÂŠWRSRVW&$(ÂŠFKDQJHLQLQIHULRUFRUQHDOI OXRUHVFHLQVWDLQLQJDW'D\LQ
IDYRURI+/WKHWHVWRIWKHGL IIHUHQFHLQWKHFKDQJHIURPE DVHOLQHRIWKHSUH&$(ÂŠHL036 Ophthalmic Solution 
Clinical Study Protocol HL036-DED-US-P301Sponsor: HanAll Biopharma, Co., Ltd. 
24 January 2019
Confidential Page 45
RFXODUGLVFRPI[INVESTIGATOR_13318]DW'D\LVDO VRVWDWLVWLFDOO\VLJQLILFDQWL QIDYRURI+/WKHQ
+/ZLOOEHGHFODUHGVXSHULRU WRSODFHERLQERWKWKHFKDQJHI URPEDVHOLQHRIWKHSUH
&$(ÂŠWRSRVW&$(ÂŠFKDQJHLQLQIHULRUFRUQHDOIOXRUHVFHLQVWDLQLQJDQGWKHFKDQJH IURP
EDVHOLQHRIWKHSUH&$(ÂŠRFXODUGLVFRPI[INVESTIGATOR_13318]DW'D\
3ULPDU\(IILFDF\$QDO\VHV
)RUERWKHQGSRLQWVFKDQJHIURPED VHOLQHZLOOEHFDOFXODWHGDV YLVLWÂ±EDVHOLQHVXFKWKDWD
SRVLWLYHGLIIHUHQFHLQGLFDWHVDZRUVHQLQJRIGU\H\HVLJQVRUV \PSWRPV,QDGGLWLRQ
WUHDWPHQWFRPSDULVRQVEHWZHHQD FWLYHDQGSODFHERZLOOEHFDOFXO DWHGDVDFWLYHÂ±SODFHER
VXFKWKDWDQHJDWLYHUHVXOWLQG LFDWHVDEHWWHUVFRUHIRUWKHDF WLYHWUHDWPHQWLHWKHDFWLYH
WUHDWPHQWKDGDVPDOOHULQFUHDVHL QGU\H\HVLJQVRUV\PSWRPVW KDQWKHSODFHERJURXS
$1&29$PRGHOVZLOOEHXVHGWRFRPSD UHWKHFKDQJHIURPEDVHOLQH LQWKHSUH&$(ÂŠWR
SRVW&$(ÂŠFKDQJHLQLQIHULRUFRUQHDOIO XRUHVFHLQVWDLQLQJDW'D\9LV LWDV
PHDVXUHGRQWKH2UD&DOLEUDÂŠVFDOHEHWZHHQ+/ 2SKWKDOPLF6ROXWLRQDQG
3ODFHER7KH$1&29$PRGHOVZLOOLQ FOXGHWHUPVIRUEDVHOLQHSUH &$(ÂŠWRSRVW&$(ÂŠ
FKDQJHLQLQIHULRUFRUQHDOIOXRU HVFHLQVWDLQLQJDQGVWXG\VLWH ,QDGGLWLRQWKHVWXG\VLWH
E\WUHDWPHQWLQWHUDF WLRQZLOOEHH[SORUHGLQDVHSDUDWHPRGHOW RHYDOXDWHKRZWKH
WUHDWPHQWHIIHFWPD\GLIIHUDFUR VVVWXG\VLWHV7KHSULPDU\DQD O\VLVZLOOXVH0&0&
LPSXWDWLRQWRKDYHDI XOODFFRXQWLQJRIWKH,77SRSXODWLRQDWW KH'D\YLVLWDV
GHVFULEHGLQ6HFWLRQ$VVXSSRU WLYHDQDO\VHVLPSXWDWLRQ E\/2&)PXOWLSOH
LPSXWDWLRQE\SDWWHUQPL[WXUHP RGHOVDQGDQDO\VHVRIREVHUYHGG DWDRQO\ZLOODOVREH
FRQGXFWHG7ZRVDPSOHWWHVWV DQG:LOFR[RQUDQNVXPWHVWVZLOO DOVREHFRQGXFWHGDV
VXSSRUWLYHDQDO\VHV
2FXODUGLVFRPI[INVESTIGATOR_13318]ZLOOEHDQDO\ ]HGVLPLODUO\$1&29$PRGHOVZLO OEHXVHGWRFRPSDUH
WKHFKDQJHIURPEDVHOLQHLQWKHSUH&$(ÂŠRFXODUGLVFRPI[INVESTIGATOR_13318]VFRUH DW'D\9LVLWDV
PHDVXUHGRQWKH2UD&DOLEUDÂŠ2FXODU'LVFRPI[INVESTIGATOR_13318]6FDOHEHWZHHQ+/
2SKWKDOPLF6ROXWLRQDQG3ODFHER7 KH$1&29$PRGHOVZLOOLQFOXGH WHUPVIRUEDVHOLQH
9LVLWRFXODUGLVFRPI[INVESTIGATOR_13318]DQGV WXG\VLWH,QDGGLWLRQWKHVW XG\VLWHE\WUHDWPHQW
LQWHUDFWLRQZLOOEHH[S ORUHGLQDVHSDUDWHPRGHOWRHYDOXDWHKR ZWKHWUHDWPHQWHIIHFWPD\
GLIIHUDFURVVVLWHV
6HFRQGDU\(IILFDF\$QDO\VHV
7KHFRQWLQXRXVDQGRUGLQDOVHFRQGD U\HIILFDF\YDULDEOHVFROOHFW HGDWHDFKYLVLWZLOOEH
VX[COMPANY_003]UL]HGGHVFULSWLYHO\QP HDQVWDQGDUGGHYLDWLRQPHGLDQ PLQDQGPD[DQG
DQDO\]HGZLWKWZRVDPSOHWWHVWVFRPSDULQJHDFKRIWKHDFWLYHW UHDWPHQWJURXSVWR
SODFHER$OOYLVLWEDVHGGDWDZLOO EHDQDO\]HGDWHDFKYLVLWDQ GFKDQJHIURPEDVHOLQH
&KDQJHVFRUHVIURPSUHWRSRVW&$(ÂŠZLOOEHFDOFXODWHGDV3RVW&$(ÂŠVFRUHÂ±3UH
&$(ÂŠVFRUH$:LOFR[RQUDQNVXPWHV WDQGDQ$1&29$PRGHODGMXVWLQJ IRUEDVHOLQH
DQGVLWHZLOODOVREHD VVHVVHGZKHUHDSSURSUL DWH1RLPSXWDWLR QZLOOEHSHUIRUPHGIRU
VHFRQGDU\HIILFDF\YDULDEOHV
&RUQHDOIOXRUHVFHLQVWDLQLQJE\ UHJLRQDQGWRWDOFRQMXQFWLYDO OLVVDPLQHJUHHQVWDLQLQJE\
UHJLRQ7)%87FRQMXQFWLYDOUHGQH VVXQDQHVWKHWL]HG6FKLUPHUÂ¶V WHVWGURSFRPI[INVESTIGATOR_13318]
DVVHVVPHQW26',Â‹RFXODUGLVFRPI[INVESTIGATOR_13318]DQGGU\H\H V\PSWRPVRFXODUGLVFRPI[INVESTIGATOR_13318]GXU LQJ
&$(ÂŠSUHWRSRVW&$(ÂŠFKDQJHVDQGFKDQJHVIURPEDVH OLQHLQWKHVHPHDVXUHVZLOOEH
DQDO\]HGE\YLVLWXVLQJWZRVD PSOHWWHVWVDQG:LOFR[RQUDQNVX PWHVWVDV DSSURSULDWHHL036 Ophthalmic Solution 
Clinical Study Protocol HL036-DED-US-P301Sponsor: HanAll Biopharma, Co., Ltd. 
24 January 2019
Confidential Page 46
7KHZRUVWV\PSWRPIRUHDFKVXEMHFWZLOOEHLGHQWLILHGDVWKHV\ PSWRPZLWKWKHKLJKHVW
DYHUDJHVFRUHGXULQJWKHUXQ LQSHULRG'D\VWRDVUHFR UGHGLQWKHVXEMHFWGLDU\
)RUPRUQLQJHYHQLQJDQGGDLO\DYHUDJHDVVHVVPHQWVWKHZHHNO\ DYHUDJHVRIWKHZRUVW
V\PSWRPDQGHDFKLQGLYLGXDOV\PS WRPZLOOEHDQDO\]HGXVLQJWZR VDPSOHWWHVWVDQG
:LOFR[RQUDQNVXPWHVWV
6DIHW\9DULDEOHV
$GYHUVHHYHQWVZLOOEHFRGHGXVLQJ WKH0HG'5$GLFWLRQDU\)UHTX HQFLHVDQG
SHUFHQWDJHVRIVXEMHFWVZLWKWUHDWPHQWHPHUJHQWDGYHUVHHYHQWV 7($(VVHULRXV7($(V
DQG7($(VFDXVLQJSUHPDWXUHGL VFRQWLQXDWLRQZLOOEHSURYLGHGE\ WUHDWPHQWJURXS$Q
$(LVWUHDWPHQWHPHUJHQWLILW RFFXUVDIWHUWKHILUVWGRVHR IUDQGRPL]HGVWXG\WUHDWPHQW
RULILWLVSUHVHQWSULRUW RUHFHLSWRIUDQGRPL]HGVWXG\WUH DWPHQWEXWZRUVHQVLQVHYHULW\
RULQFUHDVHVLQIUHTXHQF\DIWHU WKHILUVWGRVHRIUDQGRPL]HGVW XG\WUHDWPHQW)XUWKHUPRUH
IUHTXHQFLHVZLOOEHJLYHQRIVXEM HFWVZLWK7($(VE\V\VWHPRUJD QFODVVDQGSUHIHUUHG
WHUPE\V\VWHPRUJDQFODVVSUHI HUUHGWHUPDQGPD[LPDOVHYHULW \E\V\VWHPRUJDQFODVV
SUHIHUUHGWHUPIRUWUHDWPHQWUHODWHG$(VE\V\VWHPRUJDQFODVV DQGSUHIHUUHGWHUPIRU
6$(VDQGE\V\VWHPRUJDQFOD VVSUHIHUUHGWHUPDQGGD\RIRQV HW6HSDUDWHDQDO\VHVZLOO
EHSHUIRUPHGIRURFXODUVSHFLILF DQGDOO$(VLQFOXGLQJV\VWHPL F
2WKHUVDIHW\HQGSRLQWVLQFOXGLQJ YLVXDODFXLW\VOLWODPSELRPL FURVFRS\GLODWHG
IXQGRVFRS\DQGLQWUDRFXODUSUHVVX UHZLOOEHVX[COMPANY_003]UL]HGE\WUH DWPHQWJURXSDQGYLVLW
XVLQJGHVFULSWLYHVWDWLVWLFV&KDQJHVRUVKLIWVIURPEDVHOLQHZ LOODOVREHVX[COMPANY_003]UL]HG
ZKHUHDSSURSULDWH)RUDVVHVVPHQ WVSHUIRUPHGE\H\HVWXG\H\H DQGIHOORZH\ HZLOOEH
VX[COMPANY_003]UL]HGVHSDUDWHO\,QDGGLWL RQVKLIWVIURPEDVHOLQHWRZRU VWRQWUHDWPHQWYDOXHIRU
RFXODUVDIHW\DVVHVVPHQ WVZLOOEHVX[COMPANY_003]UL]HG
,QWHULP$QDO\VHV
1RLQWHULPDQDO\VHVDUHSODQQHGIRUWKLVVWXG\
&203/,$1&(:,7+*22'&/,1,&$/35$&7,&(6(7+,&$/
&216,'(5$7,216$1'$'0,1,675$7,9(,668(6
7KLVVWXG\ZLOOEHFRQGXFWHGLQF RPSOLDQFHZLWKWKHSURWRFROF XUUHQW*&3VLQFOXGLQJ
WKH,&+*XLGHOLQHVDQGLQJHQHU DOFRQVLVWHQWZLWKWKH'HFODUD WLRQRI+HOVLQNL,Q
DGGLWLRQDOODSSOLFDEOHORFDOV WDWHDQGIHGHUDOUHTXLUHPHQWV UHOHYDQWWRWKHXVHRI,3VLQ
WKHFRXQWULHVLQYROYHGZ LOOEHDGKHUHGWR
3URWHFWLRQRI+XPDQ6XEMHFWV
6XEMHFW,QIRUPHG&RQVHQW
,QIRUPHGFRQVHQWPXVWWDNHSODFHEHIRUHDQ\VWXG\VSHFLILFSURF HGXUHVDUHLQLWLDWHG
6LJQHGDQGGDWHGZULWWHQLQIRUPH GFRQVHQWPXVWEHREWDLQHGIURP HDFKVXEMHFW
$OOLQIRUPHGFRQVHQWDVVHQWIRUP VPXVWEHDSSURYHGIRUXVHE\W KHVSRQVRUDQGUHFHLYH
DSSURYDOIDYRUDEOHRSLQLRQIURPDQ ,5%,(&SULRUWRWKHLUXVH ,IWKHFRQVHQWIRUP
UHTXLUHVUHYLVLRQHJGXHWRD SURWRFRODPHQGPHQWRUVLJQLILFD QWQHZVDIHW\LQIRUPDWLRQ
LWLVWKHLQYHVWLJDWRUÂ¶VUHVSRQVLE LOLW\WRHQVXUHWKDWWKHDPHQ GHGLQIRUPHGFRQVHQWLV
UHYLHZHGDQGDSSURYHGE\2UDSU LRUWRVXEPLVVLRQWRWKHJRYHUQL QJ,5%,(&DQGWKDWLWHL036 Ophthalmic Solution 
Clinical Study Protocol HL036-DED-US-P301Sponsor: HanAll Biopharma, Co., Ltd. 
24 January 2019
Confidential Page 47
LVUHDGVLJQHGDQGGDWHGE\DOOV XEMHFWVVXEVHTXHQWO\HQUROOHG LQWKHVWXG\DVZHOODV
WKRVHFXUUHQWO\HQUROOHGLQWKHVWXG\
,ILQIRUPHGFRQVHQWLVWDNHQXQGH UVSHFLDOFLUFXPVWDQFHVRUDO LQIRUPHGFRQVHQWWKHQ
WKHSURFHGXUHVWREHIROORZHGPXV WEHGHWHUPLQHGE\2UDDQGRU VWXG\VSRQVRUDQG
SURYLGHGLQZULWLQJE\2UDDQGRU VWXG\VSRQVRUSULRUWRWKHFR QVHQWSURFHVV
,QVWLWXWLRQDO5HYLHZ%RDUG,5%$SSURYDO
7KLVVWXG\LVWREHFRQGXFWHGL QDFFRUGDQFHZ LWK,QVWLWXWLRQDO 5HYLHZ%RDUGUHJXODWLRQV
86&RGHRI)HGHUDO 5HJXODWLRQV>&)5@3DUW7KHLQ YHVWLJDWRUPXVWREWDLQ
DSSURSULDWH,5%DSSURYDOEHIRUHLQLWLDWLQJWKHVWXG\DQGUHDSS URYDODWOHDVWDQQXDOO\
2QO\DQ,5%(5&DSSURYHGYH UVLRQRIWKH,&)ZLOOEHXVHG
(WKLFDO&RQGXFWRIWKH6WXG\
7KLVVWXG\ZLOOEHFRQGXFWHGLQDFF RUGDQFHZLWKWKHHWKLFDOSUL QFLSOHVWKDWRULJLQDWHG
ZLWKWKH'HFODUDWLRQRI+HOVLQNL
6XEMHFW&RQILGHQWLDOLW\
$OOSHUVRQDOVWXG\VXEMHFWGDWD FROOHFWHGDQGSURFHVVHGIRUWKH SXUSRVHVRIWKLVVWXG\
VKRXOGEHPDLQWDLQHGE\WKHLQYH VWLJDWRUDQGKLVKHUVWDIIZLWK DGHTXDWHSUHFDXWLRQVDVWR
HQVXUHWKDWWKHFRQILGHQWLDOLW\ RIWKHGDWDLQDFFRUGDQFHZLWK ORFDOVWDWHDQGIHGHUDOODZV
DQGUHJXODWLRQV
0RQLWRUVDXGLWRUVDQGRWKHUDXWKRU L]HGUHSUHVHQWDWLYHVRI2UD WKHVSRQVRUWKH,5%,(&
DSSURYLQJWKLVVWXG\WKH)RRGD QG'UXJ$GPLQLVWUDWLRQWKH'HS DUWPHQWRI+HDOWKDQG
+XPDQ6HUYLFHVRWKHUGRPHVWLFJ RYHUQPHQWDJHQFLHVDQGRWKHUI RUHLJQUHJXODWRU\
DJHQFLHVZLOOEHJUDQWHGGLUHFWD FFHVVWRWKHVWXG\VXEMHFWÂ¶VR ULJLQDOPHGLFDODQGVWXG\
UHFRUGVIRUYHULILFDWLRQRIWKH GDWDDQGRUFOLQLFDOWULDOSURF HGXUHV$FFHVVWRWKLV
LQIRUPDWLRQZLOOEHSHUPLWWHGWRW KHDIRUHPHQWLRQHGLQGLYLGXDOV WRWKHH[WHQWSHUPLWWHG
E\ODZ
$UHSRUWRIWKHUHVXOWVRIWKL VVWXG\PD\EHSXEOLVKHGRUVHQW WRWKHDSSURSULDWHKHDOWK
DXWKRULWLHVLQDQ\FRXQWU\LQZKLF KWKH,3PD\XOWLPDWHO\EHPD UNHWHGEXWWKHVXEMHFWÂ¶V
LGHQWLW\ZLOOQRWEHGLVFOR VHGLQWKHVHGRFXPHQWV
'RFXPHQWDWLRQ
6RXUFHGRFXPHQWVPD\LQFOXGHD VXEMHFWÂ¶VPHGLFDOUHFRUGVKRVSL WDOFKDUWVFOLQLFFKDUWV
WKHLQYHVWLJDWRUÂ¶VVWXG\VXEMHFW ILOHVDVZHOODVWKHUHVXOWV RIGLDJQRVWLFWHVWVVXFKDV;
UD\VODERUDWRU\WHVWVDQGHOHFW URFDUGLRJUDPV7KHLQYHVWLJDWR UÂ¶VFRS\RIWKHH&5)V
VHUYHVDVWKHLQYHVWLJDWRUÂ¶VU HFRUGRIDVXEMHFWÂ¶VVWXG\UHODWH GGDWD
5HWHQWLRQRI'RFXPHQWDWLRQ
$OOVWXG\UHODWHGFRUUHVSRQGHQFH VXEMHFWUHFRUGV,&)VUHFRUG RIWKHGLVWULEXWLRQDQGXVH
RIDOO,3VDQGFRSLHVRIH&5)V VKRXOGEHPDLQWDLQHGRQILOHIRU DWOHDVW\HDUVDIWHUWKH
ODVWDSSURYDORIDP DUNHWLQJDSSOLFDWLRQLQDQ,&+UHJLRQDQGX QWLOWKHUHDUHQRSHQGLQJ
RUFRQWHPSODWHGPDUNHWLQJDSSOLF DWLRQVLQDQ,&+UHJLRQRUXQW LODWOHDVW\HDUVKDYH
HODSVHGVLQFHWKHIRUPDOGLVF RQWLQXDWLRQRIFOLQLFDOGHYHORSPHQ WRIWKH,37KHVH
GRFXPHQWVZLOOEHUHWDLQHGIRUD ORQJHUSHULRGLIUHTXLUHGE\W KHDSSOLFDEOHUHJXODWRU\HL036 Ophthalmic Solution 
Clinical Study Protocol HL036-DED-US-P301Sponsor: HanAll Biopharma, Co., Ltd. 
24 January 2019
Confidential Page 48
UHTXLUHPHQWVRUE\DQDJUHHPHQW ZLWKWKHVSRQVRU,WLVWKHUHV SRQVLELOLW\RIWKHVSRQVRU
WRLQIRUPWKHLQYHVWLJDWRULQV WLWXWLRQDVWRZKHQWKHVHGRFXPHQ WVQRORQJHUQHHGWREH
UHWDLQHG
,IWKHUHVSRQVLEOHLQYHVWLJDWRUU HWLUHVUHORFDWHVRUIRURWKH UUHDVRQVZLWKGUDZVIURPWKH
UHVSRQVLELOLW\RINHHSLQJVWXG\UH FRUGVFXVWRG\PXVWEHWUDQVI HUUHGWRDSHUVRQZKRZLOO
DFFHSWWKHUHVSRQVLELOLW\7KHV SRQVRUPXVWEHQRWLILHGLQZULW LQJRIWKHQDPHDQGDGGUHVV
RIWKHQHZFXVWRGLDQ
/DEHOLQJ3DFNDJLQJ6WRUDJH$ FFRXQWDELOLW\DQG 5HWXUQRU'LV SRVDORI
,QYHVWLJDWLRQDO3URGXFW
/DEHOLQJ3DFNDJLQJ
5XQLQDQG,QYHVWLJD WLRQDOGUXJZLOOEHSDFNDJHGDQGODEHOHGLQ WRFOLQLFDONLWV
)RUWKHUXQLQSHULRGSRXFKHV ZLOOEHSDFNDJHGLQDZHHN FOLQLFDONLW(DFKSRXFK
ZLOOFRQWDLQVLQJOHXVHYLDOV WRSURYLGHDVXIILFLHQWPHGLFDW LRQVXSSO\IRURQHGD\
)RUWKHWUHDWPHQWSHULRGSRXFKH VZLOOEHSDFNDJHGLQDZH HNFOLQLFDONLW(DFK
SDWLHQWZLOOUHFHLYHNLWV(DF KSRXFKZLOOFRQWDLQYLDOVWR SURYLGHDVXIILFLHQWVXSSO\
RIUDQGRPL]HGVWXG\GUXJIRURQHGD\
6WRUDJHRI,QYHVWLJDWLRQDO3URGXFW
7KHVWXG\GUXJVPXVWEHVWRUHGL QDVHFXUHDUHDDFFHVVLEOHRQO\ WRWKHLQYHVWLJDWRUDQG
KLVKHUGHVLJQHHV6WXG\GUXJV PXVWEHUHIULJHUDWHGÂƒ&' R1RW)UHH]HSURWHFWHG
IURPOLJKWDQGVHFXUHGDWWKHLQYH VWLJDWLRQDOV LWHLQDORFNHG FRQWDLQHU
$FFRXQWDELOLW\RI,QYH VWLJDWLRQDO3URGXFW
7KHVWXG\GUXJVDUHWRRQO\EHSUHVFULEHGE\WKHSULQFLSDOLQYH VWLJDWRURUKLVKHUQDPHG
VXELQYHVWLJDWRUVDQGLVWRRQO \EHXVHGLQDFFRUGDQFHZLWK WKLVSURWRFRO7KHVWXG\
GUXJVPXVWRQO\EHGLVWULEXWH GWRVXEMHFWVSURSHUO\TXDOLILHGX QGHUWKLVSURWRFROWR
UHFHLYHVWXG\GUXJ7KHLQYHVWLJDWRUPXVWNHHSDQDFFXUDWHDFFR XQWLQJRIWKHVWXG\GUXJV
E\PDLQWDLQLQJDGHWDLOHGLQYH QWRU\7KLVLQFOXGHVWKHDPRXQWR IVWXG\GUXJVUHFHLYHGE\
WKHVLWHDPRXQWGLVSHQVHGWRVXEM HFWVDPRXQWUHWXUQHGWRWKH VLWHE\WKHVXEMHFWVDQGWKH
DPRXQWUHWXUQHGWRWKH6SRQVRUXSRQW KHFRPSOHWLRQRIWKHVWXG\ 
5HWXUQRU'LVSRVDORI, QYHVWLJDWLRQDO3URGXFW
$OO,3ZLOOEHUHWXUQHGWRWKH VSRQVRURUWKHLUGHVLJQHHRUGHV WUR\HGDWWKHVWXG\VLWH
7KHUHWXUQRUGLVSRVDORI,3ZLOOEHVSHFLILHGLQZULWLQJ
5HFRUGLQJRI'DWDRQ6RXUFH'RFXPHQWVDQG&DVH5HSRUWV)RUPV& 5)V
$OOVXEMHFWGDWDZLOOEHFDSWXUH GLQWKHVXEMHFWVRXUFHGRFXPHQ WVZKLFKZLOOEH
WUDQVFULEHGLQWKHH&5)V7KHLQYH VWLJDWRULVUHVSRQVLEOHIRUH QVXULQJWKDWVWXG\GDWDDUH
FRPSOHWHO\DQGDFFXUDWHO\UHFR UGHGRQHDFKVXEMHFWÂ¶VH&5)VRXU FHGRFXPHQWVDQGDOO
VWXG\UHODWHGPDWHULDOV$OO VWXG\GDWDVKRXO GDOVREHDWWULEXW DEOHOHJLEOH
FRQWHPSRUDQHRXVDQGRULJLQDO5 HFRUGHGGDWXPVKRXOGRQO\EHFR UUHFWHGLQDPDQQHU
WKDWGRHVQRWREOLWHUDWHGHVWUR\R UUHQGHULOOHJLEOHWKHSUHY LRXVHQWU\HJE\GUDZLQJD
VLQJOHOLQHWKURXJKWKHLQFRUUHFWHQWU\DQGZULWLQJWKHUHYLVLR QQH[WWRWKHFRUUHFWHGGDWDHL036 Ophthalmic Solution 
Clinical Study Protocol HL036-DED-US-P301Sponsor: HanAll Biopharma, Co., Ltd. 
24 January 2019
Confidential Page 49
$QLQGLYLGXDOZKRKDVFRUUHFWHGD GDWDHQWU\VKRXOGPDNHFOHDU ZKRPDGHWKHFRUUHFWLRQ
DQGZKHQE\DGGLQJWRWKHFRUU HFWLRQKLVKHULQLWLDOVDVZHOO DVWKHGDWHRIWKHFRUUHFWLRQ
'DWDHQWU\RIDOOHQUROOHGDQGU DQGRPL]HGVXEMHFWVZLOOXVHVRI WZDUHWKDWFRQIRUPVWR
&)53DUWUHTXLUHPH QWVDQGZLOOEHSHUIRUPHGRQO\E\VWDIIZ KRKDYHEHHQWUDLQHGRQ
WKHV\VWHPDQGKDYHDFFHVVWRWKH V\VWHP'DWDZLOOQRWEHHQWH UHGIRUVFUHHQIDLOXUH
VXEMHFWV$QDXGLWWUDLOZLOOEHP DLQWDLQHGZLWKLQWKHHOHFWURQ LFV\VWHPWRFDSWXUHDOO
FKDQJHVPDGHZLWKLQWKHH&5)GD WDEDVH$IWHUWKHHQGRIWKHVWX G\DQGGDWDEDVHORFN
FRPSDFWGLVFVFRQWDLQLQJFRSLHV RIDOODSSOLFDEOHVXEMHFWVÂ¶H&5 )VZLOOEHSURYLGHGWR
HDFK,QYHVWLJDWRU6LWHWREHPDLQWDLQHGRQILOHE\WKH,QYHVWLJ DWRU
+DQGOLQJRI%LRORJLFDO6SHFLPHQV
%ORRGVDPSOHVZLOOEHVXEPLWWHGWRRQH RUPRUHFHQWUDOODERUDWR ULHVDQGRUDQDO\WLFDO
ODERUDWRULHVIRUSURFHVVLQJVWR UDJHDQGDQDO\VLV$OOODERUDWR ULHVPHHW*RRG/DERUDWRU\
3UDFWLFHUHTXLUHPHQWV 
3XEOLFDWLRQV
$XWKRUVKLSDQGPDQXVFULSWFR PSRVLWLRQZLOOUHIOHFWFRRSHUDWLRQ DPRQJDOOSDUWLHV
LQYROYHGLQWKHVWXG\$XWKRUVKL SZLOOEHHVWDEOLVKHGEHIRUHZU LWLQJWKHPDQXVFULSW2UD
DQGWKHVWXG\VSRQVRUZLOOKDYHW KHILQDOGHFLVLRQUHJDUGLQJWK HPDQXVFULSWDQG
SXEOLFDWLRQ
HL036 Ophthalmic Solution 
Clinical Study Protocol HL036-DED-US-P301Sponsor: HanAll Biopharma, Co., Ltd. 
24 January 2019
Confidential Page 50
5()(5(1&(6
 6FKDXPEHUJ'$'DQD5%XULQJ-(6XOOLYDQ'$3UHYDOHQFHRI GU\H\HGLVHDVH
DPRQJ86PHQHVWLPDWHVIURPWKH3K\VLFLDQV
+HDOWK6WXGLHV$U FKLYHVRI
RSKWKDOPRORJ\ 6FKDXPEHUJ'$6XOOLYDQ'$%XULQJ-('DQD053UHYDOHQFHR IGU\H\H
V\QGURPHDPRQJ86ZRPHQ$PHUL FDQMRXUQDORIRSKWKDOPRORJ\ 
 6FKDXPEHUJ'$6XOOLYDQ'$'DQD05(SLGHPLRORJ\RIGU\H\H V\QGURPH
$GYDQFHVLQH[SHULPHQWDOPHG LFLQHDQGELRORJ\
 %UHZLWW+6LVWDQL)'U\H\HGLVHDVHWKHVFDOHRIWKHSURE OHP6XUYH\RI
RSKWKDOPRORJ\6XSSO6HL036 Ophthalmic Solution 
Clinical Study Protocol HL036-DED-US-P301Sponsor: HanAll Biopharma, Co., Ltd. 
24 January 2019
Confidential Page 51
$33(1',&(6
$33(1',;6&+('8/(2)9,6,76$1'0($685(0(176
3URFHGXUH9LVLW
'D\Â“9LVLW
'D\9LVLW
'D\
Â“9LVLW
'D\Â“9LVLW
'D\Â“ 9LVLW
'D\Â“
3UH
&$(ÂŠ3RVW
&$(ÂŠ3UH
&$(ÂŠ3RVW
&$(ÂŠ1RQ
&$(ÂŠ3UH
&$(ÂŠ3RVW
&$(ÂŠ3UH
&$(ÂŠ3RVW
&$(ÂŠ3UH
&$(ÂŠ3RVW
&$(ÂŠ
,QIRUPHG&RQVHQW+,3$$ ;
0HGLFDO0HGLFDWLRQ+LVWRU\
DQG'HPRJUDSKLFV;
0HGLFDO0HGLFDWL RQ8SGDWH ; ; ; ; ;
3ODFHER5XQ,Q'LVSHQVDWLRQ ;
3ODFHER5XQLQ&ROOHFWLRQ ;
5DQGRPL]DWLRQ ;
5XQLQ,QVWLOODWLRQ ;
6WXG\'UXJ'LVSHQVDWLRQ ; ;; ; 
6WXG\'UXJ,QVWLOODWLRQ ; ;
6WXG\'UXJ&ROOHFWLRQ ; ; ; ;
'LDU\'LVSHQVDWLRQ ; ; ; ; ;
'LDU\&ROOHFWLRQ ; ; ; ; ;
5HYLHZRI4XDOLILFDWLRQ
&ULWHULD; ; ; ;
$GYHUVH(YHQW4XHU\ ; ; ; ; ; ; ; ; ; ; ;
3UHJQDQF\7HVW ; ;HL036 Ophthalmic Solution 
Clinical Study Protocol HL036-DED-US-P301Sponsor: HanAll Biopharma, Co., Ltd. 
24 January 2019
Confidential Page 52
3URFHGXUH9LVLW
'D\Â“9LVLW
'D\9LVLW
'D\
Â“9LVLW
'D\Â“9LVLW
'D\Â“ 9LVLW
'D\Â“
3UH
&$(ÂŠ3RVW
&$(ÂŠ3UH
&$(ÂŠ3RVW
&$(ÂŠ1RQ
&$(ÂŠ3UH
&$(ÂŠ3RVW
&$(ÂŠ3UH
&$(ÂŠ3RVW
&$(ÂŠ3UH
&$(ÂŠ3RVW
&$(ÂŠ
'URS&RPI[INVESTIGATOR_13318]$VVHVVPHQW ;
2UD&DOLEUDÂŠ2FXODU
'LVFRPI[INVESTIGATOR_13318]6FDOH; ; ; ; ; ; ; ; ; ; ;
2UD&DOLEUDÂŠ2FXODU
'LVFRPI[INVESTIGATOR_13318]	6\PSWRP
4XHVWLRQQDLUH; ; ; ; ; ; ; ; ; ; ;
9$6'LVFRPI[INVESTIGATOR_13318]6FDOH ; ; ; ; ; ; ; ; ; ; ;
26',Â‹4XHVWLRQQDLUH ; ; ; ; ; ;
9LVXDO$FXLW\(7'56 ; ; ; ; ; ;
6OLWODPS%LRPLFURVFRS\ ; ; ; ; ; ; ; ; ; ; ;
&RQMXQFWLYDO5HGQHVV ; ; ; ; ; ; ; ; ; ; ;
7)%87 ; ; ; ; ; ; ; ; ; ; ;
)OXRUHVFHLQ6WDLQLQJ ; ; ; ; ; ; ; ; ; ; ;
/LVVDPLQH*UHHQ6WDLQLQJ ; ; ; ; ; ; ; ; ; ; ;
&$(ÂŠ([SRVXUH ; ; ; ; ;
'LVFRPI[INVESTIGATOR_13318]*UDGLQJGXULQJ
&$(ÂŠ([SRVXUH; ; ; ; ;
6FKLUPHUÂ¶V7HVW ; ; ; ; ;
,QWUDRFXODU3UHVVXUH ; ;
'LODWHG)XQGXV([DP ; ;HL036 Ophthalmic Solution 
Clinical Study Protocol HL036-DED-US-P301Sponsor: HanAll Biopharma, Co., Ltd. 
24 January 2019
Confidential Page 53
3URFHGXUH9LVLW
'D\Â“9LVLW
'D\9LVLW
'D\
Â“9LVLW
'D\Â“9LVLW
'D\Â“ 9LVLW
'D\Â“
3UH
&$(ÂŠ3RVW
&$(ÂŠ3UH
&$(ÂŠ3RVW
&$(ÂŠ1RQ
&$(ÂŠ3UH
&$(ÂŠ3RVW
&$(ÂŠ3UH
&$(ÂŠ3RVW
&$(ÂŠ3UH
&$(ÂŠ3RVW
&$(ÂŠ
%ORRGVDPSOLQJIRU
,PPXQRJHQLFLW\WHVWLQJ; ; ;
([LW6XEMHFWIURP6WXG\ ;
7KH9LVLWVWXG\GUXJNLWLVUHGLVSHQVHGDW9LVLW
7RZRPHQRIFKLOGEHDULQJ SRWHQWLDODVGHILQHG
)RUVXEMHFWVZLWKQHJDWLYHLPPXQRJHQLFLW\UHVXOWVDWSUHYLRXVY LVLWV9LVLWVRUHL036 Ophthalmic Solution 
Clinical Study Protocol HL036-DED-US-P301Sponsor: HanAll Biopharma, Co., Ltd. 
24 January 2019
Confidential Page 54
$33(1',;(;$0,1$7,21352&('85(67(676
(48,30(17$1'7(&+1,48(6
9LVXDO$FXLW\3URFHGXUHV(7'56&KDUW
/RJ0$5YLVXDODFXLW\9$PXVW EHDVVHVVHGXVLQJDQ(DUO\7UHDW PHQW'LDEHWLF
5HWLQRSDWK\6WXG\(7'56FKDUW 7KHSURFHGXUH XVHGZLOOEHFRQ VLVWHQWZLWKWKH
UHFRPPHQGDWLRQVSURYLGHGIRUXVLQJ WKH(7'56H\HFKDUW9$VKRX OGEHHYDOXDWHGDW
WKHEHJLQQLQJRIHDFKYLVLWLQW KHVWXG\LHSULRUWRVOLWODP SH[DPLQDWLRQ9$WHVWLQJ
VKRXOGEHGRQHZLWKPRVWUHFHQWFRUUHFWLRQ
(TXLSPHQW
7KH9$FKDUWWREHXVHGLVWKH(7' 56FKDUW,IVPDOOHUUHSURGXF WLRQE\HJ
IURP3UHYHQW%OLQGQHVVZDOOFK DUWVDUHXVHGWKHVXEMHFWYLHZL QJGLVWDQFHVKRXOGEH
H[DFWO\IHHWRUDVVSHFLILHGE \WKHPDQXIDFWXUHU,Q$//F DVHVIRUSXUSRVHVRI
VWDQGDUGL]LQJWKHWHVWLQJFRQG LWLRQVGXULQJWKHVWXG\DOOVLWH VPXVWXVHRQO\WKH
5
FKDUWV
DQGWKHULJKWH\HVKRXOGEHWHVWH GILUVW)RUUHIOHFWDQFHZDOO FKDUWVWKHFKDUWVKRXOGEH
SODFHGIURQWDOO\DQGZHOOLOOXPLQDWHG
0HDVXUHPHQW7HFKQLTXH
7KHFKDUWVKRXOGEHDWDFRPI[INVESTIGATOR_255651]YLHZLQJDQJOH7KHULJKWH \HVKRXOGEHWHVWHGILUVW
7KHVXEMHFWVKRXOGDWWHPSWWRUHD GHDFKOHWWHUOLQHE\OLQHO HIWWRULJKWEHJLQQLQJZLWK
OLQHDWWKHWRSRIWKHFKDUW7 KHVXEMHFWVKRXOGEHWROGWKDW WKHFKDUWKDVOHWWHUVRQO\QR
QXPEHUV,IWKHVXEMHFWUHDGV DQXPEHUKHRU VKHVKRXOGEHUHP LQGHGWKDWWKHFKDUW
FRQWDLQVQRQXPEHUVDQGWKHH[D PLQHUVKRXOGWKHQUHTXHVWDOHW WHULQOLHXRIWKHQXPEHU
7KHVXEMHFWVKRXOGEHDVNHGWRUHD GVORZO\VRDVWRDFKLHYHWK HEHVWLGHQWLILFDWLRQRI
HDFKOHWWHU+HVKHLVQRWWRSU RFHHGWRWKHQH[WOHWWHUXQWLO KHVKHKDVJLYHQDGHILQLWH
UHVSRQVH
,IWKHVXEMHFWFKDQJHVDUHVSRQVH HJ
WKDWZDVD&QRWDQ 2
EHIRUHKHKDVUHDG
DORXGWKHQH[WOHWWHUW KHQWKHFKDQJHPXVW EHDFFHSWHG,IWKH VXEMHFWFKDQJHVDUHVSRQVH
KDYLQJUHDGWKHQH[WOHWWHUW KHQWKHFKDQJHLVQRWWREHDFFHS WHG7KHH[DPLQHUVKRXOG
QHYHUSRLQWWRWKHFKDUWRUWRV SHFLILFOHWWHUVRQWKHFKDUWGX ULQJWKHWHVW
$PD[LPXPHIIRUWVKRXOGEHPDGHW RLGHQWLI\HDFKOHWWHURQWKH FKDUW:KHQWKHVXEMHFW
VD\VKHRUVKHFDQQRWUHDGDO HWWHUKHRUVK HVKRXOGEHHQFRXU DJHGWRJXHVV,IWKHVXEMHFW
LGHQWLILHVDOHWWHUDVRIOH WWHUVKHRUVKHVKRXOGEHDVNH GWRFKRRVHOHWWHUDQGLI
QHFHVVDU\WRJXHVV:KHQLWEHFRPHVHYLGHQWWKDWQRIXUWKHUPH DQLQJIXOUHDGLQJVFDQEH
PDGHGHVSLWHHQFRXUDJHPHQWWRU HDGRUJXHVVWKHH[DPLQHUVKRX OGVWRSWKHWHVWIRUWKDW
H\H+RZHYHUDOOOHWWHUVRQWKH ODVWOLQHVKRXOGEHDWWHPSWHG DVOHWWHUGLIILFXOWLHVYDU\DQG
WKHODVWPD\EHWKHRQO\RQHUHDG FRUUHFWO\7KHQXPEHURIOHWW HUVPLVVHGRUUHDG
LQFRUUHFWO\VKRXOGEHQRWHGHL036 Ophthalmic Solution 
Clinical Study Protocol HL036-DED-US-P301Sponsor: HanAll Biopharma, Co., Ltd. 
24 January 2019
Confidential Page 55
/RJ0$59LVXDO$FXLW\&DOFXODWLRQV
7KHODVWOLQHLQZKLFKDOHWWHU LVUHDGFRUUHFWO\ZLOOEHWDNHQ DVWKHEDVHORJ0$5UHDGLQJ
7RWKLVYDOXHZLOOEHDGGHGW KHQXPEHU1[ZKHUH
1
UHS UHVHQWVWKHWRWDOQXPEHU
RIOHWWHUVPLVVHGXSW RDQGLQFOXGHGLQWKH ODVWOLQHUHDG7KL VWRWDOVXPUHSUHVHQWVWKH
ORJ0$59$IRUWKDWH\H
)RU([DPSOH6XEMHFW FRUUHFWO\UHDGVRIOHWWHUVRQWKH OLQHDQGRIOHWWHUVRQ
WKHOLQH
%DVHORJ0$5  
1WRWDOQXPEHURIOHWWHUVL QFRUUHFWRQOLQHDVZHOODV   
1[77   
%DVHORJ0$51[7  
ORJ0$59$  
5HSHDWWKHSURFHGXUHIRUWKHOHIWH\H
,QRUGHUWRSURYLGHVWDQGDUGL]H GDQGZHOOFRQWUR OOHGDVVHVVPHQW VRI9$GXULQJWKHVWXG\
DOO9$DVVHVVPHQWVDWDVLQJOH VLWHPXVWEHFRQVLVWHQWO\GRQHX VLQJWKHVDPHOLJKWLQJ
FRQGLWLRQVDQGVDPHFRUUHFWLRQLI SRVVLEOHGXULQJWKHHQWLUHVW XG\,IWKHVDPHFRUUHFWLRQ
FDQQRWEHXVHGLHDVXEMHFWIRU JHWVKLVJODVVHVWKHUHDVRQ IRUWKHFKDQJHLQFRUUHFWLRQ
VKRXOGEHGRFXPHQWHG
6OLW/DPS%LRPLFURVFRS\3URFHGXUHV
6OLWODPSELRPLFURVFRSLFREVHUYD WLRQVZLOOEHJUDGHGDV1RUPDO RU$EQRUPDO$EQRUPDO
ILQGLQJVZLOOEHFDWHJRUL]HGDV FOLQLFDOO\VLJQLILFDQWILQGLQJ VWKDWPD\LQWHUIHUHZLWK
VWXG\SDUDPHWHUVRURWKHUZLVH FRQIRXQGWKHGDWD DVGHWHUPLQHGE \WKHLQYHVWLJDWRURUQRW
FOLQLFDOO\VLJQLILFDQW1&67KHIROORZLQJZLOOEHH[DPLQHG 
x&RUQHD
x&RQMXQFWLYD
x$QWHULRU&KDPEHU
x,ULV
x/HQV
x(\HOLG
([WHUQDOPDJQLILFDWLRQDQGELRPLF URVFRS\ZLOOEHSHUIRUPHGXVLQ JDVOLWODPS
0DJQLILFDWLRQZLOOEHFRQVLVWHQ WZLWKVWDQGDU GFOLQLFDOSUDFWLF H7KHVXEMHFWZLOOEH
VHDWHGHL036 Ophthalmic Solution 
Clinical Study Protocol HL036-DED-US-P301Sponsor: HanAll Biopharma, Co., Ltd. 
24 January 2019
Confidential Page 56
'LODWHG)XQGRVFRS\
'LODWHGIXQGRVFRS\ZLOOEHSHUIRUP HGXVLQJLQGLUHFWRSKWKDOPRVF RS\7KHLQYHVWLJDWRU
ZLOOPDNHREVHUYDWLRQVRIWKHYLWU HRXVUHWLQDP DFXODFKRURLG DQGRSWLFQHUYH
2EVHUYDWLRQVZLOOEHJUDGHGDV 1RUPDORU$EQRUPDO$EQRUPDOIL QGLQJVWKDWDUH
FOLQLFDOO\VLJQLILFDQWDVGHWHUPLQHGE\WKHLQYHVWLJDWRUWKDW PD\LQWHUIHUHZLWKVWXG\
SDUDPHWHUVRURWKHUZLVHFRQIRXQGW KHGDWDDQGWKRVHWKDWDUHQ RWFOLQLFDOO\VLJQLILFDQW
ZLOOEHGHVFULEHG$ GLODWHGIXQGRVFRS\H[DPLQDWLRQVKRXOGEHS HUIRUPHGLIUHWLQDO
GLVHDVHLVGHWHFWHG
x9LWUHRXV([DPLQDWLRQVKRXOGH PSKDVL]HWKHYLVXDOD[LV
x5HWLQD0DFXOD&KRURLG,QFOXGH DQREVHUYDWLRQRIWKHUHWLQD DQGLWVEORRG
YHVVHOV(\HVVKRXOGEHH[FOXGHGIURPWKHVWXG\LIDFWLYHLQIOD [COMPANY_003]WLRQLVSUHVHQW
x2SWLF1HUYH6LJQLILFDQWGDPD JHRUFXSSLQJWRWKHRSWLFQHUYH VKRXOGEHQRWHG
,WLVUHFRPPHQGHGWKDWWURSLFD PLGHRSKWKDOPLFVROXWLRQEHXV HGWRGLODWHVXEMHFWV
7KHXVHRIF\FORSHQWRODWH RSKWKDOPLFVROXWLRQLVUHFRPPHQGHG DVVHFRQGDU\GLODWLQJ
PHGLFDWLRQVKRXOGWKHQHHGDULVH
,QWUDRFXODU3UHVVXUH
,QWUDRFXODUSUHVVXUHZLOOEHPHDV XUHGLQHDFKH\HE\FRQWDFWWR QRPHWU\E\WKHH[DPLQHU
DQGWKHUHVXOWVZLOOEH UHFRUGHGLQPP+J$ VLQJOHPHDVXUHPHQW LVPDGHWRREWDLQD
GHWHUPLQDWLRQRI,23 7KHVDPHWRQRPHWHUHPSOR\LQJWKH,QYHVWL JDWRUÂ¶VVWDQGDUG
WHFKQLTXHZLOOEHXVHGWKURXJKRXW WKHVWXG\,QDGGLWLRQDOO UHDVRQDEOHHIIRUWVZLOOEH
PDGHWRKDYHWKHVDPHH[DPLQHUREW DLQDOO,23PHDVXUHPHQWVIRU DJLYHQVXEMHFW
2UDSURSULHWDU\VFDOHVÂ±1RWIRUGLVWULEXWLRQZLWKRXWSHUPLVVLR Q
2UD&DOLEUDÂŠ 2FXODU'LVFRPI[INVESTIGATOR_13318]6FDOHIRU'U\(\H




 
 
 
 
 HL036 Ophthalmic Solution 
Clinical Study Protocol HL036-DED-US-P301Sponsor: HanAll Biopharma, Co., Ltd. 
24 January 2019
Confidential Page 57
2UD&DOLEUDÂŠ2FXODU'LVFRPI[INVESTIGATOR_13318]	6\PSWRP4XHVWLRQQDLUHIRU'U\(\H








9LVXDO$QDORJXH6FDOH9$6
6XEMHFWVZLOOEHDVNHGWKHIROOR ZLQJTXHVWLRQVUHJDUGLQJRFXODU GLVFRPI[INVESTIGATOR_13318]XQUHODWHGWR
VWXG\GUXJLQVWLOODWLRQDWDOOYLVLWV
7KHVXEMHFWZLOOEHDVNHGWRUD WHHDFKRFXODUV\PSWRPGXHWRRF XODUGU\QHVVE\SODFLQJD
YHUWLFDOPDUNRQWKHKRUL]RQWDO OLQHWRLQGLFDWHWKHFXUUHQWOH YHORIGLVFRPI[INVESTIGATOR_13318]
FRUUHVSRQGVWRÂ³QRGLVFRPI[INVESTIGATOR_13318]Â´D QGFRUUHVSRQGVWRÂ³PD[LPDO GLVFRPI[INVESTIGATOR_13318]Â´

HL036 Ophthalmic Solution 
Clinical Study Protocol HL036-DED-US-P301Sponsor: HanAll Biopharma, Co., Ltd. 
24 January 2019
Confidential Page 58
2FXODU6XUIDFHDQG'LVHDVH,QGH[26',Â‹IRU'U\(\H


HL036 Ophthalmic Solution 
Clinical Study Protocol HL036-DED-US-P301Sponsor: HanAll Biopharma, Co., Ltd. 
24 January 2019
Confidential Page 59
HL036 Ophthalmic Solution 
Clinical Study Protocol HL036-DED-US-P301Sponsor: HanAll Biopharma, Co., Ltd. 
24 January 2019
Confidential Page 60
2UD&DOLEUDÂŠ&RQMXQFWLYDO5HGQHVV 6FDOHIRU'U\(\H


 
 
 
 
 

7HDU)LOP%UHDN8S7LPH7)%87Â‹
7KHH[DPLQHUZLOOLQVWLOO VROXWLRQLQWR
WKHLQIHULRUFRQMXQFWLYDOFXOGHVDFRIHDFKH\H7RWKRURXJKO\ PL[WKHIOXRUHVFHLQZLWK
WKHWHDUILOPWKHVXEMHFWZLOOEH LQVWUXFWHGWREOLQNVHYHUDO WLPHV,QRUGHUWRDFKLHYH
PD[LPXPIOXRUHVFHQFHWKHH[DPLQ HUVKRXOGZDLWDSSUR[LPDWHO\ VHFRQGVDIWHU
LQVWLOODWLRQEHIRUHHYDOXDWLQJ7)%87
:LWKWKHDLGRIDVOLW ODPSWKHH[DPLQHUZLOOPRQLWRUWKHLQWH JULW\RIWKHWHDUILOPQRWLQJ
WKHWLPHLWWDNHVWRIRUPPLFHOOHVIURPWKHWLPHWKDWWKHH\HL VRSHQHG7)%87ZLOOEH
PHDVXUHGLQVHFRQGVXVLQJDVWRSZ DWFKDQGDGLJLWDOLPDJHUHFRU GLQJV\VWHPIRUWKHULJKW
H\HIROORZHGE\WKHOHIWH\H $:UDWWHQ\HOOR ZILOWHUZLOO EHXVHGWRHQKDQFHWKH
DELOLW\WRJUDGH7)%87
)RUHDFKH\HPHDVXUHPHQWVZ LOOEHWDNHQDQGDYHUDJHGXQOHVV WKHPHDVXUHPHQWVDUH
!VHFRQGVDSDUWDQGDUHHDFK VHFRQGVLQZKLFKFDVHDW KLUGPHDVXUHPHQWZRXOG
EHWDNHQDQGWKHFORVHVW RIWKHZRXOGEHDYHUDJHG
)OXRUHVFHLQ6WDLQLQJ
7KHH[DPLQHUZLOOLQVWLOO VROXWLRQLQWR
WKHLQIHULRUFRQMXQFWLYDOFXOG HVDFRIHDFKH\H,QRUGHUWRD FKLHYHPD[LPXP
IOXRUHVFHQFHWKHH[DPLQHUVKRXOGZ DLWDSSUR[LPDWH O\PLQXWH VDIWHULQVWLOODWLRQ
EHIRUHHYDOXDWLQJIOXRUHVFHLQV WDLQLQJ$:UDWWHQ\HOORZIL OWHUZLOOEHXVHGWR
HQKDQFHWKHDELOLW\WRJUDGHIOXRUHVFHLQVWDLQLQJ7KHVWDLQLQJ ZLOOEHJUDGHGZLWKWKH2UD
&DOLEUD70&RUQHDODQG&RQMXQFWLYDO6WDLQ LQJ6FDOHDQG1(,VFDOHHL036 Ophthalmic Solution 
Clinical Study Protocol HL036-DED-US-P301Sponsor: HanAll Biopharma, Co., Ltd. 
24 January 2019
Confidential Page 61
2UD&DOLEUDÂŠ&RUQHDODQG&RQMXQFWLYDO6WDLQLQ J6FDOHIRU*UDGLQJRI)OXRUHVF HLQ
6WDLQLQJ




 
 
 
 
 
6WDLQLQJDUHDV

  










 
 
 
HL036 Ophthalmic Solution 
Clinical Study Protocol HL036-DED-US-P301Sponsor: HanAll Biopharma, Co., Ltd. 
24 January 2019
Confidential Page 62
/LVVDPLQH*UHHQ6WDLQLQJ
7KH,QYHVWLJDWRUZLOOLQVWLOO 
LQWRWKHLQIHULRUFRQMXQFWLYDOF XOGHVDFDQGZDLWDSSUR[LPDWH O\VHFRQGVEHIRUH
HYDOXDWLQJVWDLQLQJ7KHVXEMHFW ZLOOEHLQVWUXFWHGWREOLQNVH YHUDOWLPHVWRGLVWULEXWHWKH
OLVVDPLQHJUHHQ7KHVWDLQLQJZ LOOEHJUDGHGZLWK WKH2UD&DOLE UD70&RUQHDODQG
&RQMXQFWLYDO6WDLQLQJ6FDOHDV ZHOODVWKH1(,VFDOH
2UD&DOLEUDÂŠ&RUQHDODQG&RQMXQFWLYDO6WDLQLQ J6FDOHIRU*UDGLQJRI/LVVDPLQ H
*UHHQ6WDLQLQJ




 
 
 
 
 
6WDLQLQJDUHDV

HL036 Ophthalmic Solution 
Clinical Study Protocol HL036-DED-US-P301Sponsor: HanAll Biopharma, Co., Ltd. 
24 January 2019
Confidential Page 63
  










 
 
 
8QDQHVWKHWL]HG6FKLUPHUÂ¶V7HVW
6FKLUPHU7HDU7HVWZLOOEHSHUIRUPHGDFFRUGLQJWRWKHIROORZLQJ SURFHGXUH
x8VLQJDVWHULOH7HDU)OR6FKLUPHU WHVWVWULS5RVH(QWHUSULVHV DEHQGLQWKHVWULS
ZLOOEHPDGHLQOLQHZLW KWKHQRWFKLQWKHVWULS
x7KHVXEMHFWZLOOEHLQVWUXFWHGWRJD]HXSDQGLQ
x7KH6FKLUPHUWHVWVWULSZLOOEH SODFHGLQWKHORZ HUWHPSRUDOOL GPDUJLQRIHDFK
H\HVXFKWKDWWKHVWULSILWVWLJKWO\6XEMHFWVZLOOEHLQVWUXFW HGWRFORVHWKHLUH\HV
x$IWHUPLQXWHVKDYHHODSVHGWKH 6FKLUPHUVWULSZLOOEHUHPRYH G7KHOHQJWKRI
WKHPRLVWHQHGDUHDZLOOEHU HFRUGHGPPIRUHDFKH\H
'URS&RPI[INVESTIGATOR_13318]$VVHVVPHQWV
7KLVSURFHGXUHZLOOEHSHUIRUPHGD FFRUGLQJWR2UD,QF623VDQ GRUJXLGDQFH
GRFXPHQWV
6XEMHFW5HSRUWHG'URS&RPI[INVESTIGATOR_13318]6FDOH


HL036 Ophthalmic Solution 
Clinical Study Protocol HL036-DED-US-P301Sponsor: HanAll Biopharma, Co., Ltd. 
24 January 2019
Confidential Page 64
2UD&DOLEUDÂŠ 'URS&RPI[INVESTIGATOR_13318]6FDOH
6XEMHFW5HSRUWHG'URS&RP IRUW4XHVWLRQQDLUH


2UD&DOLEUDÂŠ'URS&RPI[INVESTIGATOR_13318]4XHVWLRQQDLUH









%ORRG6DPSOLQJIRU,PPXQRJHQLFLW\7HVWLQJ
6HUXPEORRGGUDZVZLOOEHFR OOHFWHGDW9LVLWVDQGOLPL WHGWRVXEMHFWVZLWKSRVLWLYH
UHVXOWVIURPSUHYLRXVYLVLWV RUIRULPPXQRJHQLFLW\WHV WLQJ%DVHGRQ
LPPXQRJHQLFLW\UHVXOWVIURPYLVLWVDQGVXEMHFWVPD\EH DVNHGWRSDUWLFLSDWHLQ
IROORZXSYLVLWVPRQWKVDIWHU 9LVLW,QVWUXFWLRQVIRUW KHFROOHFWLRQKDQGOLQJDQG
VKLSSLQJRIEORRGIRULPPXQRJHQLFLW \WHVWLQJDUHJLYHQLQDVHS DUDWHODERUDWRU\PDQXDO
HL036 Ophthalmic Solution 
Clinical Study Protocol HL036-DED-US-P301Sponsor: HanAll Biopharma, Co., Ltd. 
24 January 2019
Confidential Page 65
&RQMXQFWLYLWLV$(V5HSRUW)RUP
$ 3KDVH  0XOWLFHQWHU 5DQGRPL]HG 'RXEOHÂ±0DVNHG DQG 3ODFHERÂ±& RQWUROOHG 6WXG\ (YDOXDWLQJ
WKH(IILFDF\DQG6DIHW\RI+/2SKWKDOPLF6ROXWLRQ&RPS DUHGWR3ODFHERLQ6XEMHFWVZLWK'U\(\H
'DWHRI5HSRUW GGPP\\\\ 
6XEMHFWÂ¶V,'  
6XEMHFW+LVWRU\
Â‡3DVW0HGLFDO+LVWRU\ Ü†&RQMXQFWLYLWLV Ü†3ROOHQDOOHUJ\ Ü†6HDVRQDODOOHUJLF[LOCATION_006]LQRFRQMXQFWLYLWLV
,I\HVLQGLFDWHWKHODVWRFFXUUHQFHRIHDFKRIWKHDERYH PP\\\\
(YHQW,QIRUPDWLRQ
Â‡$GYHUVH(YHQW Ü†&RQMXQFWLYLWLV Ü†$OOHUJLF&RQMXQFWLYLWLV
Â‡6WDUW'DWHRI(YHQWGGPP\\\\
Â‡:KLFKH\HVLVDUHDIIHFWHG" Ü†/HIWÜ†5LJKWÜ†%RWK
Â‡&KHFNV\PSWRPVZKLFKSDWLHQWFRPSODLQHGRIRUSK\VLFLDQQRWHG
Ü†,QMHFWHGVFOHUD Ü†5HGQHVV Ü†%XUQLQJ Ü†8QXVXDOFUXVWLQJRQH\HZKHQDZDNHQLQJ
Ü†2FXODULWFKLQHVV Ü†1DVDOLWFKLQHVV Ü†6QHH]LQJ Ü†([FHVVLYHWHDULQJ
Ü†2WKHUVLJQVRUV\PSWRPV
'LGDQ\XQXVXDODFWLYLW\RUH[SRVXUHSUHFHGHWKHVWDUWRIWKLV FRQMXQFWLYLWLV" Ø»<HVØ»Í‘1R
,IVRZKDW"  
,QYHVWLJDWRUDVVHVVPHQWRIVHYHULW\" 
Ü†8QNQRZQ Ü†0LOG Ü†0RGHUDWH Ü†6HYHUH
5HODWHGQHVV 
Ü†8QOLNHO\ Ü†3RVVLEOH Ü†3UREDEOH Ü†'HILQLWH
5HDVRQZK\\RXFRQVLGHUHYHQWWREH,3UHODWHG LIDSSOLFDEOH 
$FWLRQ7DNHQ 
Ü†'UXJ&RQWLQXHG Ü†'UXJ:LWKGUDZQ Ü†1RW$SSOLFDEOH
$'LJLWDO3LFWXUHRI%RWK(\HV 
Ü†$WWDFKHGWRWKHUHSRUWIRUP
6LWH,QYHVWLJDWRU&RPPHQWV Ü†1$
3ULQWHG1DPHRI6LWH,QYHVWLJDWRU 6LJQDWXUH 'DWH$33(1',;&21-81&7,9,7,6$'9(56((9(176
5(3257)250HL036 Ophthalmic Solution 
Clinical Study Protocol HL036-DED-US-P301Sponsor: HanAll Biopharma, Co., Ltd. 
24 January 2019
Confidential Page 66
$33(1',;[ZIP_CODE]&2/$0(1'0(176800$5<
1RWDSSOLFDEOHHL036 Ophthalmic Solution 
Clinical Study Protocol HL036-DED-US-P301Sponsor: HanAll Biopharma, Co., Ltd. 
24 January 2019
Confidential Page 67
$33(1',;  6321625$1'25$$[ZIP_CODE]$/6
3URWRFRO7LWOH$3KDVH0XOWLFHQWHU5D QGRPL]HG'RXEOHÂ±0DVNHGDQG
3ODFHERÂ±&RQWUROOHG6WXG\(YDOXDWLQ JWKH(IILFDF\DQG6DIHW\RI
+/2SKWKDOPLF6ROXWL RQ&RPSDUHGWR3ODFHERLQ
6XEMHFWVZLWK'U\(\H
3URWRFRO1XPEHU
)LQDO'DWH+/'('863
-DQ
7KLVFOLQLFDOVWXG\SURWRFROZDV VXEMHFWWRFULWLFDOUHYLHZDQG KDVEHHQDSSURYHGE\WKH
VSRQVRU7KHIROORZLQJSHUVRQQH OFRQWULEXWHGWRZULWLQJDQGRU DSSURYLQJWKLVSURWRFRO
6LJQHG 'DWH
3URGXFWDQG%XVLQHVV'H YHORSPHQW+DQ$OO
6LJQHG 'DWH

93'U\(\H2UD,QF
6LJQHG 'DWH

2UD,QF
6LJQHG 'DWH
3URGXFWDQG%XVLQHVV'H YHORSPHQW+DQ$OO
6LJQHG 'DWH

&OLQLFDO3URMHFW0DQDJHU2UD,QF
6LJQHG 'DWH

3ULQFLSDO5HVHDUFK% LRVWDWLVWLFLDQ6'&
6LJQHG 'DWH

0HGLFDO0RQLWRUHL036 Ophthalmic Solution 
Clinical Study Protocol HL036-DED-US-P301Sponsor: HanAll Biopharma, Co., Ltd. 
24 January 2019
Confidential Page 6807Feb201907Feb2019
$33(1',;  6321625$1'25$$[ZIP_CODE]$/6
3URWRFRO7LWOH$3KDVH0XOWLFHQWHU5D QGRPL]HG'RXEOHÂ±0DVNHGDQG
3ODFHERÂ±&RQWUROOHG6WXG\(YDOXDWLQ JWKH(IILFDF\DQG6DIHW\RI
+/2SKWKDOPLF6ROXWL RQ&RPSDUHGWR3ODFHERLQ
6XEMHFWVZLWK'U\(\H
3URWRFRO1XPEHU
)LQDO'DWH+/'('863
-DQ
7KLVFOLQLFDOVWXG\SURWRFROZDV VXEMHFWWRFULWLFDOUHYLHZDQG KDVEHHQDSSURYHGE\WKH
VSRQVRU7KHIROORZLQJSHUVRQQH OFRQWULEXWHGWRZULWLQJDQGRU DSSURYLQJWKLVSURWRFRO
6LJQHG 'DWH
3URGXFWDQG%XVLQHVV'H YHORSPHQW+DQ$OO
6LJQHG 'DWH

93'U\(\H2UD,QF
6LJQHG 'DWH

'LUHFWRU'U\(\H2UD,QF
6LJQHG 'DWH
3URGXFWDQG%XVLQHVV'H YHORSPHQW+DQ$OO
6LJQHG 'DWH

&OLQLFDO3URMHFW0DQDJHU2UD,QF
6LJQHG 'DWH

3ULQFLSDO5HVHDUFK% LRVWDWLVWLFLDQ6'&
6LJQHG 'DWH

0HGLFDO0RQLWRUHL036 Ophthalmic Solution 
Clinical Study Protocol HL036-DED-US-P301Sponsor: HanAll Biopharma, Co., Ltd. 
24 January 2019
Confidential Page 6807Feb201907Feb2019
$33(1',;  ,19(67,*$725Â¶66,*1$785(
3URWRFRO7LWOH
3URWRFRO1XPEHU
)LQDO'DWH$3KDVH0XOWLFHQWHU5D QGRPL]HG'RXEOHÂ±0DVNHGDQG
3ODFHERÂ±&RQWUROOHG6WXG\(YDOXDWLQJWKH(IILFDF\DQG6DIHW\RI+/2SKWKDOPLF6ROXWL RQ&RPSDUHGWR3ODFHERLQ
6XEMHFWVZLWK'U\(\H+/
+/'('863-DQ
,DJUHHWRLPSOHPHQWDQGFRQGXFW WKHVWXG\GLOLJHQWO\DQGLQVW ULFWFRPSOLDQFHZLWKWKH
SURWRFROJRRGFOLQLFDOSUDFWLFHV DQGDOODSSOLFDEOHODZVDQGU HJXODWLRQV,DJUHHWR
PDLQWDLQDOOLQIRUPDWLRQVXSSOLH GE\2UDDQGWKHVSRQVRULQFRQ ILGHQFHDQGZKHQWKLV
LQIRUPDWLRQLVVXEPLWWHGWRDQ,Q VWLWXWLRQDO5HYLHZ%RDUG,5% (WKLFDO5HYLHZ
&RPPLWWHH(5&RUDQRWKHUJURXS LWZLOOEHVXEPLWWHGZLWKDG HVLJQDWLRQWKDWWKH
PDWHULDOLVFRQILGHQWLDO
,KDYHUHDGWKLVSURWRFROLQLWV HQWLUHW\LQFOXGLQJWKHDERYH VWDWHPHQWDQG,DJUHHWRDOO
DVSHFWV
6LJQHG 'DWH
HQWHUQDPHDQGFUHGHQWLDOV!
HQWHUWLWOH!HQWHUDIILOLDWLRQ!HQWHUDGGUHVV!HQWHUSKRQHQXPEHU!HL036 Ophthalmic Solution 
Clinical Study Protocol HL036-DED-US-P301Sponsor: HanAll Biopharma, Co., Ltd. 
24 January 2019
Confidential Page 69